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Six electronic databases were searched and 153 studies which identified the number 
or the rate of paediatric medication errors were identified; mainly from the US. These 
studies were compared to identify factors responsible for the great variations seen in 
reported error rates (Chapter 2). The most important factors were the use of different 
denominators, different definitions of medication errors, and the use of different 
methods of data collection.  
 
To explore further the reasons for the wide ranges of error rate identified in Chapter 2, 
the studies that used the same denominators, methods, and error types were compared, 
yet showed a difference between the highest and lowest error rate of more than 50% 
(Chapter 3). Factors identified for the variation in error rates included differences in 
setting, drugs studied, participants, study design details and countries involved. 
 
To try to clarify the relationship between the method of data collection and results 
obtained (Chapter 3), the rates of specific types of medication errors reported by 
studies using different methods but the same denominator were compared. 
Conclusions were difficult to draw due to the heterogeneity of the current literature. 
Prescription errors are probably best studied using chart review and administration 
errors by direct observation. 
 
The relationship between the clarity of definitions and results was investigated in 
Chapter 3, in terms of how clearly the studies had defined errors and the degree to 
which the definition(s) used PDWFKHG HDFK VWXG\¶V DLP Studies were too 
heterogeneous and unfortunately could not adequately be compared. 
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Chapter 3 also explores the interventional tools reported. Of all studies, 59 used 
interventional tools and assessed their benefit. These included dosing supporting 
tools, electronic prescribing, education, health and safety strategies, clinical 
pharmacist services and pre-printed forms among others. Most studies reported that 
their interventions effectively reduced or prevented medication errors, despite in some 
cases not measuring errors before and after interventions and even in some studies 
where error rates increased.  
 
Chapter 3 also explores the UK studies. Very few studies occurred in the same 
setting and used both the same methodology and denominators to identify the rate of 
the same types of medication errors. It was difficult to draw firm conclusions but 
prescribing and administration errors seem to happen more often in paediatric units in 
JHQHUDO KRVSLWDOV WKDQ LQ VSHFLDOLVW FKLOGUHQ¶V KRVpitals. Most studies were of 
prescribing errors with other types of error rarely studied in the UK.  
 
Four studies identified the time of day most associated with errors; three the time of 
day and days of the week most associated with errors; and one the days of the week 
most associated with errors (Chapter 3). However, given the diversity of definitions 
of times of day, shifts, and weekdays, it was impossible to draw conclusions regarding 
the temporal aspect of medication errors from these studies.  
 
A second systematic review was conducted to explore the current literature that 
examines the role of paediatric clinical pharmacists in reducing the rate of medication 
errors (Chapter 4). Twenty-five studies published until the end of July 2013 were 
identified WKDW UHSRUWHG SKDUPDFLVWV¶ activities in reducing or preventing medication 
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errors. The most commonly intercepted types of errors were wrong dose, wrong drug 
and wrong route of administration. The most common types of SKDUPDFLVWV¶ 
contributions were reactive information giving in response to other healthcare 
SURIHVVLRQDOV¶TXHULHVeducation of healthcare professionals and cost saving. 
 
Based on knowledge gained from the second systematic review, an observational 
study of the role of paediatric clinical pharmacists was conducted in two NHS Trusts 
in the UK (Chapter 5). By shadowing pharmacists, they were observed during their 
day-to-day work and their contributions to health care were documented, as well as 
the errors that they identified and addressed. Having ultimately shadowed 14 
pharmacists over the course of 197 ward visits, clinical pharmacists were found to 
play an important role in improving the health care services provided to paediatric 
patients and are effective in averting different types of medication errors. Pharmacists 
intercepted errors in 8.4% of all prescriptions and the overall contribution rate of all 
prescriptions was 54.8%. The most common types of errors intercepted by 
pharmacists were omission errors (27.9%), wrong dose (24%) and illegible 
prescribing (19.2%). The most common types of contributions were annotating 
prescriptions with information (e.g. administration instructions) (19.2% of all 
prescriptions), drug history check (97% of all new patients) and allergy status checked 
(100% of all new patients). The acceptance rate of SKDUPDFLVWV¶UHFRPPHQGDWLRQVE\
doctors was very high (99.5%). 
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&KDSWHU,QWURGXFWLRQ 
Medications are used generally to help improve health and decrease morbidity and 
mortality (1). There is an undoubtedly positive effect of using medications for treating 
and preventing diseases, but only if they are used safely and effectively. Improving 
patient health is an important goal to be achieved by healthcare facilities which can be 
improved by preventing medication errors (2). Medication errors comprise the largest 
portion of all types of medical errors (3). Medication errors might occur at any stage 
of therapeutic management (4). This involves the prescribing, transcribing, 
dispensing, preparing and administering, monitoring and documentation of 
medications and patients (4, 5). According to these stages, all healthcare providers 
taking part in therapeutic management may be involved in medication errors. It is 
important to find solutions to decrease harmful and potentially deadly errors (6). 
 
Medication errors in general are an important topic to address, particularly with 
regard to the paediatric patient (7). Information regarding preventative strategies and 
detection tools is more commonly available for adult patients than paediatric patients 
(8). Medication errors are internationally recognised, and the challenge is more 
common in paediatric patients because they are at a greater risk of harm from 
medication errors than adult patients (9). Therefore, my thesis will look at the 
different aspects of medication errors with regard to children. 
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1.1. %DFNJURXQG 
Despite using medications effectively and safely, adverse drug events (ADEs) cannot 
always be prevented.  Adverse drug reactions (ADRs) may occur (1). These are called 
non-preventable ADEs (1). These events are not caused by human mistakes but rather 
by the drugs themselves (1). Preventable A'(VLQFOXGLQJ³PHGLFDWLRQHUURUV´IROORZ
human mistakes (1). Medication errors, if they are intercepted before reaching the 
SDWLHQWV DUH FDOOHG ³QHDU PLVVHV´ RU ³SRWHQWLDO $'(V´ (10, 11). These also include 
medication errors which reached the patient but did not cause harm. Medication errors 
can be prevented, and most of them do not cause harm (11-13). Figure 1.1 illustrates 
the relationship between ADEs and medication errors. 
 
 
Figure 1.1.: Relationship between preventable and non-preventable ADEs. 
 
 
 
 
 
 
 
 
Adapted from Kaushal et al. (2002) (11). 
 
 
Adverse drug events (ADEs) 
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The Institute of Medicine (IOM) in the US focused on issues related to patient safety 
DQG SXEOLVKHG D UHSRUW ³7R HUU LV +XPDQ %XLOGLQJ D 6DIHU +HDOWK 6\VWHP´ ZKLFK
discussed the high mortality and morbidity rates resulting from medical errors (3). 
7KH FRQFHUQ IRU SDWLHQWV¶ VDIHW\ LQ JHQHUDO DQG PHGLFDWLRQ HUURUV LQ SDUWLFXODU KDV
clearly increased since the publication of this report in 1999 (14). The IOM 
recommends focusing on providing the correct treatment, instead of blaming people 
(3). They UHSRUWHGWKDW³,WPD\EHSDUWRIKXPDQQDWXUHWRHUUEXW LW LVDOVRSDUWRI
human nature to create solutions, find better alternatives and meet the challenges 
DKHDG´(3). 
1.2. 'HILQLWLRQVRIPHGLFDWLRQHUURUV 
Terminology around the subject of medication errors can be confusing with numerous 
definitions having been used. Some examples are given below: 
 
x ,DWURJHQLF HYHQW ³$Q\ HYHQW WKDW RFFXUUHG GXULQJ KRVSLWDOL]DWLRQ WKDW
FRPSURPLVHGWKHVDIHW\RIWKHSDWLHQWHYHQLIWKHSDWLHQWZDVQRWKDUPHG´(15). 
x ADEs³$QLQMXU\UHVXOWLQJIURPPHGLFDOLQWHUYHQWLRQUHODWHGWRDGUXJ´(16). 
x 0HGLFDOHUURUV³$OOHUURUV WKDWRFFXUZLWKLQ WKHKHDOWKFDUHV\VWHPLQFOXGLQJ
mishandled surgery, diagnostic errors, equipment failures, and medication 
HUURUV´(17). 
x MHGLFDWLRQ HUURU ³$Q\ SUHYHQWDEOH HYHQW WKDW PD\ FDXVH RU OHDG WR
inappropriate medication use or patient harm while the medication is in the 
control of the health care professional, patient, or consumer. Such events may 
be related to professional practice, health care products, procedures, and 
systems, including prescribing; order communication; product labelling, 
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packaging, and nomenclature; compounding; dispensing; distribution; 
DGPLQLVWUDWLRQHGXFDWLRQPRQLWRULQJDQGXVH´(18). 
x Medication error ³$ PLVWDNH PDGH DW DQ\ VWDJH LQ WKH SURYLVLRQ RI D
SKDUPDFHXWLFDOSURGXFWWRDSDWLHQW´(19). 
x MHGLFDWLRQ HUURU ³$Q\ HUURU LQ WKH PHGLFDWLRQ XVH SURFHVV LQFOXGLQJ GUXJ
RUGHULQJWUDQVFULELQJGLVSHQVLQJDGPLQLVWHULQJRUPRQLWRULQJ´(5). 
 
1.2.1. Problems associated with definitions 
In the previous studies on this topic no authoritative definition for medication error 
has emerged (17, 20). Consequently; results unsurprisingly will differ from one study 
to another, according to the definitions used. In a systematic literature review by 
Ghaleb et al. (2006) to identify the rate of medication errors in paediatric patients; it 
was found that some studies identified a rate of medication error without stating 
whether any definition was used and some studies used more than one definition to 
clarify different types of medication errors, e.g. a prescribing error (17).  
 
Different types of medication errors are considered in some studies and not in others; 
making studies difficult to compare in terms of the rate of errors identified (17). 
Ghaleb et al. pointed out that most definitions for medication errors considered adult 
patients, without considering some important issues related to children, such as 
GRFXPHQWLQJSDWLHQWV¶ZHLJKWVDQGXVLQJXQOLFHQVHGDQGRII-label drugs (17). 
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In a systematic literature review by Lisby et al. (2010) to identify definitions used for 
medication errors, it was found that 45 definitions appeared in 203 studies (of which, 
17 used the National Coordinating Council for Medication Error Reporting and 
3UHYHQWLRQ¶V 1&&-MERP) definition from the US) (20). The studies used different 
methods and different study designs, involved different populations and different 
ages, provided results using different denominators and were conducted in different 
settings in nine different countries (20). The authors stated that results cannot be 
summarised due to differences in methods and outcome measures (20). They also 
stated that the prevalence of medication error cannot be determined from studies 
which obtained their results from reporting systems, interview and questionnaires as 
there are no baseline data available to put the results into contexts (20).  
 
Lisby et al found no relationship between definitions used and prevalence of 
medication errors in the studies identified. They stated that there is a need for 
standardised methods and a clear definition, using clear terminology to avoid wrong 
explanations and to provide an accurate rate of medication error. They concluded that 
as more types of errors are considered in definitions, this will lead to an increase in 
the rate of medication errors identified (20). 
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1.3. &ODVVLILFDWLRQRIPHGLFDWLRQHUURUV 
Medication errors have been classified according to the stages of therapeutic 
management, degree of harm caused and a psychological approach. According to the 
stages of therapeutic management; errors can be classified into five types: prescribing, 
transcribing, dispensing, preparing and administering, and monitoring of medications 
and patients (5). According to the degree of harm caused; errors can be classified into 
five types: no harm, low harm, moderate harm, severe harm and death (21). Table 1.1 
shows the definitions according to the degree of harm used by the UK National 
Patient Safety Agency (NPSA). 
 
Table 1.1: Classifications of medication errors according to the degree of harm caused 
Degree of harm Definition by National Patient Safety Agency 
No harm Impact prevented: any patient safety incident that had the 
potential to cause harm but was prevented, resulting in no harm 
to the person(s) receiving NHS-funded care. 
No harm Impact not prevented: any patient safety incident that ran to 
completion but no harm occurred to the person(s) receiving 
NHS-funded care. 
Low harm Any patient safety incident that required extra observation or 
minor treatment, and caused minimal harm to the person(s) 
receiving NHS-funded care. 
Moderate harm Any patient safety incident that resulted in a moderate increase 
in treatment, and which caused significant but not permanent 
harm to the person(s) receiving NHS-funded care. 
Severe harm Any patient safety incident that resulted in permanent harm to 
the person(s) receiving NHS-funded care. 
Death Any patient safety incident that directly resulted in the death of 
the person(s) receiving NHS-funded care. 
Adapted from the UK National Patient Safety Agency (21). 
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Using a psychological approach; medication errors have been classified into two types 
of error: mistakes and skill based errors (Table 1.2) (22).  
 
Table 1.2: Classifications of medication errors according to the psychological 
approach 
Type of error Explanation Classifications 
Mistakes Errors resulting from 
applying wrong plans. 
 Knowledge based. 
 Rule based (applying the rule 
incorrectly or applying the wrong 
rule). 
Skill based 
 
Errors resulting from 
applying right plans 
wrongly. 
 Memory based (forgetfulness or 
inattention). 
 Incorrect performance or poor 
technical skill. 
Adapted from Ferner et al. (2006) (22). 
 
1.3.1. Prescribing Errors 
One definition is³$FOLQLFDOO\PHDQLQJIXOSUHVFULELQJHUURURFFXUVZKHQDVDUHVXOW
of a prescribing decision or prescription writing process, there is an unintentional 
significant reduction in the probability of treatment being timely and effective or 
LQFUHDVHLQWKHULVNRIKDUPZKHQFRPSDUHGZLWKJHQHUDOO\DFFHSWHGSUDFWLFH´(23). 
These errors can involve incomplete prescriptions, wrong drug, dose, frequency, rate 
of infusion, route of administration, quantity, patient, transcribing, not considering 
LPSRUWDQW LVVXHV VXFK DV SDWLHQWV¶ ZHLJKW ZURQJ LQGLFDWLRQ RU SUHVFULELQJ
contraindicated drugs (24-26). The cause of medication error may sometimes be 
related to the clinical situation, e.g. a medication error could result from giving a 
regular dose of chemotherapy to a patient with a low neutrophil count instead of 
adjusting the dose according to the neutrophil count (27). 
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It has been suggested, that doctors should increase their knowledge of drugs used for 
paediatric patients and to consider drug interactions FRQWUDLQGLFDWLRQV SDWLHQWV¶
allergy and weight; and to make sure all this information is documented clearly and 
DFFXUDWHO\RQSDWLHQWV¶FKDUWV(28). 
 
Tenfold errors are commonly seen in paediatric patients (e.g. 5 mg prescribed instead 
of 0.5) (29, 30). Tenfold errors can lead to death, especially with low therapeutic 
index drugs (29). It has been recommended for doctors to write down each step of a 
calculation and thereafter get this double checked by other healthcare providers (28). 
 
Prescribing errors happen as a result of several different factors. Of these some are 
related to healthcare providers, some to the surrounding environment and some to the 
medication treatment process. The following factors may contribute to prescribing 
errors (25): 
x Insufficient knowledge of medications prescribed, accurate doses and essential 
information about patients, such as allergies. 
x Illegible handwriting. 
x History including wrong medications being taken. 
x Confusion in names of medications. 
x Calculation mistakes, leading to tenfold errors in some situations. 
x Use of inappropriate or unclear abbreviations (Table 1.3 illustrates examples of 
some dangerous abbreviations). 
x Ordering medication verbally. 
x Insufficient training. 
x Lack of awareness of errors. 
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x Work environment and workload. 
x Poor communication with other healthcare providers. 
x Look-Alike-Sound-Alike (LASA) errors (Table 1.4 illustrates examples of drugs 
associated with LASA errors) 
 
Table 1.3: Abbreviations associated with medication errors 
Abbreviation Common Error 
U (Unit) Read as 0 or 4. 
µg (Micrograms) Read as mg. 
SC or SQ (Subcutaneous) Read as SL (Sublingual). 
TIW (Three Times a Week) Read as TID (Three Times a Day). 
IU (International Unit) Read as IV (Intravenous) OR result in 
administration of large quantities e.g. 81 U 
instead of 8 IU. 
.5 (0.5) Read as 5 e.g. 5 ml or 5 mg 
Adapted from the National Coordinating Council for Medication Error Reporting and 
Prevention (18). 
 
 
Table 1.4: Examples of drugs associated with LASA errors. 
Drug name  Confused drug name 
Aminophylline Amitriptyline 
Amoxicillin Ampicillin 
Erythromycin Azithromycin 
Cefotaxime Cefuroxime 
Penicillamine Penicillin 
Cyclosporin Cycloserine 
Azithromycin Erythromycin 
Bisacodyl Bisoprolol 
Humulin® Novolin® 
Zantac® Zyrtec® 
Adapted from Derby Hospitals NHS Foundation Trust Formulary (31). 
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Many procedures have been recommended to minimise errors during the prescribing 
process. These include: 
1. Clear and effective communications with other healthcare providers (31). 
2. Completing prescriptions with all required information, and identifying drug 
allergy (31, 32). 
3. Using generic names (31). 
4. Avoiding abbreviations (of drug names, dosage units and instructions), verbal 
orders, unclear instructions and use of trailing zeroes (31, 32). 
5. Making sure all drug related information is provided clearly, e.g. strengths, 
frequency, dose, volume and route of administration (32). 
6. Use of reliable equipment (such as electronic prescribing) to help in increasing the 
safety of medication delivery, reduce time spent and avoiding risks such as 
calculation errors (28). 
7. (QVXULQJ FRUUHFW FDOFXODWLRQV DQG SDWLHQWV¶ ZHLJKW GXULQJ SUHVFULELQJ GUXJV WR
children (32). 
8. Hospital environment should be quiet and safe to avoid errors (32). 
9. Healthcare professionals should be qualified and have an adequate level of training 
and education (28). 
10. Prescribers should update their information regarding paediatric diseases and 
medications and to ensure that prescriptions are written correctly and safely (32). 
11. Prescribers should use all available sources of information, including pharmacists, 
about medications if required (32). 
12. Prescribers should know the hospital systems for prescribing drugs and current 
drugs used by patients (32). 
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13. Prescribers should provide patients with information related to their medications 
(32). 
14. Non-punitive reporting systems should be provided in the hospital, and healthcare 
providers should be encouraged to report all incidents (28, 32). 
15. Barriers to reporting incidents should be considered and healthcare providers 
should understand the importance of reporting incidents to learn from these events 
and to avoid such events in future (28). 
16. LASA drugs showed be reviewed regularly, limit verbal orders and healthcare 
providers should be educated about their risks (33).  
 
1.3.1.1. Junior doctors and trainees 
In a study at a UK teaching hospital, Dean et al. 2002 found that junior doctors are 
responsible for the majority of prescribing and also the majority of prescribing errors 
(12). Doctors just graduating from medical school often feel that they are not ready to 
start prescribing and have emphasised the need for further education on accurate and 
safe prescribing for patients of all ages (34). The rate of prescribing error amongst 
foundation trainees has been shown to be 7% of medicine orders (52 errors per 100 
admissions) (35). 
 
1.3.1.2. Unlicensed and off-label drugs 
Using unlicensed and off-label drugs for children has been suggested to increase the 
incidence of errors because of the need for calculating the dose and the need for 
manipulating the medicine (36) &RQUR\¶V  VWXG\ LQ D UK paediatric hospital 
found that unlicensed drugs are associated with more medication errors and greater 
harm to children than other medications (37). It has been estimated that 46-65% of all 
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paediatric prescriptions are either unlicensed or off-label (38, 39). Payne et al. (2007) 
suggested that when doctors prescribe off-label drugs, they need to apply their 
understanding of pharmacokinetics and pharmacodynamics in addition to their 
experience as a prescriber to these drugs (40). It has been estimated that around 75% 
RI FKLOGUHQ¶V PHGLFDWLRQV KDG QRW EHHQ VWXGLHG VXIILFLHQWO\ GHVSLWH WKH
encouragHPHQWRI IHGHUDO OHJLVODWLRQ WRGRPRUH VWXGLHV LQWR FKLOGUHQ¶VPHGLFDWLRQV
(41). 
 
1.3.2. Dispensing errors 
A dispensing error has beeQGHILQHGDV³$Q\GHYLDWLRQIURPWKHPHGLFDOSUHVFULSWLRQ
LQGLVSHQVLQJPHGLFDWLRQ´ (42). Errors can occur in all stages of dispensing starting 
from receiving prescriptions through to supplying drugs (3, 25). Errors may include 
the wrong dose, drug, concentration, dosage form and patient; missing doses; 
omission of drugs, dispensing expired medications and medications being stored 
inappropriately (25, 42). Typing errors may occur during computerised labelling and 
cause error (e.g. typing wrong drug name, patient name, dose, dosage form, quantity, 
instruction; wrong selection of drugs and selecting a wrong drug saved on the patient 
medical record) (25, 42-44). 
 
Dispensing errors have many contributing factors such as (44): 
x Similarity in drug names and containers (LASA drugs). 
x Poor handwriting. 
x Unclear prescriptions and direction. 
x Interruptions, not concentrating, noise and poor light. 
x Workload. 
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x Poor communication. 
x Poor dispensing procedures. 
x Lack of experience, training or knowledge. 
x Systems used such as labelling computer programs. 
x Continuous work without taking break, working alone, hunger, fatigue and 
stress. 
x Not following guidelines. 
x Drugs on shelves not arranged correctly. 
 
The following steps have been advised when pharmacy staff deal with medications, 
patients and other healthcare professional: 
1. Following the right steps during dispensing (25). 
2. Dealing more carefully with LASA drugs and drugs associated with errors (such 
as potassium chloride, heparin and insulin) (25, 32). 
3. Ensuring separating LASA drugs when storing medications (25). 
4. Working in a quiet place to avoid disruptions (32). 
5. Working in an organised and suitable place (32). 
6. Ensuring correct transcribing of prescriptions (45). 
7. Checking medications against correct times, drug interactions and duplication 
(46). 
8. Checking that prescriptions and labels are correct and fully completed (45). 
9. Taking care with calculations and abbreviations (45). 
10. Reducing workload and stress (45). 
11. Arranging and storing medications safely (45). 
12. Double check before issuing to the patient (45). 
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13. Discussing medication prescribed with the patient (32). 
14. Discussing with prescribers for confusing medications (32). 
15. &KHFNLQJSDWLHQWV¶DOOHUJ\EHIRUHGLVSHQVLQJ(46). 
16. More reliable equipment (such as barcode technology) should be provided to help 
in increasing safety, reduce time spent and avoiding some risks such as calculation 
errors (28). 
17. Non-punitive reporting systems should be in operation, and healthcare providers 
should be encouraged to report all incidents (28, 32). 
18. Barriers to reporting incidents should be considered and healthcare providers 
should understand the importance of reporting incidents to learn from these events 
and to avoid such events in future (28). 
 
1.3.3. Preparation and administration errors 
$PHGLFDWLRQDGPLQLVWUDWLRQHUURUKDVEHHQGHILQHGDV³7KHDGPLQLVWUDWLRQRIDGRVH
of medication that deviates from the prescription, as written on the patient medication 
chart, or from standard hospital policy and procedures. This includes errors in the 
SUHSDUDWLRQ DQG DGPLQLVWUDWLRQ RI LQWUDYHQRXV PHGLFLQHV RQ WKH ZDUG´ (24). 
Medication administration errors can cause more harm to patients than any other 
stages of therapeutic management, as being the final step are difficult to prevent (47).  
 
Nurses and other healthcare professionals DUHUHTXLUHGWRFRQVLGHUWKH³)LYH5LJKWV´
(right dose, drug, patient, time and route) (25). The administration of drugs by the 
wrong route may lead to death (e.g. administering certain cytotoxic drugs such as 
vincristine intrathecally) (25). Administration errors can also include the omission of 
doses (more common), the administration of wrong or expired drugs, wrong rate of 
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administration, wrong time, wrong dose, wrong patient, wrong preparation or 
administration technique (24, 25). 
 
Many things may contribute to administration errors including (25): 
x Lack of knowledge of the risks associated with the administration process. 
x Lack of knowledge of the right technique for administering and preparing 
medications. 
x The complexity of equipment used for preparing or administering medications. 
x Environmental issues, such as poor light or noise, and interruptions. 
x ,JQRULQJRUIRUJHWWLQJWRFKHFNSDWLHQWV¶LGHQWLW\ 
x Storing medication with similar appearance in one place. 
 
PURFHGXUHVVXJJHVWHGWRLPSURYHSDWLHQWV¶VDIHW\DQGGHFUHDVHKDUPUHODWHGWR wrong 
administration technique include: 
1. &KHFNLQJSDWLHQWV¶LGHQWLWLHVWRHQVXUHWKDWWKHULJKWGUXJVDQGGRVHVDUHGHOLYHUHG
to the right patients (25). 
2. Ensuring medications are checked against the medication administration record 
(46). 
3. Checking all prescribed medications, allergy status and past medication history 
(32). 
4. Double check calculations with another healthcare professional before 
administering (32). 
5. Working in a quiet and suitable place (25). 
6. Decreasing interruptions during doing any task (25). 
7. Familiarity with all equipment used for delivering medications (32). 
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8. Nurses being required to discuss with prescribers any confusing issues before 
administering medications (32). 
9. More reliable equipment may help in increasing safety, reduce time spent and 
avoiding some risks (28). 
10. Non-punitive reporting systems should be in operation, and healthcare providers 
should be encouraged to report all incidents (28, 32). 
11. Barriers to reporting incidents should be considered and healthcare providers 
should understand the importance of reporting incidents to learn from these events 
and to avoid such events in future (28). 
 
Parents and other caregivers may also contribute to administration errors. Poor health 
literacy and using a cup for measuring doses have been suggested to be the most 
common reasons for administration errors by parents (48). It is also known that using 
a kitchen spoon for liquid medications is associated with administration errors by 
parents (49, 50). The volume that can be measured by different spoonfuls ranges from 
1.5 to 9 ml, which can lead to error if the wrong spoon is used (51, 52). Misreading 
and misunderstanding medication labels by caregivers has also led to overdose (53). 
Despite all these recommendations for reducing errors at different stages of the 
medication management process, errors continue to occur. 
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1.4. 0HWKRGVXVHGWRLGHQWLI\PHGLFDWLRQHUURUV 
Various methods have been used to identify medication errors including: 
x 5HYLHZRISDWLHQWV¶FKDUWV(54). 
x Direct observation of care provided to patients (54). 
x Incident reporting systems (54). 
x Analysing urine samples to detect omitted and unauthorised medications (54). 
x Analysing doses returned to pharmacy (54). 
x Review of medical malpractice claim files (55). 
x Analysis and comparing administration data with prescriptions (54). 
x Mortality certificate reviews (54). 
The first three methods are most used and are discussed a little more below: 
1.4.1. Chart review 
This method is most commonly used for detecting medication errors, mainly 
prescribing errors (20). Underestimation of other types of errors is a problem with 
chart review (20). Chart review is also time consuming (56). Electronic Medical 
Records (EMRs) (if available) can be searched and reviewed to obtain the required 
data instead of reviewing charts (57). 
1.4.2. Direct observation 
This method is the most common method used for detecting dispensing and 
administration errors (20). Direct observation is a valuable method but is more 
expensive than other methods due to resources and time needed (54). Direct 
observation is usually not blind and participants know that their performances will be 
evaluated and this therefore may affect the accuracy of results (55). Poor reception by 
healthcare providers, such as nurses, has been noted (58). 
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1.4.3. Reviewing of incident reports 
Many hospitals have an incident reporting system whereby all medication error 
incidents are reported. Reviewing incident reports does not measure the rate of 
medication error but gives an overview of the different types and nature of errors that 
occurred (17). The method provides less information about medication errors than 
chart review and direct observation methods (20).  
 
In an incident report system, potentially relatively few errors will be reported (58). 
Typically, a poor reporting rate is seen because healthcare providers may be afraid of 
punishment or claims (54, 59-61). Low levels of reports may mean either that health 
care providers believe that the errors are not serious enough to be documented or that 
they did not recognise that medication errors had occurred (62). 
 
The IOM stated that the reporting system is a valuable key to decrease the incidence 
of medication error, as it helps health care providers to learn from previous committed 
errors (3). A compulsory reporting system usually provides information about serious 
errors and death, whereas a voluntary reporting system may also provide information 
about potential errors such as near misses (63). 
 
Using an anonymous reporting system in conjunction with safety strategies was found 
by Taylor et al. (2007) to increase the rate of reporting incidents by 54% in a 
paediatric hospital in the US (58). A non-punitive, continuous, anonymous and 
prospective reporting system was found, by Ligi et al. (2010), to be very effective in 
decreasing the rate of medication error and improving patieQWV¶ VDIHW\ LQDQHRQDWDO
centre in France (15). One example is MEDMARX, which is a US database accessed 
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on the Internet to report medication errors (64). This system was established by the 
United States Pharmacopeia (USP) in 1998 (6). The National Reporting and Learning 
Service (NRLS), part of the work of the National Patient Safety Agency in the UK; 
also collects and reviews incident reports from different healthcare sectors (65). The 
NRLS was established in 2001 and any healthcare professional can report any 
incident by filling an online report (65). Many studies have retrieved incident reports 
from MEDMARX and the NRLS and then performed analysis. 
 
Incident reporting has its limitations including inability to identify the rate of errors 
(because the total number of prescriptions is unknown), the reporters may be 
unknown, reports are often are not completed either at all or completely, and nobody 
checks the accuracy of these reports (66). 
 
1.5. 3DHGLDWULFSDWLHQWVDQGPHGLFDWLRQHUURUV 
Ghaleb et al. (2006) stated that many studies have aimed to identify the rate of 
medication errors for adults but the information obtained regarding paediatric patients 
is not enough (17). The rate of medication errors was identified by Kaushal et al. 
(2001) to be similar in both adult and paediatric patients. However, the rate of 
potentially harmful errors was three times higher in paediatric than adult patients (9). 
 
Many factors should be taken into consideration when calculating a dose for children, 
including their age, weight, body surface area and illness (67). Paediatric patients are 
more vulnerable to errors than adults because most doses must be calculated on an 
individual basis (67). The GRVH PXVW EH FDOFXODWHG GHSHQGLQJ RQ WKH SDWLHQW¶V DJH
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(sometimes gestational age), weight or surface area (9). When treating paediatric 
patients, it is also necessary to consider the differences in their pharmacokinetics and 
pharmacodynamics (9). Furthermore, small children cannot communicate effectively 
and, consequently, cannot complain about side effects (68). 
 
Sometimes medications designed for adults must be used for children due to a lack of 
suitable alternatives. These may need manipulation or to be diluted before being given 
to children, which may lead to errors (9). Since 2007, in accordance with the 
European regulation for paediatric medications; all applications for licenses for new 
paediatric medications must include suitable formulations for children and involve 
studies that prove efficacy and safety of these medications in paediatric patients (69). 
Following these regulations may eventually provide effective treatment for children 
using safe medications and dosage forms which may subsequently reduce paediatric 
medication errors. 
 
1.6. 1HRQDWDOSDWLHQWVDQGPHGLFDWLRQHUURUV 
Neonates may suffer from greater medication error rates than other patients because, 
in addition to the paediatric challenges, their organs responsible for absorption or 
excretion are not yet mature (70). Moreover, their weight and renal function can 
change quickly, and doses must be regularly recalculated accordingly (70). 
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1.7. 3UHYDOHQFHRIPHGLFDWLRQHUURUVLQSDHGLDWULFSDWLHQWV 
The IOM stated in one report published in 1999 that medication errors are responsible 
annually for 7,000 deaths in the US for patients of all ages (3). Because of the various 
denominators used, the results for medication errors from different studies are 
difficult to compare (20). The incidence of medication errors in children differs 
widely from one study to another, depending on the methods, definitions and 
classifications used (17, 20, 71). 
 
1.7.1. Types of medication errors mostly associated with paediatric 
patients 
Wrong dose has been suggested to be the most common type of error (17). Other 
types of errors involve wrong drug, route of administration, documentation, date, 
IUHTXHQF\ RI DGPLQLVWUDWLRQ SDWLHQWV QRW FRQVLGHULQJ SDWLHQWV¶ DOOHUJ\ GUXJ
interaction, not considering intravenous compatibility, omission and wrong rate of 
infusion (17). 
 
1.7.2. Drugs mostly associated with medication errors in paediatric 
patients 
Antibiotics and sedatives have been noted as the drug groups most associated with 
medication errors (17). The reason why these groups of drugs are associated with 
more errors may be because these drug groups are more commonly prescribed (17). 
The most common route of administration associated with error is the intravenous 
route (17). In general, errors associated with intravenous administration are 
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considered to be serious by healthcare providers and it may be that, these errors are 
reported more often (17). 
 
Narrow therapeutic index medications are more associated with harm from 
medication errors than other medications (17). LASA errors were less frequent than 
other types of medication errors in a study conducted by Basco et al. (2010) from 
paediatric emergency departments in the US (72). 
1.7.3. The time of day most commonly associated with medication 
errors in paediatric patients 
Studies by Selbst et al. 1999 in DVSHFLDOLVWFKLOGUHQ¶VKRVSLWDOLQWKH86 and by Kozer 
et al. 2002 in a paediatric emergency department in Canada identified a higher 
percentage of errors during the evening and at night, as compared to daytime (73, 74). 
However, one study conducted by Lerner et al. (2008) in a neonatal intensive care unit 
in Brazil found that 64% of all errors occur during the daytime (75). In another US 
study by Miller et al. (2010) in a tertiary care paediatric hospital aiming to identify the 
rate of medication errors in an inpatient setting, found the rate was higher at night and 
at weekends (76). 
1.8. &RQVHTXHQFHVRIPHGLFDWLRQHUURUV 
Medication errors lead to increased mortality and morbidity rates (77). In addition; if 
medication errors are not intercepted before causing harm, the cost of healthcare 
increases (77, 78). This may include increasing length of hospitalisation, the need for 
more diagnostic examinations and different types of treatment for treating adverse 
reactions and toxicity, and an increasing mortality rate (79-81). Medication errors 
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have an adverse impact not only on patients and their families but also on healthcare 
providers, including a loss of confidence in healthcare providers and, therefore, in the 
whole of healthcare services (82). 
1.9. ,QWHUYHQWLRQDOWRROVWRGHFUHDVHPHGLFDWLRQHUURUVLQ
SDHGLDWULFSDWLHQWV 
A number of interventions have been used to attempt to reduce medication errors such 
as: 
x Electronic prescribing systems (Computerised Prescriber/Physician Order 
Entry (CPOE) and computer-assisted prescribing) (11, 83, 84). 
x Ward-based clinical pharmacists (84-86). 
x Educational and training programs (87-89). 
x Barcode technology (e.g. dispensed medications) (90). 
x Electronic medical records (84). 
x Risk management programmes (91). 
x Web-based (or computerised) calculators (92, 93). 
x Unit dose dispensing system (individual doses are dispensed for each patient) 
(84, 94). 
x Intelligent infusion pump systems (smart pumps) (95). 
x Robots in pharmacy (84). 
x Enhancing communication between healthcare providers (84). 
x Automated bedside dispensing devices (84). 
x Pre-printed orders (96). 
x Double check (97). 
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Conroy et al. (2007) conducted a systematic literature review to identify interventions 
used in previous studies to reduce dosing errors in children (98). Electronic 
prescribing systems (CPOE and computer-assisted prescribing) were mostly used; 
followed by unit dose dispensing systems, educational programmes, risk management 
programmes and intelligent infusion pump systems (smart pumps). These store drug 
doses and pre-programmed concentrations, and calculate all required infusion rates 
based on patient weight (98). 
 
The most effective interventional tools to decrease the error rate found by Fortescue et 
al. (2003) in the US were CPOE plus clinical decision support systems (CDSS), ward-
based clinical pharmacists and communication enhancement among healthcare 
providers (84). 
 
Another tool used to decrease the rate of medication dosing error is the Broselow-
Luten Emergency Tape (which indicates the right dose of medications depending on 
WKH FKLOGUHQ¶V KHLJKW (99). Volume/weight based dose reformulation has also been 
used as a tool to decrease medication dosing error (100). The latter does not require 
FRQYHUWLQJWKHGRVHIURPPJWRPODQGRQO\WKHSDWLHQW¶VZHLJKWLVQHHGHGXQOLNH
the Broselow tape, which requires doing calculations to convert the required doses 
from (mg) to (ml)) (99, 100). 
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1.9.1. Electronic prescribing systems (CPOE and computer-assisted 
prescribing) 
Electronic prescribing systems may reduce some problems associated with 
prescribing, including unclear handwriting and the omission of important information, 
such as doses, frequency, routes of administration, allergy and dose units (101). 
CPOE may also reduce transcription errors (25). Not many UK hospitals use CPOE, 
however, even though it is thought to decrease the incidence of non-intercepted 
medication errors (102). It has been estimated that up to 20% of all hospitals in high 
income countries use CPOE (103). CPOE, in combination with a decision support 
system, is an effective tool in decreasing the incidence of prescribing errors, but many 
hospitals do not have access to it because it is expensive and represents a huge 
logistical change (84, 104). Using CPOE is clearly valuable with regard to adult 
patients, but there is still a need to determine whether it decreases the incidence of 
medication errors in children (105). Drawbacks of CPOE are decreasing the time that 
nurses have available to take care of patients (as they need to spend more time 
entering data into a computer), it does not detect administration errors and the chance 
of selecting the wrong medications (25, 98, 106). 
Clinical decision supporting systems (CDSSs) are usually used alongside CPOE to 
KHOS SUHVFULEHUV WR FKHFN SDWLHQWV¶ DOOHUJLHV GUXJ LQWHUDFWLRQV DQG to detect wrong 
doses (105). It is still not clear whether the use of CDSSs decrease the prevalence of 
prescribing errors in paediatric patients (105). Carefully designed CDSSs may be 
helpful in detecting inappropriate doses, as most CPOE systems alone do not alert 
prescribers to such errors as long as the dose is within the adult range (105). 
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The use of a paediatric decision support tool in conjunction with CPOE was found to 
be effective in decreasing prescribing errors for children (from 18.3 to 1.9 errors per 
100 orders) in a paediatric emergency department in the US (107). It was also found 
to decrease the rate of incidents reported by 40% in a paediatric hospital in Canada 
(108). CPOE was found to be effective in reducing both the number of medication 
errors (from 46 to 26) and also potential adverse drug events (from 94 to 35) in a 
study in paediatric intensive and general care units in the US (109). CPOE decreased 
the required time for administering medication by 27%, as compared with handwritten 
orders in a simulated study by Sowan et al. (2010) in a US paediatric intensive care 
unit (110). In a systematic review, Conroy et al. (2007) (98) found that there was a 
large reduction of medication errors identified in some studies that used CPOE, 
however in one study error rates increased after implementation of CPOE (111). 
1.9.2. Ward-based clinical pharmacists 
Clinical pharmacists were found to decrease the rate of medication error (in paediatric 
and adult patients) by 66% in intensive care units in a general hospital in one study 
conducted in the US by Leape et al. (1999) in an urban teaching hospital (85). 
Kaushal et al. (2001) in the US judged that clinical pharmacists could have prevented 
94% of potential errors in paediatric patients (9). In another study conducted in 
paediatric settings by Fortescue et al. (2003) in the US, it was judged that a clinical 
pharmacist intervention could have decreased medication errors and potential errors in 
paediatric patients by 58% and 72%, respectively (84). It was found by Kaushal et al. 
(2008) in a study in the US that having full time clinical pharmacists decreased the 
rate of serious medication errors in a paediatric intensive care unit from 29 to 6 per 
1000 patients days, while part time clinical pharmacists did not decrease the rate of 
error in a paediatric general medical unit and in a paediatric surgical unit (86).  
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1.9.3. Educational and training programs 
According to the systematic literature review by Conroy et al. (2007), educational and 
training strategies are considered to decrease the incidence of paediatric dosing errors, 
and errors may be prevented if error reports are reviewed and solutions discussed and 
considered (98). Educational interventions were also found to be a helpful tool in 
decreasing errors in a neonatal intensive care unit in the UK by Simpson et al. (2004) 
(89). Nonetheless, the incidence of prescribing errors amongst trainees in another 
study by Kozer et al. (2006) in a tertiary care paediatric hospital in Canada was almost 
the same before and after a short-term educational intervention (112).  
Kozer et al. had done a study in the same setting previously in 2002. This showed of 
all prescribing errors made by doctors, trainees were responsible for the highest 
number (74). Medication errors committed by trainees reduced by the end of their 
academic training (74). This underscores the importance of experience and training in 
decreasing errors. 
1.10. 6XPPDU\ 
Medication errors are a very important topic, deserving of being addressed and 
studied in more depth. It is important to take into consideration the effect of study 
designs, prospective and retrospective identification of errors, and direct observation 
of healthcare providers on the identified rate of errors. Rates of medication errors are 
also presented using different definitions and denominators, and this variation makes 
it difficult to compare results from different studies. 
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1.11. 7KHDLPVRIWKLVWKHVLV 
The aims of this thesis are: 
1. To conduct a systematic review of paediatric medication error studies in order to 
explore: 
 Factors influencing the reported error rate (Chapter 2). 
 Factors responsible for wide variations in error rate (Chapter 3). 
 Any relationship between methods of data collection and results (Chapter 3). 
 Any relationship between the clarity of definitions and results (Chapter 3). 
 Interventional tools used to minimise medication errors (Chapter 3). 
2. To conduct a systematic review of the role of the paediatric clinical pharmacist in 
reducing the rate of medication errors (Chapter 4) in order to: 
  Identify contributions and interventions made by clinical pharmacists to 
minimise or prevent medication errors in neonatal and paediatric patients. 
  Use this knowledge to inform the development of my own project of direct 
observation of clinical pharmacist in local hospitals. 
3. To conduct an observational study of the role of the paediatric clinical pharmacist 
(Chapter 5) in order to: 
  Document and describe their contributions to patient care and safety. 
  Identify errors that are being prevented by their presence. 
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&KDSWHU6\VWHPDWLF OLWHUDWXUHUHYLHZRISDHGLDWULF
PHGLFDWLRQHUURUVWXGLHV 
,QWURGXFWLRQ 
Ghaleb et al (2006) published a systematic literature review including all studies 
identifying the rate of medication errors in paediatric patients and their methods until 
the end of March 2006 (17). They found 32 relevant articles of which 14 used chart 
review, 10 used review of medication error incident reports and eight used 
observations of drug administration.  
 
The first part of my work takes this study further to identify all studies identifying 
paediatric medication errors published from April 2006 onwards, as it has been 
noticed that the literature on the subject has increased significantly since then. To this 
end six databases were searched to identify all relevant studies, and to extract relevant 
information.  
 
$LPV 
x To identify and explore all studies which determined the rate and/or the number of 
medication errors in neonates and children published from April 2006.  
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0HWKRGV 
Databases searched were British Nursing Index and Archive (BNI), EMBASE, 
International Pharmaceutical Abstracts (IPA), Ovid MEDLINE(R), Allied and 
Complementary Medicine (AMED) and CINAHL (Cumulative Index to Nursing and 
Allied Health Literature). The search was limited to studies published between April 
2006 and March 2011. Hand search of bibliographies was done to include relevant 
articles that were not identified from searching the databases.  
 
2.3.1. Search strategy 
BNI, EMBASE, IPA, MEDLINE and AMED databases were searched separately and 
then combined together to remove duplication. CINAHL could not be combined with 
the other databases; hence, it was searched alone and manually reviewed to remove 
duplication and to identify relevant articles. 
 
2.3.2. Keywords 
Forty three keywords were used from the search by Ghaleb et al. 2006 (17) in order to 
update this work. Fifteen keywords were added to strengthen the search strategy. 
These were: prescribing mishap OR prescribing mishaps OR incorrect drugs OR 
incorrect doses OR incorrect routes of administration OR error reduction OR medical 
error OR medical errors OR calculation error OR calculation errors OR calculation 
mistake OR calculation mistakes OR error rate AND children OR baby.  
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The total 58 keywords used and the combining strategy for the search were as 
follows:  
 
2.3.3. Inclusion criteria 
x Original research studies identifying the rate or number of medication errors in 
neonatal and paediatric settings or in the general population where neonatal and 
paediatric data were separately identified. 
 
2.3.4. Exclusion criteria 
1. Studies identifying the rate or number of medication errors in adult patients 
only. 
2. Studies identifying the rate or number of medication errors in the general 
population where paediatric data are not separately identified. 
3. Studies identifying drug toxicity and not medication errors. 
4. Review articles, short surveys, adverse drug reactions and case reports. 
5. Comment, audit, reply and editorial articles. 
medication error OR medication errors OR administration error OR administration 
errors OR prescribing error OR prescribing errors OR dispensing error OR 
dispensing errors OR drug error OR drug errors OR drug mistake OR drug mistakes 
OR prescribing mishap OR prescribing mishaps OR drug mishap OR drug mishaps 
OR medication mistake OR medication mistakes OR medication mishap OR 
medication mishaps OR administration mistake OR administration mistakes OR 
dispensing mistake OR dispensing mistakes OR prescribing mistake OR prescribing 
mistakes OR wrong drug OR wrong drugs OR wrong dose OR wrong doses OR 
incorrect drug OR incorrect drugs OR incorrect dose OR incorrect doses OR 
incorrect route of administration OR incorrect routes of administration OR error 
reduction OR medical error OR medical errors OR calculation error OR calculation 
errors OR calculation mistake OR calculation mistakes OR error rate 
AND 
pediatric OR pediatrics OR paediatric OR paediatrics OR child OR children OR 
infant OR infants OR neonate OR neonates OR neonatal OR adolescent OR 
adolescents OR baby 
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2.3.5. Quality assessment of studies 
All studies which matched the inclusion criteria were assessed to determine their 
quality. The assessment was made using ten FULWHULD DGDSWHG IURP *KDOHE¶V 
study  (17) DQG$OODQ¶V(113) study to make these clearer and increase relevance. 
The criteria applied to each study were: 
1. Aims/objectives of the study clearly stated.  
2. Errors to be studied specified. 
3. Errors to be studied defined. 
4. Presence of a clearly defined denominator. 
5. Data collection method described clearly. 
6. Setting in which study conducted described. 
7. Sampling described. 
8. Reliability of methods used. 
9. Limitations of study listed. 
10. Ethical approval mentioned. 
 
Only studies available as full articles with quality ratings six or more were included. 
 
2.3.6. Extraction of data 
All included studies that provided the rate of medication errors were analysed using 
tables according to the methods of data collection, the type of errors identified and the 
denominator used. Data extracted included country, setting, age and drugs studied. 
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2.4. 5HVXOWV 
The total number of references identified after searching the six databases was 2,689 
after limitation (April 2006 - March 2011). After removing duplication 1,774 
abstracts were identified. These were reviewed against the inclusion and exclusion 
criteria. Ninety four (5.3%) abstracts (where it was not completely clear) were 
independently reviewed by my supervisor as to whether they should be included. Of 
these 30 were excluded from the abstract and 64 required access to the full articles to 
judge whether to exclude or include, of which 16 studies were included.  
 
Of the reviewed references; 150 were relevant and three studies were added following 
hand search of bibliographies. Of the 153 included studies; eight were conference 
abstracts. Table 2.1 illustrates reasons for exclusion and Figure 2.1 illustrates the 
search strategy and its results.  
 
Table 2.1: Reasons for excluding articles from review  
Reason for exclusion Number of papers 
Not relevant  1,225 
Not original research 227 
Adverse drug reactions  81 
Case reports 36 
Literature review 26 
Medication reconciliation 13 
Editorial article 8 
Short survey 5 
Insufficient information in the abstract+ no translation  3 
Total 1,624 
 
 
 
 
 
34 
 
 
Figure 2.1: Summary of search and review process 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
BNI EMBASE IPA MEDLINE AMED CINAHL 
15 1,221 100 1,084 
 
3 266 
After limitation from April 2006 to March 2011 
2,689 
1,774 
After removing duplications  
153 
After excluding 1,624 references 
816 excluded from abstract  
808 excluded from full article 
3 added from hand search 
of bibliographies 
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2.4.1. Non-English studies   
Thirteen non-English studies were identified. Eight of these were included (six after 
full translation of the studies and for two data was extracted from the English 
abstract). Three studies were excluded because no translation was available. Two 
studies were not relevant following translation (one not in paediatric patients and the 
other not separating the paediatric data from the general population) (details are listed 
in Table 2.2).        
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Table 2.2: Non-English studies  
Number  Reference  Author  Country Language  English Abstract  Translated Included Explanation  Translator  
1 (114) Diez et al. 2009 Spanish  Spanish D D D Information taken from full article  Imti Choonara  
2 (115) Campino et al. 2006 Spanish  Spanish D D D Information taken from full article  Imti Choonara  
3 (116) Rivas et al. 2010 Chile   Spanish D D D Information taken from full article  Imti Choonara  
4 (117) Kjeldby et al. 2009 Norway  Norwegian  D D D Information taken from full article  Hanne 
Brummenaes  
Cathrine Kjeldby  
5 (118) Valizadeh et al. 2008 Iran  Persian  D D D Information taken from full article  Natasha- Vafadar-
Isfahani 
6 (119) Festini et al. 2008 Italy  Italian  8 D D Information taken from full article  Francesca-Raffi 
9 (120) Camara et al. 2011 Senegal  French  D 8 D Information taken from abstract  8 
10 (121) Trotter et al. 2009 Germany  German  D 8 D Information taken from abstract  8 
7 (122) Panknin 2008 Germany  German 8 D 8 Not relevant (not paediatric) Francesca-Raffi 
8 (123) Teigen et al. 2009 Norway  Norwegian  8 D 8 Not relevant (paediatric data not 
separately identified) 
Ingrid Gronlie 
11 (124) Jirapraphusak et al. 2009 Thailand  Thai  D 8 8 No translation available & not 
enough information in the abstract 
8 
12 (125) Berghäuser et al. 2010 Germany  German D 8 8 No translation available & not 
enough information in the abstract 
8 
13 (126) Yamanaka et al. 2007 France  French  D 8 8 No translation available & not 
enough information in the abstract 
8 
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2.4.2. Quality assessment of studies 
The quality assessment was done on all studies that were in English or when full 
translation was available (in total 143 studies). The quality assessment was not made 
for studies where the data was taken only from abstracts (two studies with no full 
translation of the papers and eight conference abstracts). From the 143 studies; 47 
studies met 10 of the quality criteria, 40 met nine criteria and 39 met eight criteria. All 
studies met more than five of the 10 quality criteria and therefore were included in the 
analysis. The results of the quality assessment can be seen in Figure 2.2. 
 
Figure 2.2: Quality Assessment of Studies  
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2.4.3. Countries  
The 153 studies were conducted in 30 different countries of which 18 are high income 
countries (according to the World Bank) (127). One study was conducted in both the 
US and Canada (reference (128)). Of all studies; 131 (85%) were conducted in high 
income countries. Figure 2.3 represents the different countries where the studies were 
conducted. 
The majority (84, 55%) of studies were conducted in the US followed by 16 studies 
(10.5%) conducted in the UK. 
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2.4.4. Settings 
The 153 studies involved a variety of settings. These included  sSHFLDOLVW FKLOGUHQ¶V
hospitals (30), neonatal units (22), paediatric units in general hospitals (16), intensive 
care units (13), simulation studies (12), emergency departments (12), national incident 
reporting systems (12), outpatients (11), poison control centres (nine), primary care 
centres (seven), paediatric oncology (five), neonatal and paediatric units in general 
hospital (five), paediatric surgical services (two), paediatric neurology ward (one), 
and a  trauma centre (one) . Nine studies were conducted in two settings and one was 
conducted in four settings. 
2.4.5. Age classification 
According to the International Conference on Harmonisation (129); children¶V ages 
should be classified according to the following: 
1. Premature baby: less than 37 weeks gestation  
2. Neonates: 0-27 days 
3. Infants: 28 days- 23 months 
4. Child: 2-11 years 
5. Adolescent: 12- 16 (or 18) years 
53 studies did not mention the age of the patients studied, 25 included children of all 
ages, 23 included neonates, infants, children and adolescents, 19 included neonates 
only, 7 included preterm babies, neonates, infants and children, 5 included infants, 3 
included children and adolescents, 3 included infants, children and adolescents and 3 
included infants and children. Twelve studies were simulation studies. 
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2.4.6. Types of medication errors  
Forty-four studies identified prescribing errors and 42 studies identified different 
types of medication errors (i.e. prescribing errors, administration errors, medication 
errors in general, transcribing errors, monitoring errors or dispensing errors). These 
will be described in more detail in the relevant sections in the following results. 
Thirty-six studies identified administration errors, 29 studies identified ³medication 
errors in general´. The type of error (e.g. prescribing errors) was not specified, one 
study identified dispensing errors and one study identified monitoring errors (i.e. 
therapeutic drug monitoring). 
 
2.4.7. Types of medications studied  
Forty-eight different medications or groups of medications were studied. Seventy 
three studies identified the error rate from all medications. Seven studies identified 
errors with chemotherapy, seven studied errors involving specific medications on a 
list, five studied errors using intravenous medications and four studies identified 
errors with antimicrobials. Section 1 in Appendix 1 illustrates all medications, or 
groups of medications studied.    
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2.4.8. Denominators  
Twenty six different denominators were used 198 times by 109 studies (Table 2.3).  
 
Table 2.3: All denominators identified by 109 studies  
Denominators  Number of studies using this denominator 
Of all errors 51 
Of all orders 50 
Of all patients 16 
Of all administrations  13 
Per 1000 patient days 13 
Of all admissions 11 
Of all medications 7 
Mean errors 5 
Per 1000 orders 5 
Of all patient visits 4 
Of all participants 3 
Of all medication days 3 
Of all doses 2 
Per 1000 administrations 2 
Of all possible errors 2 
Median errors 1 
Visits per 10,000 individuals per year 1 
Per 100 patient days 1 
Of all preparations 1 
Of all samples  1 
Per hospitalisation days 1 
Per 1000 doses 1 
Of all transcriptions 1 
Of all charts  1 
Of all ADEs 1 
Per bed day  1 
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2.4.9. Study methods  
Information (Section 2 in Appendix 1) was extracted according to the methodology 
used in each study to identify the rate of errors. All studies that identified the error 
rate (109) using 26 different denominators were analysed according to the methods of 
data collection, the type of medication errors and the denominator used.  
Sixty studies used chart/medical record review, 50 studies used review of incident 
reports, 23 studies used mixed methods, (i.e. more than one method e.g. chart review 
plus review of incident reports), 12 studies used simulation and eight studies used 
direct observation. 
Not all studies identified the rate of error. Forty four studies just identified the number 
of errors without providing denominators. These studies were excluded from analysis 
in the following chapters as they cannot be compared with others. Many studies 
identified their results using more than one denominator, hence the number of studies 
does not always match the number of denominators listed in the following tables. 
Many studies identified more than one type of error. These studies are included in the 
relevant section (i.e. prescribing errors, administration errors, etc.). This is another 
reason for the differences in the number of studies identifying the rate of errors in 
each section.     
 
2.4.9.1. Studies using chart/medical record review 
Sixty studies used chart and/or medical record review as the method of data collection: 
 34 identified prescribing errors, two identified administration errors, one 
identified dispensing errors, six identified medication errors in general, one 
identified monitoring errors and 16 identified a mixture of different types of 
medication errors.  
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2.4.9.1.1. Studies identifying prescribing errors 
Forty eight studies in total used chart/medical record review to identify prescribing 
errors: 45 identified the rate and the number of prescribing errors and three studies 
only identified the number of errors. The majority were conducted in the US (17 
studies), the UK (eight studies), Spain (five studies) and Bahrain (four studies). Figure 
2.4 illustrates the different countries.  
Figure 2.4: Countries in studies identifying the rate of prescribing errors using 
chart/medical record review 
 
 
 
Studies were conducted in VSHFLDOLVWFKLOGUHQ¶VKRVSLWDOV (10), neonatal units (eight), 
emergency departments (eight) and outpatients (four studies in outpatient clinics, one 
study in a community pharmacy and one study at both a clinic and home). One study 
was conducted in two settings (neonatal unit and emergency department) (Figure 2.5).  
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Figure 2.5: Settings for studies identifying the rate of prescribing errors using 
chart/medical record review 
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The rate of prescribing errors was given using different denominators as shown in 
Table 2.4. ³2f DOORUGHUV´, ³RIDOOHUURUV´³RIDOOSDWLHQWV´DQG³RIDOOPHGLFDWLRQV´DUH
explored further in Chapter 3 as they are associated with a wide range of results.  
 
Table 2.4: Denominators used by studies identifying the rate of prescribing errors 
using chart/medical record review 
Denominator Number of 
studies 
Range of 
reported errors 
Comment 
Of all orders 27 0-90.5% - 
Of all errors 6 0.7-89% - 
Mean errors 4 0.1±0.3-14.8 - 
Of all patients 3 4.8-74% - 
Of all medications 3 4.6-77.4% - 
Of all patient visits 2 13-32.6% - 
Of all medication days 1 (33)-52% Before and (after) 
intervention. 
Of all admissions  1 (21)-47% Before and (after) 
intervention. 
Per 1000 patient days 1 5 - 
Per 1000 
administrations 
1 0.09 - 
Median errors 1 1 - 
 
 
2.4.9.1.2. Studies identifying administration errors 
Eight studies used chart/medical record review to identify the rate of administration 
errors. Five studies were conducted in the US, one in the UK, one in Canada and one 
in Argentina. Three studies were conducted in VSHFLDOLVWFKLOGUHQ¶VKRVSLWDOV, one in a 
paediatric unit in a general hospital, one in a neonatal and paediatric unit in a general 
hospital, one involved paramedics, one in an emergency department, one in a trauma 
centre and one in an outpatient clinic. One study was conducted in two settings 
VSHFLDOLVWFKLOGUHQ¶VKRVSLWDODQGSDHGLDWULFXQLWLQa general hospital).  
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Table 2.5 illustrates the rate of administration errors identified in these studies and the 
denominators used. The studies using the GHQRPLQDWRU³RIDOOSDWLHQWV´showed error 
rates varying widely from 22.7 to 87.5%. These will be explored further in Chapter 3. 
Table 2.5: Denominators used by studies identifying the rate of administration errors 
using chart/medical record review 
Denominator Number of 
studies 
Range of 
reported errors 
Comment 
Of all patients 2 22.7-87.5% - 
Of all errors 2 0-27% - 
Of all charts 1 15-25% Two different settings 
Of all orders 1 (3)-6% Before and (after) 
intervention. 
Of all possible errors 1 (1.7)-14.8% Before and (after) 
intervention. 
Of all administrations 1 (5.9)-8.4% Before and (after) 
intervention. 
2.4.9.1.3. Studies identifying dispensing errors 
Six studies used chart/medical record review to identify the rate of dispensing errors. 
Three studies were conducted in the US, one in India, one in Thailand and one in 
Brazil.  
Two studies were conducted in VSHFLDOLVWFKLOGUHQ¶VKRVSLWDOVRQHSDHGLDWULFXQLWLQa 
general hospital, one outpatient clinic, one paediatric psychiatric care, one emergency 
department and one neonatal unit. One study was conducted in two settings 
(emergency department and neonatal unit). 
 
Table 2.6 illustrates the rate of dispensing errors identified in these studies and the 
denominators used. ³2IDOO HUURUV´ZDs the most widely used denominator (used by 
four studies) with dispensing error rates ranging from 0-21%.  
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Table 2.6: Denominators used by studies identifying the rate of dispensing errors 
using chart/medical record review 
Denominator Number of 
studies 
Range of 
reported errors 
Comment 
Of all errors 4 0-21% - 
Of all admissions 1 (0.33)-3.01% Before and (after) 
intervention. 
Of all doses 1 11.5% - 
 
 
2.4.9.1.4 Studies identifying medication errors in general 
Sixteen studies used chart/medical record review to identify medication errors in 
general. Of all studies; 14 identified the rate and the number of medication errors in 
general and two only identified the number of errors. Of the 16 studies, seven were 
conducted in the US, two in the UK, two in Iran, one in the US and Canada, one in 
India, one in Israel, one in Thailand and one in Brazil.  
 
Five studies were conducted in neonatal units, three in emergency departments, three 
in intensive care units, two in paediatric units in general hospitals, two in specialist 
FKLOGUHQ¶V KRVSLWDOs, one was in otolaryngology, one paediatric psychiatric care and 
one was in outpatient (clinic and home). Two studies were each conducted in two 
settings (neonatal unit and emergency department for one study and specialist 
FKLOGUHQ¶VKRVSLWDODQGSDHGLDWULFXQLWLQJHQHUDOKRVSLWDOIRUWKHRWKHUVWXG\ 
 
Table 2.7 illustrates the rate of errors identified in these studies and the denominators 
used. ³2IDOORUGHUV´ZDVXVHGLQfive studies and varied from 2.42-DQG³RIDOO
patients´ZDVXVHGLQWKUHHVWXGies and ranged between 26.4-55%.    
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Table 2.7: Denominators used by studies identifying the rate of medication errors in 
general using chart/medical record review 
Denominator Number 
of studies 
Range of 
reported errors 
Comment 
Of all orders 5 2.42-23% - 
Of all patients 3 26.4-55% - 
Per 1000 patient days 1 (2.4)-9.3 Before and (after) 
intervention. 
Of all admissions 1 (2.2)-7.9% Before and (after) 
intervention. 
Of all medication days 1 (34)-53% Before and (after) 
intervention. 
Of all medications 1 7.6- 12.8% In two groups of 
participants. 
Of all patient visits 1 18.8% - 
Per 1000 orders 1 24.1 - 
Of all adverse drug 
events 
1 56% - 
Per 3.9 hospitalisation 
days 
1 1 - 
Per 100 patient days 1 2.1 - 
Per bed day 1 (1.1)-1.8 Before and (after) 
intervention. 
2.4.9.1.5. Studies identifying transcribing errors 
A transcribing error was defined by Kazemi et al. in 2010 (102) DV ³$Q HUURU WKDW
RFFXUUHG DIWHU WKH SUHVFULSWLRQ VWDJH´ 7KH VDPH DXWKRUV LQ  (130) defined a 
WUDQVFULELQJHUURUDV³$PHGLFDWLRQWKDWZDVregistered with an erroneous dose in the 
paper-EDVHGQXUVLQJUHSRUWZKLOHWKHSUHVFULEHGRUGHUZDVFRUUHFW´1RRWKHUVWXGLHV
provided a definition of transcribing errors. 
Six studies used chart/medical record review to identify the rate of transcribing errors. 
Two were conducted in Iran, two in Spain, one in the US and one in Chile. Five 
studies were conducted in neonatal units, one in a paediatric unit in a general hospital, 
one in an intensive care unit, one in paediatric surgery and one was conducted in a 
VSHFLDOLVW FKLOGUHQ¶V KRVSLWDO. One study was conducted in four settings (paediatric 
unit in general hospital, neonatal unit, paediatric surgery and intensive care unit).  
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Table 2.8 illustrates the rate of transcribing errors identified in these studies and the 
denominators used. ³2IDOORUGHUV´ZDVXVHGE\two studies and ranged between 15.9-
21.3%. Of these Campino et al. 2006 (115) identified the transcribing errors in a 
neonatal unit in Spain which was 21.3% of all orders. Campino et al. in 2008 (131) 
identified the transcribing error rate in the same country and setting and this was 
20.5% of all orders at baseline and 15.9% after doctors and nurses were informed that 
their performance would be reviewed. They identified the following transcribing 
errors: omission of dose, incorrect dose, omission of units, incorrect units, omissions 
of interval, incorrect interval, omission of route and incorrect route. 
 
Rivas et al. 2010 (116) did a cross sectional analysis of prescriptions in four settings: 
a paediatric unit in a general hospital, a neonatal unit, paediatric surgery and an 
intensive care unit. They found that the rate of transcribing errors was 6% of all 
transcriptions. They identified the following: illegible transcriptions, not transcribing 
all indicated medications and transcription of medications that were not prescribed.     
 
Table 2.8: Denominators used by studies identifying the rate of transcribing errors 
using chart/medical record review 
Denominator Number of 
studies 
Range of 
reported errors 
Comment 
Of all orders 2 15.9- 21.3% - 
Of all transcriptions  1 6% - 
Of all medications 1 2.5-3% In two groups of 
participants 
Of all medication 
days 
1 1-(1)% Before and (after) 
intervention 
Of all errors 1 0% - 
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2.4.9.1.6. Studies identifying monitoring errors 
Three studies used chart/medical record review to identify the rate of monitoring 
errors. All studies were conducted in the US (two in VSHFLDOLVWFKLOGUHQ¶VKRVSLWDOs and 
one in outpatients (clinic and home)). Two studies just identified the rate of different 
types of errors without mentioning the medications associated with these. One study 
was conducted by Takata et al. 2008 (132) in 12 FKLOGUHQ¶VKRVSLWDOs in the US. They 
reviewed 960 randomly selected charts and identified 62.5% of all medication errors 
to be monitoring errors. They GHILQHG D PRQLWRULQJ HUURU WR EH ³IDLOXUH WR UHYLHZ D
prescribed regimen for appropriateness and detection of problems or failure to use 
appropriate clinical or laboratory data for adequate assessment of patient response to 
SUHVFULEHG WKHUDS\´ The remaining were prescribing and dispensing errors. The 
second study by Walsh et al. 2009 (27) was done in an outpatient clinic and home in 
the US. The monitoring error rate was 5% of all medication errors after reviewing all 
patienWV¶ FKDUWV IRU FKLOGUHQ with cancer treated with chemotherapy. The remaining 
were prescribing, administration and dispensing errors. This will be explored further 
in Chapter 3 because of the wide range of error rates reported in these studies (5-
62.5% of all medication errors). No examples were given by either of the studies 
regarding the nature of the monitoring errors.  
 
The third study was conducted by Abboud et al. 2006 (133) who reviewed the effects 
of implementing a corollary order screen (in which prescribers are asked via a screen 
regarding the need for checking the blood level and the time for the next blood 
sample) for three aminoglycoside medications (gentamicin, tobramycin and 
amikacin). The rate of toxic and subtherapeutic levels identified increased from 9.8% 
to 12.8% of all samples after the intervention (not statistically significant). The author 
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suggests that the reason for the increase in these rates was due to an increase in the 
rate of monitoring after the implementation of the corollary order screen. 
 
Summary of studies using chart review 
Most studies using chart review identified prescribing errors. The majority of studies 
were conducted in the US and the UK. Most studies were conducted in specialist 
FKLOGUHQ¶V KRVSLWDOV IROORZHG E\ QHRQDWDO XQLWV Twenty two different denominators 
were used with ³RIDOORUGHUV´EHLQJWKHPRVWFRPPRQIROORZHGE\³RIDOOHUURUV´ 
Eleven denominators were used to describe prescribing errors and four denominators 
showed a wide variation in results. Administration errors were described using six 
denominators with one showing wide variation. Dispensing errors were reported by 
six studies most of which showed a rate of 0-21% of all errors. Medication errors in 
general were reported in 16 studies using 12 different denominators, most commonly 
³RIDOORUGHUV´ZKHUHUDWHVYDULHGIURP-23%. Transcribing errors were studied in 
six studies using five different denominators and showed 16-21% orders contained 
such errors.  
2.4.9.2. Studies using direct observation 
Eight studies used direct observation: one identified prescribing errors and seven 
identified administration errors. 
2.4.9.2.1. Studies identifying prescribing errors 
A study was conducted by Osterholt et al. 2006 (134) in an outpatient clinic in 
Malawi in which doctors¶ FRQVXOWDWLRQV were observed by the authors to assess the 
suitability of the prescribed antimicrobial drugs. The rate of prescribing errors was 
29.1% of all patients.  
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2.4.9.2.2. Studies identifying administration errors 
Two studies were conducted in the US, two in Malaysia, one in Germany, one in 
Canada and one in Ethiopia. Two studies were conducted in neonatal units, two in 
paediatric units in general hospitals, one in paediatric neurology, one in an intensive 
care unit and one in paediatric oncology. $OOVWXGLHVXVHG³RIDOODGPLQLVWUDWLRQV´DV
the denominator and error rates varied between studies from 5.6%-96.6%. These will 
be explored in more detail in Chapter 3.  
 
Summary of studies using direct observation  
Most studies using direct observation identified administration errors. Two 
denominators were used, ZLWK³RIDOOadministrations´EHing the most common.  
 
2.4.9.3. Studies using review of medication error incident reports 
Fifty studies used review of medication error incident reports: six identified 
prescribing errors, 12 identified administration errors, 17 identified medication errors 
in general and 15 identified a mixture of different types of medication errors.  
 
2.4.9.3.1. Studies identifying prescribing errors 
Nineteen studies used review of incident reports to identify prescribing errors. Ten 
studies identified the rate and the number of errors whereas nine studies only 
identified the number. Twelve studies were conducted in the US, three in the UK, one 
in Canada, one in Belgium, one in Australia and one in France.  
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The 19 studies were conducted in a variety of settings. They included five in specialist 
FKLOGUHQ¶VKRVSLWDOV, two in neonatal units, one in a paediatric surgical service, one in 
a paediatric pain team, one in paediatric oncology, one in a paediatric unit in a general 
hospital, one in outpatient setting (using Medicaid Paid Claim data), one in a 
paediatric gastroenterology and nutrition ward and one in a neonatal and paediatric 
unit in a general hospital. Several used data from a national incident reporting system. 
   
Table 2.9 illustrates the rate of prescribing errors identified and the denominators 
used. Seven VWXGLHV XVHG ³RI DOO HUURUV´ DV WKH GHQRPLQDWRU DQG HUURU rates varied 
between 1.1% (in a US neonatal unit) -24.4% (in a French neonatal unit).  
Table 2.9: Denominators used by studies identifying the rate of prescribing errors 
using review of medication error incident reports 
Denominator Number of studies Range of reported 
errors 
Of all errors 7 1.1-24.4% 
Per 1000 orders 3 0.03-5.93 
Per 1000 patient days 1 2.67 
 
Per 1000 orders was used by three studies to identify the prescribing error rate using 
review of incident reports. Takata et al. 2008 (135) had done DVWXG\LQIRXUFKLOGUHQ¶V
hospitals in the US and identified a prescribing error rate of 0.82 per 1000 orders (or 
2.67 per 1000 patient days). They only involved pharmacy interventions on 
prescribing errors with potential significant patient harm. Another US study by Bsaco 
et al. 2010 (72) identified 0.03 per 1000 orders to involve prescribing errors in an 
outpatient setting. Smith et al. 2011 (136)  identified 5.93 prescribing errors per 1000 
orders in a paediatric unit in a general hospital in the US. They only involved 
analgesic medications.  
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Each of the three studies mentioned above involved specific types of medications or 
prescribing errors (e.g. analgesic prescribing errors) and this is likely to be the cause 
for the low error rates identified by these studies.  
2.4.9.3.2. Studies identifying administration errors 
Twenty four studies used review of medication error incident reports to identify 
administration errors. Nine studies identified the rate and the number of 
administration errors while 15 studies only identified the number. Fifteen studies were 
conducted in the US, two in the UK, one in France, one in Australia, one in South 
Africa, one in Hong Kong, one in Thailand, one in Canada and one in Saudi Arabia.  
The 24 studies were conducted in different settings. These included poison control 
centres (4), VSHFLDOLVW FKLOGUHQ¶V KRVSLWDOV (4), neonatal units (3), national incident 
reporting systems (5), primary care centres (2), and anaesthetics (1). Several used data 
from a national incident reporting system.  
Table 2.10 illustrates the rate of administration errors identified in the studies and the 
denominators used. Seven VWXGLHVXVHG ³RI DOO HUURUV´ DV WKHGHQRPLQDWRU DQG HUURU
rates varied between 30-93.2% WKUHHLQQHRQDWDOXQLWVRQHLQDVSHFLDOLVWFKLOGUHQ¶V
hospital, one in paediatric oncology, one in paediatric gastroenterology and nutrition 
and one used a national incident reporting system to identify antidepressant 
medication errors). These will be explored further in Chapter 3. 
Table 2.10: Denominators used by studies identifying the rate of administration errors 
using review of medication error incident reports 
Denominator Number of 
studies 
Range of reported 
errors 
Comment 
Of all errors 7 30-93.2% - 
Tenfold errors (per 
1000 administrations) 
1 0.595-0.718 For each individual 
year in five years. 
Of all patient visits 1 8% - 
Visits per 10,000 
individuals per year 
1 0.7 - 
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2.4.9.3.3. Studies identifying medication errors in general 
Thirty two studies used review of medication error incident reports to identify 
medication errors in general where the type of error was not specified. Of all studies; 
six identified the rate and the number of medication errors in general and 26 only 
identified the number. Nineteen studies were conducted in the US, four in the UK, 
two in France, one in the Netherlands, one in Finland, one in Morocco, one in Italy, 
one in Germany, one in Australia and one in Canada.  
The 32 studies were conducted in different settings. These included specialist 
FKLOGUHQ¶V KRVSLWDOs (seven), poison control centres (five), neonatal units (four) and 
intensive care units (two). Several used data from a national incident reporting 
system.  
 
Table 2.11 illustrates the rate of medication errors in general identified in the studies 
and the denominators used. 7ZRVWXGLHVXVHG³RIDOOSDWLHQWV´GHQRPLQDWRUDQGHUURU
rates were between 4.9-34.3%. One of these was conducted by Hayes et al. in 2008 
(137) using review of incident reports retrieved from a poison control centre in the 
US. The aim was to identify the rate of errors that are associated with intravenous 
acetylcysteine and this was found to be 34.3% of all patients. The other study was 
conducted by Ligi et al. 2010 (15) in a neonatal unit in France. The rate of errors was 
4.9% of all patients before starting safety initiatives and iatrogenic events prevention 
strategies and 7% after the intervention. According to authors; this increase was 
because of the increase in the rate of reporting.  
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Table 2.11: Denominators used by studies identifying the rate of medication errors in 
general using review of medication error incident reports 
Denominator Number of 
studies 
Range of reported 
errors 
Comment 
Of all patients 2 4.9-34.3% - 
Of all orders 2 0.21- 0.24% - 
Of all admissions 1 4.9% - 
Of all medications  1 (0.02)-3.3% Before and (after) 
intervention. 
 
The tZRVWXGLHVXVLQJ³RIDOORUGHUV´GHQRPLQDWRU have similar rate of errors. One was 
conducted by Burny et al. 2006 (138) in an intensive care unit in the US whereas the 
other was conducted by Narula et al. 2010 (139) in a paediatric gastroenterology and 
nutrition ward in the UK, looking only for medication errors associated with 
parenteral nutrition.   
2.4.9.3.4. Studies identifying dispensing errors 
Ten studies used review of incident reports to identify dispensing errors. Five 
identified the rate and the number of dispensing errors and five only identified the 
number. Seven studies were conducted in the US, two in the UK and one in Canada.  
The ten studies were conducted in different settings. These included specialist 
FKLOGUHQ¶VKRVSLWDOV (three), paediatric gastroenterology and nutrition ward (one) and 
neonatal and paediatric unit in general hospital (one). Several used data from a 
national incident reporting system.   
All the five studies identifying an error rate XVHGRQHGHQRPLQDWRU³RIDOOHUURUV´DQG
ranged between 11.8-35.7%. Rinke et al. 2007 (140) identified a dispensing error rate 
of 30.3% of all errors. This was associated with chemotherapy using paediatric 
oncology data from a national incident reporting system in the US. Stavroudis et al. 
2010 (141) identified a dispensing error rate of 11.8% of all errors and used neonatal 
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data from a national incident reporting system in the US, whereas 0LOOHUHWDO¶V
study (76) was conducted in a specialisW FKLOGUHQ¶V KRVSLWDO LQ WKH 86 DQG IRXQG
35.7% of errors to be dispensing errors. One study which was conducted in a 
paediatric gastroenterology and nutrition ward in the UK and identified the dispensing 
error rate with parenteral nutrition which was 24% of all errors. Rinke et al. 2010 (66) 
identified 30% of all errors with antidepressant drugs were dispensing errors when 
also using a national incident reporting system data.   
2.4.9.3.5. Studies identifying monitoring errors 
Six studies used review of incident reports to identify monitoring errors. Of all 
studies; three identified the rate and the number of monitoring errors and the other 
three only identified the number. Five studies were conducted in the US and one in 
Canada. No examples were given by any of these studies. 
One study was conducted in a specialist cKLOGUHQ¶VKRVSLWDODQGWKHRWKHUILYHVWXGLHV
used data from a national incident reporting system. 
All three studies identifying the error rate were conducted in the US and used one 
GHQRPLQDWRU³RIDOOHUURUV´. Rates of errors ranged between 0.6-1.4%. These studies 
did not mention the methodology of detecting the monitoring errors or medications 
associated with these errors and only provided the rate of monitoring errors. The first 
study was conducted by Rinke et al. 2007 (140) in paediatric oncology using a 
national incident reporting system to identify medication errors associated with 
chemotherapy. The monitoring error rate was 0.6% of all errors. 
A second study also conducted by Rinke et al. in 2010 (66) and showed that the rate 
of monitoring errors was 0.7% of all errors for antidepressant medications and used a 
national incident reporting system, yet Stavroudis et al. 2010 (141) found that the rate 
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of monitoring errors was 1.4% of all errors using neonatal data from a national 
incident reporting system.      
2.4.9.3.6. Studies identifying transcribing errors 
Nine studies used review of incident reports to identify transcribing errors. Of all 
studies; five identified the rate and the number of transcribing errors and the other 
four only identified the number. Seven studies were conducted in the US and two in 
the UK.  
Two studies were conducted in VSHFLDOLVWFKLOGUHQ¶VKRVSLWDOV and one in a paediatric 
gastroenterology and nutrition ward. Six studies used data from a national incident 
reporting system. 
All five studies that identified the rate of transcribing errors used the same 
denominator. The rate of transcribing errors ranged between 7.1 and 28% of all errors. 
Rinke et al. 2007 (140) identified a transcribing errors rate of 7.1% of all errors 
associated with chemotherapy in paediatric oncology using a national incident 
reporting system in the US whereas Stavroudis et al. 2010 (141) identified a 
transcribing error rate of 18.4% of all errors for their neonatal data. Neither provided 
specific examples of the types of errors. 
One study which was conducted in a paediatric gastroenterology and nutrition ward in 
the UK by Narula et al. in 2010 (139) identified the transcribing error rate with 
parenteral nutrition which was 20% of all errors. They identified the following types 
of transcribing errors: incorrect patient identification, surname, date of birth, rate or 
inadequate amount of medication.  
Miller et al.¶V 2010 study (76) ZDVFRQGXFWHGLQDVSHFLDOLVWFKLOGUHQ¶VKRVSLWDOLQWKH
US and found 24.2% of errors as transcribing errors. Rinke et al. 2010 (66) used 
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national incident reporting system data to identify transcribing errors with 
antidepressant drugs and found the highest rate of 28% of all errors.  
 
Summary of studies using review of medication error incident 
reports  
Most studies using review of medication error incident reports identified medication 
errors in general followed by administration errors. The majority were conducted in 
the US followed by the UK. Most studies were conducted using national incident 
reporting systems followed by studies in VSHFLDOLVWFKLOGUHQ¶VKRVSLWDOV. Ten different 
GHQRPLQDWRUVZHUHXVHGZLWK³RIDOOerrors´EHLQJWKHPRVWFRPPRQ 
 
2.4.9.4. Studies using mixed methods 
This section includes studies that used more than one method to collect the data to 
identify medication errors, for example, studies that used chart review and review of 
incident reports to identify the rate of medication errors.  
Twenty three studies used mixed methods: two identified prescribing errors, four 
identified administration errors, six identified medication errors in general and 11 
identified a mixture of different types of medication errors.  
2.4.9.4.1. Studies identifying prescribing errors 
Thirteen studies used mixed methods to identify prescribing errors. Of all studies; 
eight identified the rate and the number of prescribing errors and five only identified 
the number. Eight studies were conducted in the US, two in the UK, one in New 
Zealand, one in Iran and one in India.  
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The 13 studies were conducted in different settings. These included a paediatric unit 
in a general hospital (three), VSHFLDOLVW FKLOGUHQ¶V KRVSLWDOs (three), emergency 
department (one), outpatient clinic (one) and paediatric oncology unit (one).  
Table 2.12 illustrates the rate of prescribing errors identified in the studies and the 
denominators used. ³2I DOO RUGHUV´ ZDV XVHG by four studies and ranged between 
1.06-27%. 7KHVWXGLHVXVLQJ³Rf all patients´ denominator identified a wide range of 
error rates from 40-189% and therefore will be explored further in Chapter 3 to 
determine the reasons for this. 
 
Table 2.12: Denominators used by studies identifying the rate of prescribing errors 
using mixed methods 
Denominator Number of 
studies 
Range of reported 
errors 
Comment 
Of all orders 4 1.06-27% - 
Of all errors 2 26-54% - 
Of all patients 2 40-(189)% (More than one 
error per patient) 
Per 1000 patient days 1 74 - 
Of all admissions  1 43% - 
2.4.9.4.2. Studies identifying administration errors 
Thirteen studies used mixed methods to identify administration errors. Of all studies; 
seven identified the rate and the number of administration errors and six only 
identified the number. Seven studies were conducted in the US, two in the UK, one in 
New Zealand, one in the Netherlands, one in Iran and one in Brazil.  
The 13 studies were conducted in different settings. These included two in specialist 
FKLOGUHQ¶VKRVSLWDOV, two in paediatric units in general hospitals, two in an outpatient 
clinic and one in a paediatric oncology unit.  
Table 2.13 illustrates the rate of administration errors identified in the studies and the 
denominators used. ³2IDOODGPLQLVWUDWLRQV´DQG³RIDOOHUURUV´ZHUHHDFKXVHGWZLFH
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and ranged respectively between 1.2-63.8% and 12-70%. Conroy et al. 2007 (142) 
identified administration errors separately after using direct observation of nurses 
(1.2% of all administrations). This result will be explored with results identified for 
the seven studies in Section 4.9.2.2. (Page 56) with a wide range of administration 
errors (1.2-96.6% of all administrations) in Chapter 3. 7KH³RIDOOHUURUV´GHQRPLQDWRU
will also be explored further in Chapter 3 as the two studies using this denominator 
identified a wide range of error rates (12-70%).    
Table 2.13: Denominators used by studies identifying the rate of administration errors 
using mixed methods 
Denominator Number of studies Range of reported 
errors 
Of all administrations 2 1.2- 63.8% 
Of all errors 2 12- 70% 
Of all patients 1 75% 
Per 1000 patient days 1 54 
Of all admissions 1 32% 
Of all orders 1 5.2% 
Of all possible errors 1 19.1% 
2.4.9.4.3. Studies identifying medication errors in general 
Twelve studies used mixed methods to identify medication errors in general. Ten 
identified the rate and the number of medication errors in general and two only 
identified the number. Nine studies were conducted in the US, one in Morocco, one in 
India and one in New Zealand. The 12 studies were conducted in different settings. 
These included three in neonatal and paediatric units in general hospitals, two in 
paediatric units in general hospitals, two in VSHFLDOLVW FKLOGUHQ¶V KRVSLWDOV, one in a 
neonatal unit and one in an outpatient clinic.  
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Table 2.14 illustrates the rate of medication errors in general identified in these 
studies and the denominators used. ³3HUSDWLHQWGD\V´ZDVWKHPRVWFRPPRQO\
used denominator being used in six studies with a wide range of results from 4-167. 
³2I DOO DGPLVVLRQV´ GHQRPLQDWRU ZDV XVHG E\ WKUHH VWXGLHV DQG ZLWK HUURU UDWH RI
29.5-127%. The studies using these two denominators will be explored further in 
Chapter 3.  
Table 2.14: Denominators used by studies identifying the rate of medication errors in 
general using mixed methods 
Denominator Number of 
studies 
Range of 
reported errors 
Comment 
Per 1000 patient 
days 
6 4-167 - 
Of all orders  3 1.29-11.6% - 
Of all admissions  3 29.5-127% - 
Of all patients 2 3-7.8% - 
Per 1000 doses 1 69.5-79.7 Before and after an 
intervention 
Of all medications 1 9.9% - 
Per 1000 orders 1 15 - 
2.4.9.4.4. Studies identifying dispensing errors 
Six studies used mixed methods to identify dispensing errors. Of all studies; four 
identified the rate and the number of dispensing errors and two only identified the 
number. Five studies were conducted in the US and one in New Zealand.  
 
One study was conducted in DVSHFLDOLVWFKLOGUHQ¶VKRVSLWDORQHLQa paediatric unit in 
a general hospital, one in a neonatal and paediatric unit in general hospital, one in 
outpatient clinic, one in paediatric oncology and one in an intensive care unit. Table 
2.15 illustrates the rate of dispensing errors identified in the studies and the 
denominators used. 7ZR VWXGLHV XVHG ³RI DOO HUURUV´ DQG WKH UHVXOW Uanged between 
0.2-3%.  
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Table 2.15: Denominators used by studies identifying the rate of dispensing errors 
using mixed methods 
Denominator Number of studies Range of reported 
errors 
Of all errors 2 0.2-3% 
Per 1000 patient days 1 11 
Of all admissions 1 7% 
Of all orders  1 1.1% 
Of all preparations  1 0% 
 
2.4.9.4.5. Studies identifying transcribing errors 
Three studies used mixed methods to identify transcribing errors. Two studies 
identified the rate and the number of transcribing errors and one only identified the 
number. All studies were conducted in the US. One study was conducted in an 
outpatient clinic, one in an intensive care unit and one in a neonatal and paediatric 
unit in a general hospital. The only example of specific transcribing errors was 
provided by Buckley et al. 2007 (143) who did not identify the rate of error, but 
identified the following types of errors: wrong dose, omission and wrong drug. The 
two studies identifying the rate of transcribing errors used ³RIDOOHUURUV´GHQRPLQDWRU
and the error rates varied between 2-32%. One study was conducted by Kaushal et al. 
2007 (144) in an outpatient clinic using review of medication charts and telephone 
interview with parents. The transcribing error rate was 2% of all errors. The second 
study by Wang et al. 2007 (106) in neonatal and paediatric units in a general hospital 
used review of medical records and review of medication error incident reports. The 
rate of transcribing errors was 32% of all errors.   
2.4.9.4.6. Studies identifying monitoring errors 
Two studies used mixed methods to identify the rate of monitoring errors. One study 
was conducted in the US and the other in New Zealand. ³2IDOOHUURUV´GHQRPLQDWRU
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was used in a neonatal and paediatric unit in a general hospital in the US and was 
1.3%, reviewing all medication records and incident reports (106). The other study by 
Kunac et al. 2008 (145) was conducted in a paediatric unit in a general hospital in 
New Zealand. The rate of monitoring errors from reviewing incident reports and 
reviewing charts showed the error rates to be 18 per 1000 patient days, 11% of all 
admissions and 1.7% of all orders. Neither of the studies provided examples of 
monitoring errors. 
 
Summary of studies using mixed methods   
Most studies using mixed methods identified prescribing and administration errors 
followed by medication errors in general. Most were conducted in the US, then the 
UK and India. Most studies were conducted in speciaOLVWFKLOGUHQ¶VKRVSLWDOV followed 
by paediatric units in general hospitals. Eleven different denominators were used with 
³of all orders´DQG³SHUSDWLHQWGD\V´EHLQJWKHPRVWFRPPRQ.  
 
2.4.9.5. Simulation studies 
Twelve studies used simulation to explore medication errors: one study examined 
prescribing errors and 11 studies examined administration errors 
 
2.4.9.5.1. Studies identifying prescribing errors 
A study was conducted in the US by Vaidya et al. 2006 (146) to assess the effect of 
CPOE. The prescribing error rate of continuous medication infusions decreased from 
73% to 4.3% of all orders after the intervention. 
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2.4.9.5.2. Studies identifying administration errors 
Ten studies identified the rate and the number of administration errors and one only 
identified the number. Ten studies were conducted in the US and one in Australia. 
Table 2.16 illustrates the rate of administration errors identified in the studies and the 
denominators used.  
 
Table 2.16: Denominators used by studies identifying the rate of administration errors 
using simulation studies 
Denominator Number of 
studies 
Range of 
reported errors 
Comment 
Of all participants 3 21-86% - 
Of all 
administrations 
3 0-100% - 
Of all orders 2 0.63-35.6% - 
Mean errors 1 (0.7)-1.8 (with) and without 
intervention. 
Of all doses 1 (0-21) and 12-
28% 
Before and (after) 
intervention. 
 
³2I DOO SDUWLFLSDQWV´ GHQRPLQDWRU ZDV XVHG E\ WKUHH VWXGLHV FRQGXFWHG LQ WKH 86
Wheeler et al. 2008 (147) identified dosing errors by doctors using mass 
concentration (e.g. 1 mg in 1 ml) or ratio concentration (e.g. 1 ml of 1:1000) labels. 
The error rate was higher with ratio concentration labels (86% of all doctors) than 
with mass concentration labels (21%). The second study, by Sobhani et al. 2008 
(148), assessed the measurement of 5 ml acetaminophen suspension by participants 
using a dosing cup (associated with 85.4% errors) or oral syringe (33.3% errors). The 
third study was conducted by Yin et al. 2011 (149) to assess pareQWV¶PHDVXUHPHQWRI
acetaminophen using a dropper. The error rate was 59% of all participants when 
written instructions about the administration of paracetamol were provided and 43.9% 
of all participants when pictogram instructions were provided.   
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As can be seen from Table 16; three VWXGLHV XVHG ³RI DOO DGPLQLVWUDWLRQV´ DV WKH
denominator with a wide range of results from 0-100%. All studies were conducted in 
the US. The first study was conducted by Sowan et al. 2010 (110) and identified 
errors by nurses for setting infusion pumps. The error rate was 39% with handwritten 
orders and 37% with CPOE.  
The second study was conducted by Yin et al. 2010 (48) to identify the error rate by 
parents administering 5 ml of acetaminophen to their children using six different 
instruments. Errors were mostly associated with dosing cups with printed calibration 
marking (69.5%) followed by dosing cups with etched calibration marking (50%). 
The instrument associated with the lowest rate of administration errors was an oral 
syringe (9%) followed by a dosing spoon (14%).  
 
7KHWKLUGVWXG\E\3DXO\2¶1HLO(150) identified administration errors by nurses 
before and after an educational session followed by an exam. Administration errors 
involved wrong medication, wrong patient, wrong time, wrong route of 
DGPLQLVWUDWLRQZURQJGRVHZURQJGLOXWLRQDQGQRWDVVHVVLQJSDWLHQWV¶DOOHUJ\ status. 
The error ranged from 5-100% before the intervention and 0-53% after the 
intervention. All types of administration errors were reduced apart from wrong dose 
which slightly increased from 12 to 16.7%.   
 
Summary of studies using simulation studies    
Most studies using simulation identified administration errors. Most studies were 
conducted in the US. )LYH GLIIHUHQW GHQRPLQDWRUV ZHUH XVHG ZLWK ³RI DOO
DGPLQLVWUDWLRQV´DQG³RIDOORUGHUV´being the most common which was each used by 
three studies to identify the rate of administration errors.  
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2.4.9.6. Summary of all studies 
Table 2.17 summarises all results identified and illustrates the number of studies using 
each denominator to identify each type of errors categorised according to the methods 
of data collection.   
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Table 2.17: Number of studies providing error rates by denominators and methods   
 
 
Denominator 
Chart/medical record review Direct 
observation 
Medication error incident 
report review 
Mixed methods Simulation  Total 
number of 
studies   
M
PE
s 
M
A
Es
 
M
Es
 
M
TE
s 
M
M
Es
 
M
D
Es
 
M
PE
s 
M
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Es
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PE
s 
M
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Es
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Es
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Es
 
M
PE
s 
M
A
Es
 
M
Es
 
M
TE
s 
M
M
Es
 
M
D
Es
 
M
PE
s 
M
A
Es
 
Of all errors 6 2  1 2 4   7 7  5 3 5 2 2  2 1 2   51 
Of all orders 27 1 5 2       2    4 1 3  1 1 1 2 50 
Of all patients 3 2 3    1    2    2 1 2      16 
Of all administrations   1      8        1      3 13 
Per 1000 patient days 1  1      1      1 1 6  1 1   13 
Of all admissions 1  1   1     1    1 1 3  1 1   11 
Of all medications 3  1 1       1      1      7 
Mean errors 4                     1 5 
Per 1000 orders   1      3        1      5 
Of all patient visits 2  1       1             4 
Of all participants                      3 3 
Of all medication days 1  1 1                   3 
Of all doses      1                1 2 
Per 1000 administrations 1         1             2 
Of all possible errors  1              1       2 
Median errors 1                      1 
Visits per 10,000 individuals per year          1             1 
Per 100 patient days   1                    1 
Of all preparations                    1   1 
Of all samples      1                  1 
Per 3.9 hospitalisation days   1                    1 
Per 1000 doses                 1      1 
Of all transcriptions    1                   1 
Of all charts   1                     1 
Of all ADEs   1                    1 
Per bed day    1                    1 
Total number of studies  50 8 18 6 3 6 1 8 11 10 6 5 3 5 10 8 17 2 4 6 1 10 198 
Legend: Bold underlined numbers are studies with wide variations (> 50%) in results. These studies will be explored further in Chapter 3.   
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2.5. 'LVFXVVLRQ 
*KDOHEHWDO¶V V\VWHPDWLF UHYLHZLGHQWLILHGUHOHYDQWVWXGLHVRIPHGLFDWLRQ
errors in children from 1966 to March 2006. In my project, 153 studies have been 
identified from the five years April 2006 - March 2011. This suggests that the 
literature on the subject is increasing very quickly.  
 
Many factors in study design can affect the rate of errors determined. These factors 
make comparing the rates of errors in different studies difficult and often impossible. 
The following summary of my findings illustrates this: 
1. Two hundred and thirty six different definitions of medication errors were 
used by 78 studies. 
2. Many studies did not identify the rate of medication errors (44 studies only 
identified the number of errors). 
3. Five different methods were used to identify errors (chart/medical record 
review (39.2%), review of incident reports (32.7%), mixed methods (15.1%), 
simulation (7.8%) and direct observation (5.2%). Lots of US studies seem to 
rely on reviewing medication error incident reports. 
4. The rate of error identified in some studies was for specific types of 
medication errors and in others was general: prescribing errors (28.8%), 
several specific types of errors (27.5%), administration errors (23.5%), 
medication errors in general (18.9%), dispensing errors (0.65%) and 
monitoring errors (0.65%).  
5. Twenty six different denominators were used. The commonest denominators 
XVHGZHUHUHVSHFWLYHO\³RIDOOHUURUV´³RIDOORUGHUV´DQG³RIDOOSDWLHQWV´ 
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6. Twenty two different settings were used PRVWO\VSHFLDOLVWFKLOGUHQ¶VKRVSLWDOs 
followed respectively by neonatal units and paediatric units in general 
hospitals). 
7. Studies were conducted in 30 different countries often using different 
healthcare systems (mostly the US followed by the UK). 
8. Some studies investigated medication errors with all medications (73 studies) 
while some studies only investigated errors with specific medications such as 
chemotherapy (seven studies) and antimicrobials (four studies). 
9. Some studies investigated errors with only a particular route of administration, 
e.g. intravenous. 
10. Studies used different designs, e.g. prospective or retrospective chart review. 
11. Some studies identified the rate of errors in the whole paediatric population 
and some identified the rate of errors in specific ages.  
12. Some studies focused only on medication errors, while others focused on 
medical errors in general or adverse drug events (which include medication 
errors). 
13. Fifty-nine out of 153 studies used 65 interventional tools which affected the 
error rates. 
14. Many settings used routine strategies for decreasing the rate of medication 
error (e.g. electronic prescribing or clinical pharmacy services); therefore, the 
rate of medication errors may be altered by these strategies.  
15. Some studies used simulation rather than collecting data from clinical settings. 
16. Chart /medical record review was used to identify prescribing errors more than 
other types of errors.  
17. Direct observation was mainly used to identify administration errors.  
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18. Review of medication error incident reports was used mostly to identify 
medication errors in general. 
19. Prescribing and administration errors followed by medication errors in general 
were the commonest errors identified using mixed methods. 
20. Simulation studies mostly focused on administration errors.  
21. The ranges reported for specific types of errors identified by the same methods 
are very wide in many cases. 
 
McLeod et al. 2013 (151) identified quantitative observational studies exploring 
administration error rates in the UK. They aimed to measure the effect of variations in 
methods on the rate of administration errors identified. They identified 44 
administration errors subcategories from 16 UK studies using four different 
denominators. Different factors were identified to be responsible for the variation in 
the administration error rates found. These factors include: methods of data collection, 
URXWHRIDGPLQLVWUDWLRQSDWLHQWV¶DJHGHILQLWLRQVXVHGLQFOXGLQJH[SOLFLWLQFOXVLRQDQG
exclusion criteria, subtypes of errors and denominators. McLeod only studied 
observational methods measuring administration errors. In my own systematic review 
of the factors influencing the rate of all medication errors in paediatric patients; the 
above factors identified by McLeod plus 15 other factors were identified.  
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All of these factors make it very challenging to compare studies and therefore the plan 
is to study the following in more depth in the next chapter of my thesis: 
a) The reasons for the wide variation in reported error rates in studies which used 
the same methods, the same denominators and identified the same types of 
medication error.  
b) The relationship between the methods used for data collection and the results; 
i.e. how did specific types of error rates vary between studies using different 
methods of data collection. 
c) The relationship between the clarity of definitions used in studies and their 
results. 
d) The effect of different interventional tools in reducing the rate of medication 
errors. 
e) Studies conducted in the UK identifying the rate of medication errors and 
different methods used to prevent these errors. 
f) Studies describing the time of the day and days of the week mostly associated 
with errors.  
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&KDSWHU'HWDLOHGDQDO\VLVRISDSHUVIURP
&KDSWHU 
3.1. ,QWURGXFWLRQ 
From reviewing the studies in Chapter 2 it has been noticed that the reported error 
rates for studies of the same types of errors using the same methods of data collection 
are very wide. It has been also noticed that different studies used different methods of 
data collection to identify the same type of medication errors using the same 
denominators. Moreover, different studies used different definitions of medication 
errors and different interventional tools. Few studies identified the time of the day 
and/or the days of the week mostly associated with errors. The UK studies represented 
10.5% of all studies. Because my project is based in the UK, these studies were 
explored in more detail in this chapter in order to establish what has already been 
done and what gaps in knowledge exist.  
3.2. $LP 
1. To identify factors responsible for wide variations in error rate  
2. To identify the relationship between methods of data collection and results  
3. To identify the relationship between the clarity of definitions and results 
4. To identify interventional tools used to minimise medication errors 
5. To explore the UK studies   
6. To identify the time of day and days of the week mostly associated with errors 
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3.3. 0HWKRGV 
3.1. To identify factors responsible for wide variations in error rate; comparable 
studies must have identified the rate of the same type of medication errors, used the 
same denominator, used the same methods of data collection and conducted in the 
same setting. To compare studies, one has to identify studies with wide variation and 
this was defined as a difference between the highest and the lowest error rate of 
more than 50%. This was chosen as this was felt to be a significant difference 
unlikely to be explained by variation, for example times of year that the study was 
done. Simulation studies were not included in the analysis as they do not reflect the 
true error rate in real-life.  
3.2. To identify the relationship between methods of data collection and results; 
comparable studies must have identified the rate of the same type of medication 
errors, used the same denominator and used different methods of data collection. 
Simulation studies were not used in comparisons as they do not reflect the true error 
rate in the real-life. Tables containing details of the relevant studies can be found in 
Appendix 2 for further reference. 
3.3. To identify the relationship between the clarity of definitions and results; 
comparable studies must have identified the rate of the same type of medication 
errors, used the same denominator, used the same methods of data collection and used 
different clarity rating of definitions.  
All studies which provided an error rate and used one or more definitions for 
medication errors were assessed in terms of the clarity of the definitions they used and 
whether this matched the aim of each study.  
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Clarity of definitions was judged according to the following rating: 
1. Definitions not clear enough to meet study aims. 
2. Definitions clear enough to meet some of study aims. 
3. Definitions very clear and will meet all study aims. 
Each definition in relation to the stated aims of each study was rated by both my 
supervisors and myself independently. These ratings of the clarity of the definitions 
were then compared, and a discussion between the three of us was conducted to agree 
on final ratings. 
3.4. Studies with intervention were separately identified in order to explore the types 
of interventions used and their effects on the rate of medication errors in children. 
3.5. The UK studies were separately identified to identify the rate of medication errors 
and the different methods used either to identify or prevent these errors.  
3.6. Studies which identified the time of the day and days of the week mostly 
associated with errors were separately identified. 
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3.4. 5HVXOWV 
3.4.1. Identifying factors responsible for wide variations in error rate 
Four groups of studies with a wide variation in error rates (which were conducted in 
the same setting) were identified.   
Table 3.1: Studies using the same denominators showing wide variation in error rates 
classified according to methodology and type of errors  
 
Method  Type of 
medication 
errors  
Denominator Number 
of studies 
Range of 
reported 
errors 
Number of different 
settings  
 with wide 
variation  
Chart/medical 
record review 
MPEs Of all orders 27 0-90.5% 10 3 
Of all errors 6 0.7-89% 6 1 
Direct 
observation 
MAEs Of all 
administrations 
8 1.2-96.6% 5 1 
Mixed methods MEs Per 1000 patient 
days 
6 4-167 * 4 2 
 
* Wang et al. 2007 (106) identified more than one error per admission. 
 
 
 
3.4.1.1.Studies using ³RIDOORUGHUV´as the denominator and identified prescribing 
errors using chart/medical record review  
Studies LQWKUHHGLIIHUHQWVHWWLQJVVSHFLDOLVWFKLOGUHQ¶VKRVSLWDOSULPDU\FDUHFHQWUHV
and outpatients) were associated with a wide variation in error rate. 
)RXU VWXGLHV LQ VSHFLDOLVW FKLOGUHQ¶V hospitals showed error rates of 1.2-82% of all 
orders (68). Two of these studies used interventions. The rate of error was very high 
in only one study looking at controlled substances such as opiate drugs and was 82% 
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of all orders. The authors of this study suggested that the cause for the high error rate 
was because the drugs studied were high risk medications. Another study (96) just 
looking at sedation medication found the next highest error rate of 25%. The 
remaining studies looked at all medications. The Senegal study (120) showed a 
relatively high rate of 17% compared to a UK study (152) that identified a very low 
error rate both before and after the intervention (introduction of CPOE). The authors 
of this study suggested that this is because the study only identified dosing prescribing 
errors.   
Four studies were conducted by the same authors in primary care centres in Bahrain. 
The overall error rate range was between 2.5-90.5% of all orders. In each study 
specific subsets of prescribing errors were studied with specific types of medications 
and this accounts for much of the variation. One study (153) identified a very high 
rate of errors (90.5% of all orders) and involved all medications, unlike the other three 
studies (154-156) which identified errors with particular drug groups. The authors 
identified three types of prescribing errors for the study involving all medications, 
omission, commission and integration errors. They define each type as following: 
x 0LQRU RPLVVLRQ HUURUV ³DEVHQFH RI SUHVFULSWLRQ FRPSRQHQWV VXFK DV GDWH RI
SUHVFULSWLRQ DQ\ SDUDPHWHU RI SDWLHQW¶V SHUVRQDO LGHQWLILHUV SK\VLFLDQ¶V VWDPS
and/or direction IRU XVH´ 0DMRU RPLVVLRQ HUURUV ³DEVHQFH YDJXH LQFRPSOHWH
DQGRULOOHJLELOLW\RIDQ\FRPSRQHQWRIERG\RIWKHSUHVFULSWLRQ´ 
x &RPPLVVLRQ HUURUV ³LQFRUUHFWO\ ZULWWHQ FRPSRQHQWV RI ERG\ RI WKH
SUHVFULSWLRQ´ 
x Errors of integration or knowledge-based errors LQSUHVFULELQJ³LQFOXGHSRWHQWLDO
drug-drug interactions or drug allergies which may reflect a failure of the 
SUHVFULEHUWRLQWHJUDWHLQIRUPDWLRQDERXWWKHSDWLHQWRUGUXJKLVWRU\´ 
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According to the study authors; the reason for high error rate is because of the lack of 
a national drug policy and irrational drug use in primary care centres. 
Two studies (157) (57) were conducted in outpatients (error rate between 9.7-62.2% 
of all orders). Neither study used an intervention and both involved all medications. 
The Nigerian study (157) relates its high rate of error (62.2%) to irrational 
prescribing. Under-dosing (38% of all medications) and overdosing (19% of all 
medications) were identified as common errors as well as inadequate treatment 
courses (28% of all medications). They emphasised the urgent need for a prescribing 
monitoring committee. The other study conducted in the US found a far lower error 
rate of 9.7% (57).    
3.4.1.2.Studies using ³RIDOO HUURUV´ as the denominator and identified prescribing 
errors using chart/medical record review  
One study showed wide variation in error rate. Jain et al. 2009 (70) from India 
explained most of the wide variation with an error rate seen. This study identified 
only prescribing and dispensing errors of which 43 prescribing errors were in the 
emergency department and 24 prescribing errors in the neonatal unit. Of all 
medication errors in the emergency department; 79% were prescribing errors (70% of 
all errors by senior doctors and 9% by junior doctors). Eighty-nine percent of all 
errors in the neonatal unit were related to prescribing errors by senior doctors. The 
authors suggested that environmental issues in emergency departments (e.g. stress, 
QRLVH DQG FURZGLQJ FDXVHG E\ SDWLHQWV¶ FDUHUV YHUEDO RUGHUV DQG a shortage of 
healthcare professionals could be causes of the high rate of prescribing errors. The 
reason why senior doctors were involved in more prescribing errors than junior 
doctors is not explained. However, as this study only identified two types of 
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medication errors (prescribing and dispensing) it is clearly an important reason for the 
high prescribing error rates identified. 
3.4.1.3.Studies using ³RI DOO administrations´ as the denominator and identified 
administration errors using direct observation   
Three studies in paediatric units in general hospitals showed a wide variation in error 
rates. The error rate was very high (89.9%) in the study (158) in Ethiopia which 
identified administration errors by nurses and parents. A wrong time error (delay in 
administration by more than one hour) was responsible for the highest portion of 
errors (28%). Conroy, in the UK, showed a very low error rate of 1.2% of all 
administrations (142) and Chua, in Malaysia, showed 11.7% of all administrations 
(67). Only doctors and/or nurses were involved in administration in these studies.  
3.4.1.4.Studies using ³SHUSDWLHQWGD\V´and identified medication errors in 
general and using mixed methods  
Studies in two different settings (neonatal and paediatric units in general hospitals and 
paediatric units in general hospitals) showed wide variation in error rates.  
Two studies (106, 159) identified the error rate in neonatal and paediatric units in 
general hospitals in the US. One (159) only identified serious medication errors and 
therefore had a much lower number of errors identified. 
For the two studies (145, 160) that were conducted in paediatric units in general 
hospitals; the study by Walsh (160) was retrospective and only identified errors 
related to electronic order entry which is likely to explain the much lower error rate 
than the prospective study from New Zealand (145).  
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3.4.2. Identifying the relationship between methods of data collection 
and results 
All denominators that were used by the different studies are presented in Tables 2-7 
according to the type of errors identified.   
3.4.2.1. Prescribing errors 
Table 3.2 shows the 12 different denominators used by studies that identified the rate 
of prescribing erroUV6WXGLHVXVLQJ³RIDOORUGHUV´³RIDOO HUURUV´ ³RI DOOSDWLHQWV´
³SHU  SDWLHQW GD\V´ DQG ³RI DOO DGPLVVLRQV´ GHQRPLQDWRUV ZLOO EH GLVFXVVHG LQ
more detail as each of these denominators was used by studies using different 
methodologies.  
 
Table 3.2: Denominators used in prescribing error studies 
 
Denominator Range of reported errors  Chart/medical 
record review     
Direct 
observation      
Medication 
error incident 
report review      
Mixed 
methods        
Number of studies 
Of all orders Range of reported errors  0-90.5% 8 8 1.06-27% 
Number of studies 27 8 8 4 
Of all errors Range of reported errors  0.7-89% 8 1.1-24.4% 26-54% 
Number of studies 6 8 7 2 
Mean errors Range of reported errors  0.1±0.3-14.8 8 8 8 
Number of studies 4 8 8 8 
Of all patients Range of reported errors  4.8-74% 29.1% 8 40-189% 
Number of studies 3 1 8 2 
Of all medication 
days 
Range of reported errors  33-52% 8 8 8 
Number of studies 1 8 8 8 
Of all patient 
visits 
Range of reported errors  13-32.6% 8 8 8 
Number of studies 2 8 8 8 
Per 1000 orders Range of reported errors  8 8 0.03-5.93 8 
Number of studies 8 8 3 8 
Median errors Range of reported errors  1 8 8 8 
Number of studies 1 8 8 8 
Per 1000 patient 
days 
Range of reported errors  5 8 2.67 74 
Number of studies 1 8 1 1 
Per 1000 
administrations 
Range of reported errors  0.09 8 8 8 
Number of studies 1 8 8 8 
Of all admissions Range of reported errors  47% 8 8 43% 
Number of studies 1 8 8 1 
Of all medications Range of reported errors  4.6-77.4% 8 8 8 
Number of studies 3 8 8 8 
Total number of studies  50 1 11 10 
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3.4.2.1.1. 6WXGLHVXVLQJ³RIDOORUGHUV´WRLGHQWLI\SUHVFULELQJHUURUV 
³2IDOORUGHUV´GHQRPLQDWRUZDVXVHGE\VWXGLHV7DEOHLQ$SSHQGL[WKDWXVHG
chart/medical record review. This denominator was used also by four studies (Table 2 
in Appendix 2) that used mixed methods. Two of the four studies using mixed 
methods identified the error rate separately for each method (24, 93). They identified 
the prescribing error rates separately after chart review and other types of errors using 
different methods. Therefore there are 29 studies used the same method (i.e. 
chart/medical record review) and so they offer no information on differences in data 
collection methods and results. They can be compared with the two further studies 
that used mixed methods and provided prescribing error rates from the combined 
methods (145, 161).  
 
Landrigan et al. 2008 (161) found prescribing errors in 1.06% of all orders in a 
VSHFLDOLVW FKLOGUHQ¶V KRVSLWDO LQ WKH 86 XVLQJ FKDUW UHYLHZ SOXV UHYLHZ RI LQFLGHQW
reports. This was similar to the error rate of 2.2% found by Jani et al. 2010 (152) in 
the same setting in the UK using chart review alone. 
Kunac et al. 2008 (145) found a prescribing error rate of 7.1% in a paediatric unit in a 
general hospital in New Zealand using chart review plus incident reporting. This was 
much lower than the rates of 30.5% found by Davey et al. 2008 (104) in the same 
setting in the UK and 26.8% found by Kjeldby et al. 2009 (117) in Norway.      
Review of incident reports in addition to chart review does not seem to have a major 
effect on the results.  
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3.4.2.1.2. 6WXGLHVXVLQJ³RIDOOHUURUV´WRLGHQWLI\SUHVFULELQJHUURUV 
Six studies used chart/medical record review (Table 3 in Appendix 2) and seven 
studies used revieZRILQFLGHQWUHSRUWV7DEOHLQ$SSHQGL[DQGWKH³RIDOOHUURUV´
denominator to identify the rate of prescribing errors.  
2QO\ WZR VWXGLHV ZHUH FRQGXFWHG LQ WKH VDPH VHWWLQJ LH D VSHFLDOLVW FKLOGUHQ¶V
hospital. Takata et al. 2008 (132) identified prescribing errors as 50% of all errors via 
chart review (other types of errors were administration, dispensing, transcribing and 
monitoring errors) while Miller et al. 2010 (76) identified 12.8% of all errors as 
prescribing errors via reviewing of incident reports (other types of errors were 
administration, dispensing and transcribing errors).  
Overall studies using chart/medical record review identified a wide range of results 
from 0.7% to 89% of all errors being prescribing errors. Most studies gave results of 
28% and above. The studies using incident reporting as the method of data collection 
gave much smaller figures ranging from 1.1 to 13.9%.    
As can be seen from this comparison; chart review seems to identify a higher 
proportion of all errors as prescribing errors than review of incident reports.    
Two US studies each used two methods without separating the error rates. Kaushal et 
al. 2007 (144) used chart review and patients (or parents) telephone interview after 
SDWLHQWV¶ GLVFKDrge from the hospital. Wang et al. 2007 (106) used medical record 
review and review of medication error incident reports and was conducted in a 
neonatal and paediatric unit in a general hospital.   
Kaushal et al. study was conducted in an outpatient department and identified 26% of 
all errors to be prescribing errors (other types were administration, dispensing and 
transcribing). Walsh et al. 2009 (27) (Table 3 Appendix 2) also studied US outpatient 
department and identified 64% of all chemotherapy errors as prescribing errors 
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(others were administration, dispensing and monitoring) using chart review. The 
mixed methods study by Kaushal et al. identified far less prescribing errors (for all 
medications) than Walsh et al. The different drugs studied is however likely to 
influence the variation in prescribing error rates between these two studies. Adding 
parental telephone interview to chart review methods did not seem to increase the 
errors detected however, but the differences in medications studied makes this 
difficult to compare. 
Wang et al. study was conducted in a neonatal and paediatric unit in a general hospital 
and identified 54% of all errors as prescribing errors (others were administration, 
dispensing, monitoring and transcribing). This was a higher rate of error therefore 
using both methods may have increased error detection in this study, however no 
other study was conducted in this setting to compare it to. 
3.4.2.1.3. 6WXGLHVXVLQJ³RIDOOSDWLHQWV´WRLGHQWLI\SUHVFULELQJHUURUV 
Three studies used chart/medical record review (Table 5 in Appendix 2) and one 
VWXG\ GHWDLOHG EHORZ XVHG GLUHFW REVHUYDWLRQ DQG ³RI DOO SDWLHQWV´ GHQRPLQDWRU WR
identify the rate of prescribing errors.  
Osterholt et al. 2006 (134) used direct observation to identify prescribing errors in 
outpatients in Malawi. The study involved infants and children and found 29.1% of 
patients with antimalarial drug prescribing errors. This study cannot helpfully be 
compared with the three studies using chart review because they were conducted in 
different settings (an emergency department, an intensive care unit and a specialist 
FKLOGUHQ¶VKRVSLWDODQGHDFKLQYROYHGGLIIHUHQWW\SHVRIGUXJV (all drugs, resuscitation 
drugs and aciclovir).   
Two studies used mixed methods. Pote et al. 2007 (162) conducted a study in India in 
a paediatric unit in D JHQHUDO KRVSLWDO 7KH\ UHYLHZHG SDWLHQWV¶ FKDUWV SURVSHFWLYHO\
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and interviewed patients or their parents. They identified errors in 40% patients. 
Porter et al. 2008 (163) was conducted in two US emergency departments and used 
questionnaire, telephone interview and chart review. More than one error per patient 
was identified in one emergency department for both the control and the intervention 
JURXSV SDUHQWV XVLQJ D PRELOH NLRVN WR HQWHU V\PSWRPV SDWLHQW¶V DOOHUJ\ DQG
medication history). The rate of error did not decrease significantly between both 
control and intervention groups (173% vs. 134% of all patients; p=0.35). Marcin et 
al.¶VVWXG\LQ 2007 (164) (Table 5 in Appendix 2) also in an emergency department in 
the US identified 11.9% of all patients to involve prescribing errors using chart 
review. Using mixed methods (i.e. questionnaire, telephone interview and chart 
review) seemed to identify a higher rate of prescribing errors than using chart review 
alone.    
3.4.2.1.4. StudLHVXVLQJ³SHUSDWLHQWGD\V´WRLGHQWLI\SUHVFULELQJHUURUV 
Three studies identified the prescribing error rates using ³SHU  SDWLHQW GD\V´
denominator. Two were conducted in the same setting. Di Pentima et al. 2009 (165) 
ZDV FRQGXFWHG LQ D VSHFLDOLVW FKLOGUHQ¶V KRVSLWDO LQ WKH 86 using chart review for 
antimicrobials. They did not provide the prescribing error rate before their 
intervention (using CPOE and an antimicrobial stewardship program) and identified a 
prescribing error rate of 5 per 1000 patient days after the intervention for 13 
antimicrobials. The second study by Takata et al. 2008 (135), also in a specialist 
FKLOGUHQ¶V KRVSLWDO LQ WKH 86 identified a prescribing error rate of 2.67 per 1000 
patient days after reviewing incident reports for all medications. Again chart review 
seems able to identify a higher rate of prescribing errors compared to review of 
incident reports, however this is very limited by only being able to compare two 
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studies and this will be influenced by the fact that Di Pentima only studied 
antimicrobials. Error rates seem low in both studies.     
Mixed methods (chart review and review of incident reports) were used by Kunac et 
al. 2008 (145) in a paediatric unit in a general hospital in New Zealand and identified 
74 errors per 1000 patient days for all medications. Using these two methods together 
resulted in a much higher prescribing error rate being identified compared with the 
studies detailed above. The setting was different but the difference in results suggests 
that combining methods in the study may have increased error detection.  
3.4.2.1.5. 6WXGLHVXVLQJ³RIDOODGPLVVLRQV´WRLGHQWLI\SUHVFULELQJHUURUV 
³2IDOODGPLVVLRQV´GHQRPLQDWRUZDVXVHGE\WZRVWXGLHVA UK study by Eisenhut et 
al. 2011 (166) identified 47% of all admissions to be associated with prescribing 
errors using chart review. Kunac et al. 2008 (145) from the New Zealand identified 
43% of all admissions to involve prescribing errors using chart review and review of 
incident reports. Both studies included all medications and were conducted in 
paediatric units in general hospitals. The study using mixed methods identified similar 
error rate to the study using chart review alone but care needs to be taken as before as 
they are only two studies so firm conclusions are difficult to make.    
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3.4.2.2.Administration errors 
Table 3.3 shows the 11 different denominators that were used by studies that 
LGHQWLILHG WKH UDWH RI DGPLQLVWUDWLRQ HUURUV 6WXGLHV XVLQJ ³RI DOO RUGHUV´ ³RI DOO
SRVVLEOH HUURUV´ ³RI DOO DGPLQLVWUDWLRQV´ ³RI DOO HUURUV´ DQG ³RI DOO SDWLHQWV´
denominators will be discussed in more detail as these studies used different methods.    
 
Table 3.3: Results from administration error studies 
 
Denominator Range of reported errors  Chart/medical 
record review    
Direct 
observation      
Medication 
error incident 
report review        
Mixed/ other 
methods           
Number of studies 
Of all charts Range of reported errors  15-25% 8 8 8 
Number of studies 1 8 8 8 
Of all orders Range of reported errors  3-6% 8 8 5.2% 
Number of studies 1 8 8 1 
Of all possible 
errors 
Range of reported errors  14.8% 8 8 19.1% 
Number of studies 1 8 8 1 
Of all 
administrations 
Range of reported errors  5.9-8.4% 1.2- 96.6% 8 20.5- 63.8% 
Number of studies 1 8 8 1 
Of all errors Range of reported errors  0-5% 8 30-93.2% 12- 70% 
Number of studies 2 8 7 2 
Of all patient visits Range of reported errors  8 8 8% 8 
Number of studies 8 8 1 8 
Per 1000 patient 
days 
Range of reported errors  8 8 8 54 
Number of studies 8 8 8 1 
Visits per 10,000 
individuals per year 
Range of reported errors  8 8 0.7 8 
Number of studies 8 8 1 8 
Tenfold errors (per 
1000 
administrations) 
Range of reported errors  8 8 0.595-0.718 8 
Number of studies 8 8 1 8 
Of all patients Range of reported errors  22.7-87.5% 8 8 75% 
Number of studies 2 8 8 1 
Of all admissions Range of reported errors  8 8 8 32% 
Number of studies 8 8 8 1 
Total number of studies  8 8 10 8 
 
 
3.4.2.2.1. 6WXGLHVXVLQJ³RIDOORUGHUV´WRLGHQWLI\DGPLQLVWUDWLRQHUURUV 
7ZRVWXGLHVLGHQWLILHGWKHDGPLQLVWUDWLRQHUURUUDWHXVLQJ³RIDOORUGHUV´GHQRPLQDWRU
Larose et al. 2008 (167) used chart review and identified 6% of all orders before using 
a standard order form and 3% after. This study was conducted in an emergency 
department in Canada and only involved IV medications and fluids. Kunac et al. 2008 
87 
 
(145) used chart review and review of incident reports and identified 5.2% of all 
orders (for all medications) to involve administration errors in a paediatric unit in a 
general hospital in New Zealand. Both studies identified similar error rates and may 
suggest that using chart review plus review of incident reports does not increase 
administration error rates identified.  
 
3.4.2.2.2. 6WXGLHVXVLQJ³RIDOOSRVVLEOHHUURUV´WRLGHQWLI\DGPLQLVWUDWLRQHUURUV 
Sullivan et al. 2010 (168) used chart review and identified 14.8% of all insulin 
DGPLQLVWUDWLRQWREHDVVRFLDWHGZLWKHUURUVLQDVSHFLDOLVWFKLOGUHQ¶VKRVSLWDOLQWKH86
Ghaleb et al. 2010 (24) used direct observation of nurses and review of incident 
reports in UK VSHFLDOLVWFKLOGUHQ¶VKRVSLWDOVDQGSDHGLDWULFXQLWVLQJHQHUDOKRVSLWDOV, 
and identified administration errors as 19.1% of all possible errors for all medications 
(except parenteral nutrition). No administration errors were reported on incident 
reports. As the two studies involved different drugs the effect of each method on 
identifying administration errors is unclear for this denominator.  
3.4.2.2.3. 6WXGLHVXVLQJ³RIDOODGPLQLVWUDWLRQV´WRLGHQWLI\DGPLQLVWUDWLRQHUURUV 
Eight studies used direct observation (Table 6 in Appendix 2). Error rates varied 
between 1.2-42% of all administrations when healthcare professionals were studied. 
Rates were much higher when parents were included.  
 
Otero et al. 2008 (29) used chart/medical record review ZLWK WKH ³RI DOO
DGPLQLVWUDWLRQV´GHQRPLQDWRUWRLGHQWLI\WKH rate of administration errors in a neonatal 
and paediatric unit in a general hospital in Argentina. They identified 8.4% of all 
administrations by nurses to involve an error before an educational programme and 
5.9% after the education. This study involved neonates, infants, children and 
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adolescents. Administration error rate detection therefore seems generally lower with 
chart review than direct observation though rates vary and only one study could be 
compared.  
From the studies using direct observation the highest rate of administration errors was 
seen when parents administered medications to their children (96.6% of all 
administrations) in a paediatric neurology unit in Germany by Bertsche et al. 2010 
(169). The lowest error rate was found by Conroy et al. 2007 (142) in a UK paediatric 
unit in a general hospital when only nurses were involved in the administration 
process (1.2% of all administrations). When the rate was identified for administration 
errors by both doctors and nurses the rate was 11.7% in a Malaysian study by Chua et 
al. 2010 (67) in a paediatric unit in a general hospital. This may suggest that 
administration error rates are high by parents and low by nurses, the number of 
comparable studies are few and cannot be generalised.      
Van Den Bemt et al. 2007 (47) LQ 1HWKHUODQGV XVHG GLUHFW REVHUYDWLRQ RI SDUHQWV¶
preparation and administration of medication in addition to review of incident reports. 
During the study period no administration error was documented through the 
reporting system. They observed errors in 63.8% of all administrations in one 
intellectual disability unit and 20.5% in another. Comparing this study to Bertsche et 
al. 2010 (169) which identified the rate of administration errors separately by nurses 
and by parents using direct observation; more administration errors were identified 
(96.6%) by parents in a paediatric neurology department in Germany. Both studies 
identified high administration error rates and the difference may be related to the 
setting (paediatric neurology is a high risk area) and/or the country. Incident reporting 
did not contribute any additional information. 
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3.4.2.2.4. 6WXGLHVXVLQJ³RIDOOHUURUV´WRLGHQWLI\DGPLQLVWUDWLRQHUURUV 
Seven studies used review of medication error incident reports (Table 7 in Appendix 
2). Administration errors were identified as 48-63% of all errors where all drugs were 
studied. Two studies using chart/medical record review (Table 8 in Appendix 2) 
identified the rate of administration errors to be 0% (Takata et al. 2008 (132)) and 5% 
(Walsh et al. 2009 (27) ³RI DOO HUURUV´ ,QFLGHQW UHSRUWLQJ VFKHPHV IRXQG D PXFK
higher proportion of errors to be administration errors than chart review.   
Comparing two of these studies which took place in the same setting and country; 
Miller et al. 2010 (76) used review of incident reports and identified administration 
errors to be 56.4% of all errors (other types of errors were prescribing, dispensing and 
WUDQVFULELQJHUURUV LQ D VSHFLDOLVW FKLOGUHQ¶VKRVSLWDO LQ WKH86 ,Q WKH VDPH VHWWLQJ
and country Takata et al. 2008 (132) identified no administration errors via chart 
review (other types of errors were prescribing, monitoring, transcribing and 
dispensing errors).  
Two studies used mixed methods. Kaushal et al. 2007 (144) from an outpatient 
department in the US identified 70% of all errors as administration errors (other types 
included prescribing, dispensing and transcribing) using FKDUW UHYLHZ DQG SDUHQWV¶
interview. Wang et al. 2007 (106) identified 12% of all errors as administration errors 
(others included prescribing, dispensing, transcribing and monitoring) in a neonatal 
and paediatric unit in a general hospital in the US. They used chart review and review 
of incident reports. This may suggest that using parental¶ LQWHUYLHZUHVXOWHGLQPRUH
administration errors being detected than using incident reports, however the settings 
and participants involved were quite different and probably more influential on the 
results than the methods used.    
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Comparing the two studies conducted in outpatients, the study mentioned above by 
Kaushal et al. 2007 identified far more administration errors (70% of all errors) 
compared with the study by Walsh et al. 2009 (27) (5% of all errors) which only 
identified chemotherapy administration errors using chart review, though again the 
drugs and participants involved were very different.  
3.4.2.2.5. 6WXGLHVXVLQJ³RIDOOSDWLHQWV´WRLGHQWLI\DGPLQLVWUDWLRQHUURUV 
Two studies used chart review and one used mixed methods. Kaji et al. 2006 (170) 
used chart review and identified 72% of all patients to be associated with 
administration errors by paramedics in the US before using the Broselow tape was 
compulsory and 43% after. Using the same method Sullivan et al. 2010 (168) from the 
US identified errors in 87.5% of all patients before education of nurses and 22.7% 
DIWHU LQD VSHFLDOLVW FKLOGUHQ¶VKRVSLWDO$OYHVHW DO (171) from a primary care 
unit in Brazil used questionnaires to study administration errors by parents using two 
antipyretics (acetaminophen and dipyrone) that were given just less than 24 hours 
prior to their arrival to emergency department. They identified 75% of all patients to 
be involved in administration errors. Similar administration error rates were found in 
the two studies using chart review with the study using questionnaires even though 
different participants were involved in each study. Participants involved in the 
administration process may be more responsible for the high error rate errors found 
rather than the methods used.  
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3.4.2.3.Medication errors in general 
Table 3.4 shows the 13 different denominators used by studies that identified the rate 
of medication errors in general. SWXGLHVXVLQJ³RIDOORUGHUV´³RIDOOSDWLHQWV´³SHU
SDWLHQWGD\V´³RI DOO DGPLVVLRQV´³SHURUGHUV´DQG³RIDOOPHGLFDWLRQV´
denominators will be discussed in more detail because these used different methods of 
data collection.     
Table 3.4: Results from medication errors in general studies 
 
Denominator Range of reported errors  Chart/medical 
record review    
Direct 
observation   
Medication 
error incident 
report review     
Mixed 
methods          
Number of studies 
Of all orders Range of reported errors  2.42-23% 8 0.21-0.24% 1.29-11.6% 
Number of studies 5 8 1 3 
Of all patients Range of reported errors  26.4-55% 8 4.9-34.3% 3-7.8% 
Number of studies 3 8 2 2 
Per 1000 patient 
days 
Range of reported errors  3.4- 4.5 8 8 4-167 
Number of studies 1 8 8 6 
Of all 
admissions 
Range of reported errors  2.2- 7.9% 8 4.9% 29.5-127% 
Number of studies 1 8 1 3 
Of all 
medication days 
Range of reported errors  34-53% 8 8 8 
Number of studies 1 8 8 8 
Per 1000 orders Range of reported errors  24.1 8 8 15 
Number of studies 1 8 8 1 
Of all 
medications 
Range of reported errors  7.6- 12.8% 8 0.02-3.3% 9.9% 
Number of studies 1 8 1 1 
Per 3.9 
hospitalisation 
days 
Range of reported errors  1 8 8 8 
Number of studies 1 8 8 8 
Of all patient 
visits 
Range of reported errors  18.8% 8 8 8 
Number of studies 1 8 8 8 
Of all adverse 
drug events 
Range of reported errors  56% 8 8 8 
Number of studies 1 8 8 8 
Per 100 patient 
days 
Range of reported errors  2.1 8 8 8 
Number of studies 1 8 8 8 
Per 1000 doses Range of reported errors  8 8 8 69.5-79.7 
Number of studies 8 8 8 1 
Per bed day Range of reported errors  1.1-1.8 8 8 8 
Number of studies 1 8 8 8 
Total number of studies  18 0 5 17 
 
92 
 
3.4.2.3.1. 6WXGLHVXVLQJ³RIDOORUGHUV´WRLGHQWLI\PHGLFDWLRQHUURUVLQJHQHUDO 
Five studies using chart/medical record review (Table 9 in Appendix 2) and one study 
XVLQJUHYLHZRILQFLGHQWUHSRUWVXVHG³RIDOORUGHUV´GHQRPLQDWRUWRLGHQWLI\WKHUDWH
of medication errors in general.  
Two studies were in the same setting of a paediatric intensive care unit. Burny et al. 
2006 (138) identified a 0.21% error rate of all orders in a US intensive care unit using 
review of incident reports. Kadmon et al. 2009 (105) conducted a study in Israel in the 
same setting and identified 8.2% of all orders to have medication errors by using chart 
review. Both studies involved all medications. Chart review seems more sensitive in 
identifying medication errors in general compared to review of incident reports from 
these two studies. This is supported by the studies in Table 9 using chart/medical 
record review where error rates ranged from 2.4% of all orders in psychiatric care to 
23% in a paediatric unit in a general hospital.   
Three studies used mixed methods. All used chart review and review of incident 
reports and involved all medications. Landrigan et al. 2008 (161) conducted a study in 
DVSHFLDOLVWFKLOGUHQ¶VKRVpital in the US. They identified errors in 1.29% of all orders 
before implementation of Accreditation Council for Graduate Medical Education and 
1.5% errors of all orders after. From a paediatric unit in New Zealand, Kunac et al. 
2008 (145) identified 11.6% of all orders as medication errors. Wang et al. 2007 (106) 
from a neonatal and paediatric unit in general hospital in the US identified 5.2% of all 
orders.  
The higher error rate was identified by studies using chart review followed by studies 
using chart review and review of incident reports. However, all studies identified error 
rates less than 23% (the most found by chart review alone) of all orders, therefore it is 
difficult to judge one method above the other in their ability in detecting medication 
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errors in general, but incident reporting does not seem to improve detected error rates 
over chart review alone.    
3.4.2.3.2. 6WXGLHVXVLQJ³RIDOOSDWLHQWV´WRLGHQWLI\PHGLFDWLRQHUURUVLQJHQHUDO 
Three studies used chart/medical records review (Table 10 in Appendix 2) and two 
studies used review of incident reports (Table 11 in Appendix 2) to identify the rate of 
medication errors in general using ³RIDOOSDWLHQWV´GHQRPLQDWRU 
Lerner et al. 2008 (75) and Ligi et al. 2010 (15) studies were both conducted in 
neonatal units. Lerner et al. 2008 identified 55% of patients in Brazil to be associated 
with medication errors by using chart review whereas Ligi et al. 2010 identified only 
4.9% of all patients in France to be associated with medication errors using a review 
of incident reports. This may be influenced by the country but suggests that chart 
review again is more sensitive in identifying medication errors in general than review 
of incident reports. Similar error rates of 26% and 39% were found in US emergency 
departments by chart review.  
Two studies used mixed methods. Benkirane et al. 2009 (172) from a Moroccan 
intensive care unit and a neonatal unit used direct observation and review of incident 
reports. They identified 7.8% of all patients to involve medication errors. Kaushal et 
al. 2007 (144) from a US outpatient department identified 3% of all patients to 
LQYROYHPHGLFDWLRQHUURUVDIWHUFKDUWUHYLHZDQGSDUHQWV¶LQWHUYLHZSetting probably 
had more influence than methods here though error rates were similar.    
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3.4.2.3.3.  6WXGLHVXVLQJ³SHUSDWLHQWGD\V´WRLGHQWLI\PHGLFDWLRQHUURUVLQ
general 
Holdsworth et al. 2007 (109) used chart review and identified 4.5 per 1000 patient 
days errors before using electronic prescribing and 3.4 after in a paediatric unit in a 
general hospital in the US.  
Six studies used mixed methods and identified error rates between 4-167 errors per 
1000 patient days (Table 12 in Appendix 2). Two studies using chart review and 
review of medication error incident reports were conducted in paediatric units in 
general hospitals. Walsh et al. 2006 (160) from the US identified 53.9 per 1000 
patient days and Kunac et al. 2008 (145) from New Zealand identified 121 errors per 
1000 patient days. When only chart review was used as above in the same setting in 
the US far less errors were identified by Holdsworth et al (109). This suggests that 
chart review together with review of incident reports is better at detecting medication 
errors. There was however an approximately two fold difference in the errors detected 
by Walsh (53.9 per 1000 days) and Kunac (121 errors per 1000 patient days) using the 
same methods.   
This wide variation is also seen between the results of two US studies (106, 159) that 
were conducted in neonatal and paediatric units in general hospitals and used both 
chart review and review of incident reports. Walsh et al. 2008 (159) only identified 
serious medication errors however and identified 7.9 per 1000 patient days before 
CPOE and 6.5 after CPOE. Wang et al. 2007 (106) identified 167 per 1000 patient 
days to be associated with errors of all severities and therefore the definition of errors 
seems the most important factor here.  
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3.4.2.3.4. 6WXGLHVXVLQJ³RIDOODGPLVVLRQV´WRLGHQWLI\PHGLFDWLRQHUURUVLQJHQHUDO 
+ROGVZRUWKHWDO¶V(109) study was conducted in a paediatric unit in a general 
hospital in the US using chart review and identified 3.8% of all admissions to be 
associated with medication errors (before starting electronic prescribing) and 2.2% 
DIWHU &KLOGUHQ¶V DJHV ZHUH QRW PHQWLRQHG /LJL HW DO 10 (15) used review of 
medication error incident reports and found 4.9% of all neonatal admissions to be 
associated with medication errors in France. Similar error rates were therefore found 
despite the different settings and data collection methods. 
Three studies used mixed methods. Walsh et al. 2006 (160) as mentioned before used 
chart review and review of incident reports and identified 29.5% of all admissions to 
be associated with medication errors, whereas Kunac et al. 2008 (145) found 71% of 
all admissions to involve errors using FKDUWUHYLHZDQGSDUHQWV¶LQWHUYLHZ:DQJHWDO
2007 (106) from a neonatal and paediatric unit in a general hospital in the US 
identified 127% of all admissions to involve errors. They used medical record review 
and review of medication error incident reports. Using chart review and review of 
incident reports resulted in more medication errors being identified in a neonatal and 
paediatric unit in a general hospital but less in a paediatric unit in a general hospital. 
However, using both methods resulted in more medication errors detected than using 
FKDUW UHYLHZDORQH:KHQFKDUW UHYLHZZDV FRPELQHGZLWKSDUHQWV¶ LQWHUYLHZPRUH
medication errors were identified. The diversity of these studies makes it difficult to 
draw conclusions here.  
3.4.2.3.5. 6WXGLHVXVLQJ³SHURUGHUV´WRLGHQWLI\PHGLFDWLRQHUURUVLQJHQHUDO 
Walsh et al. 2009 (27) identified 24.1 errors per 1000 orders in an outpatient 
department in the US using chart review, they only studied chemotherapy. Walsh et 
al. 2006 (160) in their paediatric unit in a general hospital however identified 15 
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errors per 1000 orders using chart review and review of incident reports. This 
difference is likely to be because the first study only included chemotherapy (high 
risk) while the second study included all medications.  
3.4.2.3.6. 6WXGLHVXVLQJ³RIDOOPHGLFDWLRQV´WRLGHQWLI\PHGLFDWLRQHUURUVLQJHQHUDO 
Kazemi et al. 2010 (102) used chart review and found 12.8% of all medications in 
POE (Physician Order Entry) and 7.6% of all medications in NOE (Nurse Order Entry) 
to be associated with errors, in a neonatal unit in Iran. All orders entered by 
physicians were reviewed by nurses and vice versa to identify MPEs and MTEs. 
Trotter et al. 2009 (121) used review of incident reports and identified 3.3% of all 
medications before and 0.02% of all medications to involve errors after electronic 
SUHVFULELQJ7KLVVWXG\ZDVFRQGXFWHGLQDVSHFLDOLVWFKLOGUHQ¶VKRVSLWDO LQ*HUPDQ\
DQGGLGQRWPHQWLRQWKHFKLOGUHQ¶VDJHV&KDUWUHYLHZDJDLQGHWHFWHGKLJKHUUDWHVRI
errors than incident reporting however the results may also have been influenced by 
the neonatal setting in Iran. 
One study used mixed methods (medical record review and direct observation of 
parents administering medications to their children). Taylor et al. 2006 (173) from the 
US identified 9.9% of all medications to involve errors (prescribing or administration) 
in an outpatient department and paediatric oncology department. Similar error rates 
were identified by Kazemi et al and by Taylor et al., however the different errors 
studied and settings are more likely to have influenced the results than the data 
collection methods.  
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3.4.2.4.Transcribing errors 
Table 3.5 shows the five different denominators used by studies that identified the rate 
RIWUDQVFULELQJHUURUV6WXGLHVXVLQJ³RIDOOHUURUV´GHQRPLQDWRUZLOOEHGLVFXVVHGLQ
more detail as different methodologies were used.     
Table 3.5: Results from transcribing error studies 
Denominator Range of 
reported errors  
Chart/medical 
record review    
Direct 
observation   
Medication 
error incident 
report review    
Mixed 
methods    
Number of 
studies 
Of all orders Range of 
reported errors  
15.9- 21.3% 8 8 8 
Number of 
studies 
2 8 8 8 
Of all medication days Range of 
reported errors  
1-1% 8 8 8 
Number of 
studies 
1 8 8 8 
Of all medications Range of 
reported errors  
2.5-3% 8 8 8 
Number of 
studies 
1 8 8 8 
Of all errors Range of 
reported errors  
0% 8 7.1- 28% 2-32% 
Number of 
studies 
1 8 5 2 
Of all transcriptions  Range of 
reported errors  
6% 8 8 8 
Number of 
studies 
1 8 8 8 
Total number of studies  6 0 5 2 
3.4.2.4.1. 6WXGLHVXVLQJ³RIDOOHUURUV´WRLGHQWLI\WUDQVFULELQJHUURUV 
Five studies used review of incident reports (Table 13 in Appendix 2) and one study 
used chart review to identify the rate of transcribing errors. The chart review study 
(132) found transcribing errors to be 0% of all errors. Other types of errors were 
administration, dispensing, prescribing and monitoring errors. This study by Takata et 
al. 2008 (132) in a specialisW FKLOGUHQ¶V KRVSLWDO LQ WKH 86 FDQ EH FRPSDUHG ZLWK 
0LOOHU HW DO¶V 10 (76) study, which was conducted in the same setting, and 
identified 24.2% of all errors to be transcribing errors using review of medication 
error incident reports (other types of errors were administration, dispensing and 
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prescribing). Review of incident reports, as can be seen from this comparison, 
resulted in more transcribing errors being identified compared to chart review. 
Incident reporting identified similar rates of transcribing errors ranging from 7.1% of 
all errors with chemotherapy to 28% with antidepressants. Most studies using incident 
reporting were conducted in the US.     
Two US studies each used two methods and GLGQ¶Wseparate the error rate. Kaushal et 
al. 2007 (144) used chart review and patients (or parents) telephone interview after 
SDWLHQWV¶GLVFKDUJHIURPKRVSLWDO:DQJHWDO(106) used medical record review 
and review of medication error incident reports. Kaushal et al. study was conducted in 
outpatients and identified 2% of all errors to be transcribing errors whereas Wang et 
al. study was conducted in a neonatal and paediatric unit in a general hospital and 
identified 32% of all errors as transcribing errors. Chart review plus review of 
incident reports by Wang et al identified slightly more transcribing errors than studies 
that either used chart review or review of incident reports alone.    
3.4.2.5.Monitoring errors 
Table 3.6 shows the five different denominators that were used by studies that 
LGHQWLILHGWKHUDWHRIPRQLWRULQJHUURUV6WXGLHVXVLQJ³RIDOOHUURUV´GHQRPLQDWRUZLOO
be discussed in more detail as they were the only group to use more than one method.     
Table 3.6: Results from monitoring errors studies 
Denominator Range of reported errors  Chart/medical 
record review    
Direct 
observation     
Medication error 
incident report 
review                    
Mixed 
methods          
Number of studies 
Of all errors Range of reported errors  5-62.5% 8 0.6- 1.4% 1.3% 
Number of studies 2 8 3 1 
Per 1000 patient 
days 
Range of reported errors  8 8 8 18 
Number of studies 8 8 8 1 
Of all admissions Range of reported errors  8 8 8 11% 
Number of studies 8 8 8 1 
Of all orders  Range of reported errors  8 8 8 1.7% 
Number of studies 8 8 8 1 
Of all samples  Range of reported errors  9.8-12.8% 8 8 8 
Number of studies 1 8 8 8 
Total number of studies  3 0 3 4 
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3.4.2.5.1. 6WXGLHVXVLQJ³RIDOOHUURUV´WRLGHQWLI\PRQLWRULQJHUURUV 
Three studies used review of incident reports and two used chart review with the ³RI
DOOHUURUV´GHQRPLQDWRU7DEOHVDQGLQ$SSHQGL[LOOXVWUDWHWKHVHstudies. 
The rates of monitoring errors (as a % of all errors) varied between 0.6% with 
chemotherapy (140) to 0.7% with antidepressants (66) in two US studies using review 
of incident reports. When assessed by chart review in DVSHFLDOLVWFKLOGUHQ¶VKRVSLWDO
(Takata et al. 2008 (132)) also in the US this rose to 62.5% of all errors. They  defined 
DPRQLWRULQJHUURU WREH³IDLOXUH WR UHYLHZDSUHVFULEHGUHJLPHQIRUDSSURSULDWHQHVV
and detection of problems or failure to use appropriate clinical or laboratory data for 
DGHTXDWHDVVHVVPHQWRISDWLHQWUHVSRQVHWRSUHVFULEHGWKHUDS\´(132). Chemotherapy 
monitoring errors detected by chart review were more similar to those detected by 
incident reports at 5% (27).     
Wang et al. 2007 (106) from a neonatal and paediatric unit in a general hospital in the 
US used mixed methods (medical record review and review of medication error 
incident reports). They involved all medications and identified 1.3% of all errors as 
monitoring errors. Using mixed methods resulted in similar monitoring errors being 
identified compared with studies that used review of incident reports. This may be 
because both Rinke et al. 2007 and Rinke et al. 2010 identified monitoring errors for 
high-risk medications. Only one study (132) provided a definition of a monitoring 
error and therefore this may have also influenced the results obtained.  
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3.4.2.6.Dispensing errors 
Table 3.7 shows the six different denominators that were used by studies that 
LGHQWLILHGWKHUDWHRIGLVSHQVLQJHUURUV6WXGLHVXVLQJ³RIDOODGPLVVLRQV´GHQRPLQDWRU
DQG³RIDOOHUURUV´GHQRPLQDWRUZLOOEHGLVFXVVHGLQPRUHGHWDLODVWKH\XVHGGLIIHUHQW
methodologies.     
 
Table 3.7: Results from dispensing error studies 
Denominator Range of reported errors  Chart/medical 
record review        
Direct 
observation    
Medication 
error incident 
report review      
Mixed 
methods           
Number of studies 
Of all admissions  Range of reported errors  0.33-3.01% 8 8 7% 
Number of studies 1 8 8 1 
Of all errors Range of reported errors  0-21% 8 11.8-35.7% 0.2-3% 
Number of studies 4 8 5 2 
Of all doses Range of reported errors  11.5% 8 8 8 
Number of studies 1 8 8 8 
Per 1000 patient days Range of reported errors  8 8 8 11 
Number of studies 8 8 8 1 
Of all orders Range of reported errors  8 8 8 1.1% 
Number of studies 8 8 8 1 
Of all preparations  Range of reported errors  8 8 8 0% 
Number of studies 8 8 8 1 
Total number of studies  6 0 5 6 
 
3.4.2.6.1. 6WXGLHVXVLQJ³RIDOO admissions´WRLGHQWLI\GLVSHQVLQJHUURUV 
A US study in a paediatric unit in a general hospital by Holdsworth et al. 2007 (109) 
used chart review and identified 3.01% of all admissions to involve dispensing errors 
before using CPOE and 0.33% after CPOE. Kunac et al. 2008 (145) from New 
Zealand conducted a study in the same setting and identified 7% of all admissions to 
involve dispensing errors after using chart review and review of incident reports. 
Review of incident reports in addition to chart review may therefore increase the 
errors detected however the rates were quite low in both studies.   
101 
 
3.4.2.6.2. 6WXGLHVXVLQJ³RIDOOHUURUV´WRLGHQWLI\GLVSHQVLQJHUURUV 
Five studies used review of incident reports and four used chart review to identify the 
UDWH RI GLVSHQVLQJ HUURUV XVLQJ ³RI DOO HUURUV´ GHQRPLQDWRU 7DEOHV  Dnd 17 in 
Appendix 2 illustrate all of these studies. 
The studies by Miller et al. 2010 (76) and Takata et al. 2008 (132) were conducted in 
VSHFLDOLVWFKLOGUHQ¶VKRVSLWDOV0LOOHUHWDO LGHQWLILHGRIDOOHUURUV WREH
dispensing errors by reviewing incident reports (other types of errors were 
administration, transcribing and prescribing errors). Takata et al. 2008 identified just  
9% of all errors to be dispensing errors after chart review (other types of errors were 
administration, prescribing, transcribing and monitoring errors). Review of incident 
reports seems to detect more dispensing errors than chart review.   
Looking at the studies overall supports this despite them being conducted in different 
settings. Dispensing error rates ranging from 11.8% in US neonatal units nationally to 
LQDVSHFLDOLVWFKLOGUHQ¶VKRVSLWDOZHUH LGHQWLILHGE\ LQFLGHQW UHSRUWLQJV\VWHPV
whereas chart review detected rates from 0 (US chemotherapy outpatients) to 21% in 
an Indian emergency department.  
Two US studies each used two methods. Kaushal et al. 2007 (144) used chart review 
DQGWHOHSKRQHLQWHUYLHZDIWHUSDWLHQWV¶GLVFKDUJHIURPWKHKRVSLWDO:DQJHWDO
(106) used medical record review and review of medication error incident reports. 
Kaushal et al. study was conducted in outpatients and identified 3% of all errors to be 
dispensing HUURUV:DQJHWDO¶VVWXG\ZDVFRQGXFWHGLQDQHRQDWDODQGSDHGLDWULFXQLW
in a general hospital and identified 0.2% of all errors as dispensing errors. Using chart 
review plus review of incident reports identified less dispensing errors compared with 
studies that either used chart review or review of incident reports separately. An 
102 
 
exception of this is a study by Walsh et al. 2009 who identified 0% chemotherapy 
dispensing errors using chart review alone.   
3.4.3. Identifying the relationship between clarity of definitions and 
results  
Only 78 of the 153 studies (51%) identified in Chapter 2 used a definition or 
definitions (Figure 3.1). In total 236 definitions for medication errors were found as 
some studies explored more than one type of error and used more than one definition. 
Definitions were provided in: 
x Thirty eight out of 60 studies (63.3%) exploring medication errors in general 
x Seventeen out of 82 studies (20.7%) exploring prescribing errors 
x Nine out of 63 studies (14.3%) exploring administration errors 
x Two out of 18 studies (11%) exploring transcription errors 
x One out of 11 studies (9%) exploring monitoring errors  
x One out of 22 studies (4.5%) exploring dispensing errors 
x Fifty four studies used 168 other definitions (e.g. omission errors, near miss 
and harmless medication errors)       
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Figure 3.1: Number of studies and their definition clarity ratings 
Studies with no definition
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3.4.3.1. Rating the clarity of the definitions used 
The definitions from 65 out of 78 (83%) studies were given the same rating by all 
three independent scorers and for only thirteen studies there were discrepancies. 
These were resolved by discussion.  
 Of the 78 studies with definitions: 
o 22 (28.2%) were rated as 1 (definition not clear enough to meet study aims).  
o 42 (53.8%) were rated as 2 (definition clear enough to meet some of study 
aims)  
o 14 (18%) were rated as 3 (definition very clear and will meet all study aims) 
Seventeen of these 78 studies did not identify the error rate, therefore 61 studies will 
be discussed further.  
The most common definition used was the National Coordinating Council for 
0HGLFDWLRQ(UURU5HSRUWLQJDQG3UHYHQWLRQ¶V1&&-MERP) definition: 
³$Q\ SUHYHQWDEOH HYHQW WKDW PD\ FDXVH RU OHDG WR LQDSSURSULDWH PHGLFDWLRQ XVH RU
patient harm while the medication is in the control of the health care professional, 
patient, or consumer. Such events may be related to professional practice, health care 
products, procedures, and systems, including prescribing; order communication; 
product labelling, packaging, and nomenclature; compounding; dispensing; 
GLVWULEXWLRQDGPLQLVWUDWLRQHGXFDWLRQPRQLWRULQJDQGXVH´ (18). 
 
The NCC-MERP definition (from the US) was used by 13 of the 78 (16.7%) studies 
that used a definition. Based on their aims; studies in my literature review using the 
NCC-MERP definition had this rated in five as clarity level 1, seven as clarity level 2 
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and one as clarity level 3. The definition was more relevant to some studies than 
others, depending on the aims and nature of the study. 
An example of studies with the NCC-MERP definition rated as 1 is Campino et al. 
2006 (115). Because their aim was to identify prescribing errors in a neonatal unit in 
Spain, and because no clear explanation of prescribing errors is provided by this 
definition, the study definition clarity was rated as 1. The NCC-MERP definition was 
rated as 2 in a study by Shah et al. 2009 (a US study in an otolaryngology ward) (14) 
who aimed to identify medication errors in general. The definition listed most 
possible different types of medication errors but without detailed explanation, and 
because the aim was to identify different types of medication errors; this study was 
rated as 2. However, a UK study, in an intensive care unit by Burmester et al. 2008 
(10), used the NCC-MERP definition together with ten other definitions of 
prescribing errors (detailing different types of prescribing errors). Because the aim 
was to identify prescribing errors; definitions used by this study were rated as 3 as 
they were given in great detail. 
 
3.4.3.2. Comparing studies with different ratings of definitions  
Only one set of five studies used the same denominator (i.e. of all administrations) to 
identify the same type of errors (administration) and used the same method (direct 
observation) with definitions rating 1, 2 and 3 (Table 3.8).   
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Table 3.8: Comparable studies with the three different rating scores of clarity of 
definitions  
Study  Definition 
clarity 
score  
Setting  Age 
classification 
Country  Intervention  Rate of errors  
Before 
intervention 
After 
intervention  
Chua et al. 
2010 (67) 
3 Paediatric 
unit in 
general 
hospital 
All ages  Malaysia - 11.7% by 
doctors and 
nurses 
- 
Taylor et 
al. 2008 
(174) 
3 Neonatal 
unit 
Neonates  US CPOE 19.8% by 
nurses 
11.6% by 
nurses 
Raja lope 
et al. 2009 
(88) 
2 Neonatal 
unit 
Neonates  Malaysia  CPOE 31% by 
nurses 
15.4% by 
nurses 
Feleke et 
al. 2010 
(158) 
2 Paediatric 
unit in 
general 
hospital 
Neonates+ 
infants+ 
children+ 
adolescent  
Ethiopia  - 89.9% by 
nurses and 
parents   
- 
Bertsche 
et al. 2010 
(169) 
1 Paediatric 
neurology  
Not 
mentioned  
Germany  Education + 
practical 
session  
40.4% by 
nurses 
7.9% by 
nurses 
96.6% by 
parents 
5.6% by 
parents  
 
From Table 3.8 it is clear that it is impossible compare these studies as the one study 
that was rated as 1 was conducted in a completely different setting with different 
participants to the other studies. Two studies (88) and (174) with different definition 
clarity levels identified a similar reduction in error rates after using the same 
intervention (electronic prescribing) in the same setting (neonatal unit). This may 
emphasise the importance of the effect of the intervention rather than the definition 
clarity rate. Pre-intervention error rates were lower in the US study (19.8%) with the 
definition clarity rating of 3 than the Malaysian study (31%) with the definition clarity 
rating of 2. This may reflect the error differences in the individual units or countries 
or it may be that the definition clarity meant that more specific and therefore less 
errors were identified in the US study.  
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Two other studies (67, 158) with different definition clarity rates were conducted in 
the same setting, i.e. a paediatric unit in a general hospital. The error rates are most 
likely so different, not because of the clarity rate of definitions but rather the 
participants involved, with one study involving parental administration and the other 
only healthcare professionals.  
3.4.4. Interventional tools used to minimise medication errors 
Fifty nine out of 153 studies (38.6%) used 65 interventional tools. Interventional 
studies were categorised as follows: 
Dosing supporting tools ±interventions to assist in dose calculation (17), electronic 
prescribing (15), educational interventions (7), health and safety strategies (2), clinical 
pharmacist services (2), pre-printed forms (2), more than one of the above 
interventions (6) and other interventional tools (8) 
Four studies provided error results only after the intervention. Four studies provided 
the number of errors but not the rate of error either before and/or after the 
intervention. Two studies provided the overall percentage decrease in error rate rather 
than providing the error rate before and after interventions. Ten studies compared 
several different interventions, and one identified the error rate between two groups of 
participants (one with intervention and one without intervention). 
3.4.4.1. Dosing supporting tools 
Seventeen studies used dosing supporting tools, e.g. barcode medication 
administration systems, oral syringes and computerised automatic dosage calculation, 
as an intervention. The majority of studies (nine) focused on administration errors 
followed by prescribing errors (seven studies), with one study identifying medication 
errors in general.     
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Some studies compared the effectiveness of one dosing supporting tool over others. 
7KUHHVWXGLHVXVHGWKH%URVHORZWDSH³which is used during paediatric emergencies to 
quickly estimate a child's weight, determine weight-based drug doses, and select the 
correct size emergency or resuscitation equipment´ (175). Two studies compared it 
with other dosing tools (i.e. a colour coded tool on medication administration and 
standard volume/weight dose reformulation). The Broselow tape was found to be an 
effective tool in reducing the rate of administration errors from 72% to 43% of all 
patients receiving epinephrine in an arrest situation (170). However, a colour coded 
tool was shown to be more effective  by Hohenhaus et al. 2008 (176) as the rate of 
administration errors for five out of six medications was lower when the colour coded 
tool was used compared to the Broselow tape. Moreover, the Broselow tape was less 
effective when compared to a standard volume/weight dose reformulation in a 
simulation study by Fineberg et al. 2008 (100). No administration errors were 
identified when standard volume/weight dose reformulation was used but eight errors 
were identified using the Broselow tape.    
Two simulation studies (Sobhani et al. 2008 (148) and Yin et al. 2010 (48)) compared 
a dosing cup with other instruments, such as oral syringes/droppers. The dosing cup 
was associated with a higher error rate when used by parents. Yin et al. 2011 (149) 
also measured the effect of giving pictogram instructions in conjunction with written 
instructions on the use of a dropper device, which was found to be more effective than 
written instructions alone in reducing the rate of administration errors by parents. 
Three studies that used dosing supporting tools to reduce prescribing errors used 
computerised weight based calculators. These studies found a weight based calculator 
to be effective in reducing continuous infusion medication prescribing errors (93), all 
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neonatal medications errors (177) and acetaminophen and ibuprofen outpatient 
prescribing errors (178).   
All the above studies used dosing supporting tools to reduce the rate of errors to alert 
doctors when doses exceed minimum or maximum limits, reduce time needed to 
administer drugs, detect specific types of errors (e.g. wrong time error) or improve the 
quality of prescribing.  
Brown et al. 2007 (179)  used parenteral nutrition worksheet to aid prescribing. 
Senner et al. 2010 (180)  used care guideline card for 10 antibiotics to be used by 
doctors. Both interventions were found to be effective in reducing prescribing error 
rate.  
Hennings et al. 2010 (181) used an automated infusion device which was effective as 
it alerted doctors when doses exceeded the limit. Morriss et al. 2009 (90) used a 
barcode medication administration system which was able to detect wrong time errors 
and Zimmer et al. 2008 (182) used computerised prescription writers plus decision 
support for narcotics which alerted doctors when they prescribed a high dose. All of 
WKHVHLQWHUYHQWLRQVZHUHHIIHFWLYHDFFRUGLQJWRWKHDXWKRUV¶FRQFOXVLRQV even though 
error rates detected were increased in several cases.   
Eight studies that used dosing supporting tools were simulation and identified 
administration errors by nurses (4), parents (3) and doctors (1). All the three studies 
involving parents used comparison methods. Two studies compared dosing cups with 
other instruments and found that more administration errors were identified when 
cups are used (48, 148). One study found less administration errors by parents when 
pictogram instructions were provided to parents in addition to the written instructions 
(149). Two of the four studies involving nurses concluded that the Broselow tape is 
less effective than other interventions (Colour Coding Kids Hospital System (176) 
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and volume/weight dose reformulation (100)). The other two studies with nurse 
participants did not use comparison methods but instead they separately measured the 
effectiveness of two different interventions. One study identified less administration 
errors after using a colour coded medication safety system (183) whereas the other 
study identified less administration errors after using a computer to calculate doses 
(184). One study measured the administration error rates by doctors and found less 
errors when mass concentration labels were provided compared to ratio concentration 
labels (147). 
3.4.4.2. Electronic prescribing 
Fifteen studies used electronic prescribing as an intervention. The majority of studies 
(nine) focused on prescribing errors. CPOE was used alone in 11 studies of which six 
identified prescribing errors (107, 146, 152, 185-187), two administration errors (110, 
174), two medication errors in general (159) (121) and one medication errors in 
general and dispensing errors (109). Walsh et al. 2008 (159) stated that there is no 
effect of using CPOE alone on reducing the rate of serious medication errors in 
general and Sowan et al. 2010 (110) stated that there is no effect of using CPOE alone 
on reducing infusion pump programming errors. The other nine studies stated that 
CPOE alone was an effective intervention.  
CPOE was used in conjunction with CDSS in four studies (101, 105, 130, 188); three 
identified prescribing errors and one identified medication errors in general, 
prescribing errors and transcribing errors. These four studies found a significant 
reduction in the rate of prescribing errors and medication errors in general after 
adding CDSS to CPOE (but not on transcribing errors).   
Use of electronic prescribing was found by studies to be effective in reducing the rate 
of medication errors (101, 105, 107, 109, 130, 152, 174, 185, 187, 188), improving 
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the safety and efficiency of prescribing (121, 146), reducing the time needed for 
completing order forms (188) and increasing the completeness and legibility of 
prescriptions (101) &32( VDYHG WKH QXUVHV¶ WLPH DQG GHFUHDVHG WKH DGPLQLVWUDWLRQ
errors in a US simulation study by Sowan et al. 2010 (110) but did not decrease the 
identification of infusion pumps programming errors. In many of the studies however 
error rates identified even prior to the intervention were low ((105, 109, 121, 152, 
159, 185, 188)). It is therefore difficult to decide the real clinical effectiveness of this 
intervention in terms of error reduction. 
3.4.4.3. Educational interventions 
Seven studies used education as an intervention. Of the seven studies, four identified 
administration errors and three identified prescribing errors. Educational interventions 
were used to address prescribing errors by doctors and administration errors by nurses 
(or parents). Three studies identified the effect of education on prescribing error rates. 
Kozer et al. 2006 (112) used a short tutorial (30 minutes) for doctors followed by a 
test and concluded that this intervention was not effective in reducing prescribing 
errors (12% of all orders by doctors whether educated or not). Campino et al. 2009 
(189) provided 15 informative sessions about medication errors for doctors and the 
prescribing error (not including TPN) rate decreased from 20.7% to 3% of all orders. 
Eisenhut et al. 2011 (166) used an assessment of doctors followed by feedback and 
another assessment two months later which was stated to decrease the prescribing 
errors from 47% to 21% of all admissions.  
Three studies used educational interventions to reduce the administration error rates 
by nurses. Raja Lope et al. 2009 (88) provided feedback, lectures and an educational 
poster; Pauly-2¶1HLOO  (150) provided an intensive training programme about 
safety in preparation and administration of medication and Sullivan et al. 2010 (168) 
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used compulsory online education for nurses about insulin. Bertsche et al. 2010 (169) 
used a 30-minutes lecture followed by 90-minutes practical session to identify 
administration errors by both nurses and parents (169). Less administration errors 
were identified after educating nurses and parents (error rate decreased from 42.8% to 
7.8% of all administrations). From the above studies it is clear that the educational 
interventions were effective in most studies apart from one (Kozer et al.). Studies 
stated that educational interventions improved nursHV¶FRPSOLDQFHZLWKDGPLQLVWUDWLRQ
steps, reduced medication prescribing and administration errors and resulted in more 
accurate administration by nurses.   
3.4.4.4.Health and safety strategies 
Two studies used health and safety strategies as an intervention. Robinson et al. 2006 
(190) in the US identified chemotherapy prescribing, dispensing and administration 
errors using review of charts and incident reports. They used failure mode and effects 
analysis (FMEA). The FMEA team consisted of a haematology/oncology doctor, 
nurses, pharmacists and a quality improvement consultant. Their job involved 
providing strategies for decreasing medication errors, ensuring the safety of 
medication administration and identifying risks associated with the administration 
process. Actual error rates detected in this study were however very low before the 
intervention and reduced after it (potential prescribing errors decreased from 23% to 
14% of all orders after the intervention).  
Ligi et al. 2010 (15) used safety initiatives (e.g. continuous reporting medication 
errors) and iatrogenic events prevention strategies e.g. education in a neonatal unit in 
France. Even though the rate of errors increased after the intervention; the author 
stated that the intervention was effective and the reason for the error rate increasing 
was because of an increase in the rate of reporting. 
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3.4.4.5.Clinical pharmacists 
Two studies used clinical pharmacists as an intervention. One study was conducted in 
the US and identified only the rate of serious errors using review of charts and 
incident reports (86). The other was conducted in Norway and identified the 
prescribing error rate using chart review (117) . 
Clinical pharmacy was an effective intervention according to these studies. However, 
Kaushal et al. 2008 (86) US study stated that clinical pharmacy is only effective in 
reducing the rate of serious medication errors when available full time. The 
effectiveness of clinical pharmacy services was also measured by its ability to detect 
medication errors that would otherwise be missed DV LQ.MHOGE\ HW DO¶V  VWXG\
(117).     
3.4.4.6.Pre-printed order forms 
Two studies used pre-printed forms as an intervention. Larose et al. 2008 (167) 
identified IV medications and fluids prescribing and administration error rates in an 
emergency department in Canada. Broussard et al.¶V VWXG\ LQ 2009 (96) was 
FRQGXFWHGLQDVSHFLDOLVWFKLOGUHQ¶VKRVSLWDO LQ WKH86DQGLGHQWified the prescribing 
error rate for sedation medications. Both studies used chart review and concluded that 
this intervention led to an increase in the documentation and completeness of 
medication orders.   
3.4.4.7.Studies using more than one intervention 
Six studies each used two interventions in combination (10, 29, 104, 165, 191, 192). 
Three studies were conducted in the US, two in the UK and one in Australia. Most 
studies did not separately evaluate the relative contributions of the different 
interventions to the error reductions. Intervention use by the studies included clinical 
pharmacy services, safety strategies (e.g. effective communication, safety 
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environment and following important steps regarding prescribing and administration), 
new reporting form, educational, pre-printed form, bedside prescribing guidelines, 
CPOE, antimicrobial stewardship program and multidisciplinary practice (involving 
paediatric hospitalist, paediatric care coordinator, paediatric nurse, pharmacist and the 
trauma service).  
All the above studies used combinations of interventions stated to be effective apart 
from Davey et al. 2008 (104), who separately identified the effectiveness of education 
of doctors about good prescribing and after implementation of bedside prescribing 
guidelines. According to the authors the educational intervention was effective in 
reducing the rate of prescribing errors whereas the bedside prescribing guidelines 
intervention was not.  
Prescribing errors were shown to be reduced by the implementation of pre-printed 
order forms, education of doctors, following safety strategies, using electronic 
prescribing in conjunction with supporting programmes and implementation of 
multidisciplinary practice. Administration errors were shown to be decreased by 
education of healthcare professionals, following safety strategies and implementation 
of multidisciplinary practice. Medication errors in general found to be reduced 
following introduction of clinical pharmacy services and the rate of reporting 
medication errors was increased.    
The effectiveness of these studies was measured according to different parameters, i.e. 
the rate of errors identified, the severity of errors, rate of reporting and completeness 
of order forms. However, all interventions used were effective according to these 
SDUDPHWHUVDQGWKHDXWKRUV¶FRQFOXVLRQV 
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3.4.4.8.Miscellaneous interventions 
Eight studies used miscellaneous interventions. Five interventions, which were 
considered effective, were an anonymous error reporting system which decreased the 
rate of medication errors in general (58), an integrated care pathway which decreased 
the prescribing error rate (193), observation of doctors and nurses decreased the 
prescribing but not transcribing error rate (131), responding of doctors and nurses to 
alerts generated by CPOE decreased prescribing but not transcribing error rates (102) 
and consultant review and rewriting medication orders with errors decreased the 
medication error rates in general (194). Using an anonymous reporting system 
according to Taylor et al. 2007 (58) was effective even though the rate of error 
increased. The authors explained that the increase in reporting rate after the 
intervention showed it had worked. 
Three of the eight studies showed no effect of their interventions. These less effective 
interventions were: corollary order screen to decrease monitoring error rate (133), 
using a PRELOHNLRVNE\SDUHQWVWRHQWHUV\PSWRPVSDWLHQW¶VDOOHUJ\DQGmedication 
history to decrease prescribing error rate (163) DQG FKDQJLQJ GRFWRUV¶ KRXUV WR
decrease prescribing error rate (161). 
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3.4.5. Studies conducted in the UK 
Sixteen studies were conducted in the UK. Thirteen studies identified the error rate. 
The majority (14 studies) identified prescribing errors. In addition, five identified 
medication errors in general, five administration errors, two dispensing errors and one 
transcribing errors. 
According to the quality assessment (Section 3.5. Chapter 2); six studies met 10 
criteria, four met nine, two met eight and one met seven. The quality for three studies 
could not be assessed as these studies were only available as conference abstracts. 
Ages of patients were not provided in 12 studies. Two of the remaining studies 
involved neonates, infants, children and adolescents; one involved infants, children 
and adolescents; and one involved only children and adolescents.     
Eleven different denominators were used by 13 studies while the remaining studies 
purely provided numbers of errors. Eleven out of the 14 studies that identified the 
prescribing errors used VL[ GHQRPLQDWRUV 7KH PRVW FRPPRQO\ XVHG ZDV ³Rf all 
RUGHUV´ used by five studies, and results were between 2.2% of all orders in a 
VSHFLDOLVWFKLOGUHQ¶VKRVSLWDODQGRIDOORUGHUVLQDSDHGLDWULFXQLWof a general 
KRVSLWDOEHIRUHLQWHUYHQWLRQV³2IDOOSDWLHQWV´GHQRPLQDWRUZDVXVHGE\WZRVWXGLHV
and ranged between 16.8% of all patients in an intensive care unit only looking at 
UHVXVFLWDWLRQGUXJVDQGRIDOOSDWLHQWVLQDVSHFLDOLVWFKLOGUHQ¶VKRVSLWDOORRNLQJ
only at intravenous DFLFORYLU2QHVWXG\HDFKXVHG³PHDQHUURUVSHUSDWLHQW´³RIDOO
DGPLVVLRQV´³RIDOOPHGLFDWLRQV´DQG³RIDOOHUURUV´ 
Administration errors were identified by five studies. One study did not identify the 
error rate whereas the other four studies used different denominators, and showed; 
1.2% of all administration in a paediatric unit in a general hospital, 15-25% of all 
charts in a specialiVWFKLOGUHQ¶VKRVSLWDODQGDSDHGLDWULFXQLW UHVSHFWLYHO\RI
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all possible errors in specialist and general paediatric units and 30% of all medication 
errors in gastroenterology ward.  
Medication errors in general were identified by five studies of which only two 
identified the rate using denominators (1.8 errors per bed day occupancy in ICU and 
0.24% of all parenteral nutrition days in a gastroenterology ward). Only one 
GHQRPLQDWRU ³RI DOOPHGLFDWLRQHUURUV´ZDVXVHG WR LGHQWLI\GLVSHQVLQJ (24%) and 
transcribing (20%) errors in a gastroenterology ward.   
The studies were conducted in the following settings: 
6SHFLDOLVW FKLOGUHQ¶VKRVSLWDOV , paediatric units in general hospitals (3), intensive 
care units (3), sSHFLDOLVW FKLOGUHQ¶V KRVSLWDO DQG LQ a paediatric unit of a general 
hospital (2), outpatient clinic (1), paediatric gastroenterology and nutrition ward (1), 
paediatric pain team (1), neonatal and paediatric unit in a general hospital (1) and one 
study used the national incident reporting system to identify medication errors with 
aseptic products.  
The studies used chart/medical record review (10 studies), review of medication error 
incident reports (4), chart review and direct observation of nurses when administering 
drugs plus review of interventions (1) and chart review and incident reports (1).  
Eight studies used seven different interventions. Six interventions were used in seven 
studies to reduce prescribing error rates. These included electronic prescribing in 
nephrology outpatients (101), where prescribing errors reduced from 77% of all 
medications to 4.8% with CPOE+CDSS. Positive results were also seen in a specialist 
FKLOGUHQ¶VKRVSLWDOZKHUHHUURUVUHGXFHGIURPRIDll orders to 1.2% after CPOE 
alone was introduced (152); and an intensive care unit where errors reduced from 
8.8% to 4.6% of all orders (187). Chart review was used in all studies to measure 
errors. 
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Educational sessions (10, 104), pre-printed post-cardiac surgery order forms (10), 
bedside prescribing guidelines (104), an integrated care pathway (ICP) (193) and 
assessment of doctors and giving them feedback (166) were also studied. One 
intervention (daily consultant review of prescriptions and mandatory rewriting any 
prescriptions with errors) was used to reduce the rate of both prescribing and 
administration errors in an intensive care unit (194). All interventions were effective 
according to authors apart from using bedside prescribing guidelines by Davey et al. 
2008 (104) which was not found to be effective in reducing prescribing errors.   
 
3.4.6. Time of the day and days of the week mostly associated with 
errors 
Eight studies identified the time and/or the day involved in errors. Three studies using 
chart review were from the UK, Brazil and Argentina. Four studies identified the 
time, three identified the time of the day and the days of the week and one identified 
the days of the week mostly associated with errors.    
Only eight studies (5%) looked at the time of the day or days of the week where errors 
are more likely. Three studies (Burmester et al. 2008 (10), Lerner et al. 2008 (75) and 
Engum et al. 2008  (4)) found that the day shift was associated with more errors than 
other shifts. None of these studies suggested a reason for the high error rate in the 
daytime compared with other times of the day. Two of these studies (4, 75) did not 
PHQWLRQ WKH VKLIWV¶KRXUV WLPHZKHUHDVRQH VWXG\ (10) considered the time between 
07.00 to 19.00 as the day shift.  
Most authors do not concentrate on the time of medication errors or the days 
associated with more errors. For example; Rinke et al. 2007 (140) only mentioned that 
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82.9% of all errors occurred in weekdays without any further explanation. Another 
example is Engum et al. 2008 study which only provided the rate of errors in the 
daytime (57% of all errors). 
Miller et al. 2010 (76) specifically examined the time and the days mostly associated 
with medication errors. They clearly defined the day shift and the difference between 
weekdays and weekends. Nursing and pharmacy shifts were separately defined. These 
involved two nursing shifts: 07.00 to 18.59 and 19.00 to 06.59 and three pharmacy 
shifts: 07.00 to 14.59, 15.00 to 21.59 and 22.00 to 06.59. They considered weekdays 
to start from 07.00 on Monday to 18.59 on Friday, and weekends from 19.00 on 
Friday to 06.59 on Monday. In nursing shifts, fewer errors were identified in the first 
shift compared with the second shift (1.17 vs. 2.12 errors per 1000 doses, p=0.005). In 
contrast, in pharmacy more errors occurred in the second shift compared to the first 
and the third shifts (2.24 vs. 1.01 and 1.88 errors per 1000 doses, p=0.0019). They 
identified more errors at weekends compared with weekdays (2.55 vs. 1.9 per 1000 
doses, p=0.181). Miller et al. 2010 emphasised the importance of clinical pharmacy 
services in reducing the rate of errors as the rate was highest at the time when no, or 
few, pharmacists are available. Rinke et al. 2007 (140) study was conducted in a 
paediatric oncology unit in the US. They showed a high error rate at weekdays but did 
not give further details or provide an explanation for their findings.   
Hicks et al. 2007 (195) and Chuo et al. 2007 (196) found more Intralipid® prescribing 
and administration errors between 18.00 and 24.00. Both of these studies suggested 
that this is because new infusions are supplied and set up during this time. Chuo et al. 
2007 found no significant difference in the rate of error between shift change hours 
(the time of change ± 2 hours) and non-shift change hours. However, they found more 
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errors on the 2nd shift change hours (between 17.00 to 21.00) compared with the 1st 
shift change hours (between 05.00 to 09.00). 
Otero et al. 2008 (29) identified prescribing and administration errors in three shifts: 
morning shifts (07.00 to 13.59), afternoon shifts (14.00 to 20.59) and night shifts 
(21.00 to 06.59). They identified the error rate before and after the introduction of an 
intervention of education and safety strategies. Prescribing errors were highest before 
the intervention in the afternoon (67.6% of all orders) and after the intervention at 
night (30% of all orders). Administration errors were highest in the afternoon and 
decreased from 11.1% to 6.3% of all administrations after the intervention. Otero et 
al. 2008 (29) found a similar error rate between weekdays and weekends. They did 
not suggest reasons for these results.  
Hicks et al. 2007 (195) conducted a study at a neonatal unit in the US searching 
MEDMARX to identify administration medication errors by nurses associated with 
fat emulsion. They found more errors on Mondays and Fridays compared with other 
days. They suggested that this is because staff usually change on Monday and they are 
therefore not familiar with the care plan provided for patients at weekends. Another 
possibility is that management plans change after the ward round on Monday 
especially for infants who may have been reweighed requiring dose changes to be 
made accordingly.  
None of the studies identified a relation between the time of errors and patient harm 
making it difficult to measure the consequence of the higher error rates on patients at 
a particular time of the day or day of the week.  
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3.5. 'LVFXVVLRQ 
3.5.1. Clarity of definitions 
Most studies which examined transcribing, dispensing and monitoring errors did not 
provide a definition. Some studies and their definitions focused purely on specific 
indications or medications (e.g. insulin administration (168)). With brief and vague 
definitions (rating 1) it is possible that many types of errors (especially small errors) 
may be missed. For example, Kazemi et al. 2010 (102) conducted a study in a 
neonatal unit in Iran and provided a definition of prescribing errors, which simply 
VWDWHG³$QHUURUWKDWRFFXUUHGGXULQJWKHSUHVFULSWLRQVWDJH´7KH\IRXQGWKDW
of all medications involved prescribing errors in physician order entry and 4.6% in 
nurse order entry. On the other hand such a simple definition may actually result in 
more errors being identified than a more specific definition.  
It is clear that no definition has been globally agreed upon for medication errors. Of 
all definitions used, the most common one used was the NCC-MERP definition. This 
was used by 13 of the 78 (16.7%) studies that used a definition. Ghaleb in 2006 stated 
that a difference in definitions is an important factor of variation in reported 
medication error rates. This group however did not attempt to test the clarity of 
definitions and its effect (17).    
Lisby et al (2010) (20) found that 17 studies (adult and paediatric) used the NCC-
MERP definition, and in my search, which only involved paediatric patients, 13 
studies were identified. This may reflect the satisfaction of many researchers with this 
definition compared with others or it may purely be the one most cited and therefore 
well known. Even this one definition however received different clarity ratings as it 
was more relevant to some studies than others.  
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Studies using clear definitions were lowest in number. This may indicate that most 
authors did not think carefully enough about appropriate definitions when starting 
their studies. The majority of studies however used definitions rated as clear enough 
to meet some of the study aims. Since the effect on the results is not possible to assess 
it is difficult to know the significance of this. It may emphasise the need to provide 
clearer definitions when starting a study to ensure that the study aims are met and the 
results are reliable. The number of studies without definitions or with definitions not 
clear enough to meet all of the study aims is of concern. I would therefore encourage 
researchers to use very clear and carefully considered definitions in order to meet all 
the aims of their studies as this may influence the results. Information found by 
studies may then reflect more accurately the actual epidemiology of medication errors 
in the intended settings and populations.  
Lisby et al. in 2010 also did a systematic review aiming to identify studies that used 
definitions of medication errors and to identify the effect of these definitions on the 
rate of errors. Their judgments on the clarity of definitions depended only on the 
terminology (e.g. medication errors, prescribing errors, medication failure or 
medication deviations) used to create definitions. Differently; in my systematic 
review; the judgment on the clarity of definitions was done according to the aims of 
each study and whether definitions used by each study linked properly with these 
aims or not. Lisby et al found that 45 definitions used for medication errors appeared 
in 203 studies (adult or paediatric). They found no relationship between the 
definitions used and prevalence of medication errors in studies identified from their 
systematic literature review. 
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3.5.2. Interventional tools 
Unfortunately ten out of 59 studies (17%) using interventions did not identify the 
error rate before and after using the intervention. Despite this all studies stated that the 
intervention was effective. It is helpful if studies identify the rate of errors before and 
after an intervention in order to estimate LW¶V efficacy in terms of error reduction. 
Many of the studies only identifying the rate of errors after the intervention concluded 
by mentioning that the intervention was effective because it was able to detect many 
errors, for example, Zimmer et al. 2008 (182) who identified the number of alerts 
generated from the use of the web based controlled substance writer. Kjeldby et al. 
2009 (117) found around a quarter of all orders had a prescribing error which would 
not be identified and addressed if the clinical pharmacist service was not provided. 
Therefore they considered this as an effective intervention.  
Some studies identified more errors after the intervention and the authors of these 
studies stated that the intervention was effective. For example; an increase in the rate 
of reporting was suggested to be a cause of the higher error rate after patient safety 
initiatives and iatrogenic events prevention strategies by Ligi et al. 2010 (15). 
Moreover, the error rate was increased in the study by Morriss et al. 2009 (90) after 
using a barcode administration system. The authors concluded that the rate of error 
increased because the system detected and addressed wrong time errors.   
Some studies did not provide the prescribing error rate either before or after the 
intervention. Van De Velde et al. 2009 (186) compared the effect of CPOE and pre-
printed order forms on the rate of chemotherapy prescribing errors. They only 
identified the number of prescribing errors without giving the rate of errors. They 
concluded that the CPOE was more effective because it decreased prescription writing 
errors. Costello et al. 2007 (191) who conducted a study in an intensive care unit in 
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the US did not identify the error rate but only the number of errors after the 
intervention (109 medication errors). They did not provide the number of errors 
before the intervention but stated that the clinical pharmacist and education was 
effective because the reporting rate was increased by six fold and because the number 
of serious errors was decreased from 46% to 0% of all reported errors.    
 Studies did not only measure the effect of interventions on reducing the error rate but 
also looked at other parameters. For example, Fineberg et al. 2008 (100) identified the 
effect of using a standardised volume-weight dose reformulation of resuscitation 
drugs (reformulated to 0.1 ml/kg to give an identical volume of medication per 
kilogram of body weight for each drug) and critical care medications instead of using 
the Broselow tape on both administration dosing errors and time needed to deliver 
medications to patients. They found that using the weight dose formulation was 
associated with less dosing errors and led to delivering medications to patients faster.  
Thirteen out of the 17 studies using dosing support tools suggested that all 
interventions were effective. Most of these studies (nine) identified administration 
errors. The most commonly used dosing supporting tool was an automatic weight 
based dosing calculator. The remaining four studies compared different dosing tools 
of which two studies concluded that oral syringes were associated with less dosing 
errors than cups (48, 148). One study by Yin et al. 2011 (149) found that providing 
pictogram instructions helped the parent to give more accurate doses to their children 
(149). Wheeler et al. 2008 found that calculating doses by doctors using mass 
concentration labels was associated with less errors than using ratio concentration 
labels (147).     
Our review suggests that adding clinical decision supporting systems (CDSS) to 
CPOE results in more medication errors being prevented compared to CPOE alone. 
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Two studies (105, 130) identified prescribing errors when CPOE was used alone and 
in conjunction with CDSS. Both studies found that the rate of prescribing errors 
significantly decreased when CDSS was used together with CPOE.     
Authors of most studies using educational interventions concluded that education was 
an effective method to decrease the rate of administration and prescribing errors. An 
exception was one study by Kozer et al. 2006 (112) which identified the rate of 
prescribing errors in groups of doctors who attended or did not attend a tutorial. They 
stated that the rate of prescribing errors did not improve in the group of doctors who 
attended the educational session. The authors suggested that this might be because 
doctors who did not attend the session may have had better knowledge, experience or 
confidence than those who agreed to attend the session. The authors also suggested 
that the intervention was short (30 minutes) and this might be another cause for its 
poor effect.      
Even though the same intervention, e.g. education, was used by more than one study; 
it is important to notice that different factors can alter the results following such 
interventions. For instance; as before Kozer et al. 2006 (112) used a short and single 
education session and found no effect on reducing prescribing errors. On the other 
hand Campino et al. 2009 (189) used a programme of 15 informative sessions and 
found a clear effect of the education on reducing the prescribing error rate (from 
20.7% to 3% of all orders after the intervention).  
Other successful educational interventions were also much more intensive than 
.R]HU¶V)RU H[DPSOH%HUWVFKH HW DO (169) used a 90 minute practical session 
after a 30 minute lecture for all healthcare professionals and Eisenhut et al. 2011 
(166) who evaluated the effect of five prescribing tasks for doctors on the rate of 
prescribing errors followed by two assessments (the second assessment two months 
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after the first). The reduction in error rates in the latter study may also have been 
influenced by doctors learning on the job in the two months between assessments.   
The most common interventions used for prescribing errors were electronic 
prescribing followed by dosing supporting tools (e.g. computerised automatic dosage 
calculation), education and pre-printed order forms. Administration errors were 
mostly addressed by using dosing supporting tools (e.g. barcode medication 
administration systems and oral syringes) followed by electronic prescribing and 
education.  
Safety strategies were used by two studies (in the US and France), clinical pharmacy 
services were used by two studies (in the US and Norway) and pre-printed order 
forms were used by two studies (in the US and Canada). According to the authors of 
these studies all of these interventions were effective. However, clinical pharmacists 
were effective only when a full time service was provided according to Kaushal et al. 
2008 (86).  
The period between starting the intervention and examining the results may be 
important. This is because estimating the efficacy of an intervention directly after 
introducing it may not reflect its real effect, which may need lead time before starting 
to assess results. This was clear from Neal HWDO¶V(187) study which identified 
the rate of prescribing errors before and after using CPOE. The error rate did not 
improve after one week of electronic prescribing (decreased from 8.8% to 8.1% of all 
orders), but after six months the rate of error decreased significantly to 4.6% of all 
orders. 
Making interventions may be associated with new possibilities for errors. For 
example, using electronic prescribing will eliminate the problem of clarity associated 
with poorly handwritten order forms but has been associated with wrong selection 
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from the drop-down menu, e.g. selecting the wrong dose or medicine (152). 
Therefore, when developing a new system to be used to minimise the rate of 
medication errors, it is important to keep in mind any drawbacks that may be 
associated with this system. 
Campino et al. 2008 (131) found that observation alone was effective in decreasing 
the rate of prescribing errors by doctors but not transcribing errors by nurses. This is 
FDOOHG WKH ³+DZWKRUQH HIIHFW´ LH WKH HIIHFW RI EHLQJ REVHUYHG LPSURYLQJ SUDFWLFH
This finding is supported by a Tanzanian study by Leonard et al. 2006 (197) who 
found that the effect of observing doctors resulted in a 13% increase in the quality of 
care provided to patients, however, this effect reduced with time. In contrast a UK 
study by Dean et al. 2001 (198) found no effect of observing nurses in decreasing the 
rate of administration errors. 
The majority of studies (12, 75%) used chart/medical record review to collect data. 
Only 60 studies (39%) from the full literature review used chart/medical record 
review. This method was however still the most common used method of data 
collection in both the UK and non-UK studies. All the UK studies that used chart 
review identified prescribing errors. Three other studies used review of medication 
error incident reports to identify prescribing errors in addition to other types of errors 
(i.e. medication errors in general, administration errors, dispensing errors and 
transcribing errors).   
3.5.3. Comparing UK to all other studies 
UK studies identified all types of medication errors except monitoring errors. This is 
similar to the non-UK studies included in my systematic review (Chapter 2) with only 
11 studies (overall 7%) looking at monitoring errors. Even though some non-UK 
studies identified the rate of monitoring error; only one study provided a definition of 
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it and most studies identified the proportion of this error among other types of errors 
e.g. prescribing and administration errors. This may reflect the low interest of 
researchers in identifying this type of error in children or lack of awareness that 
monitoring errors can and do occur. 
Comparing the clarity rating of definitions used by UK studies (nine studies) with all 
studies (78 studies); 44%, 44% and 11% of the UK studies with definitions were rated 
respectively as 1, 2 and 3. All studies (UK and non-UK) with definitions were 
similarly rated respectively as 28%, 53% and 18%. Both the UK and non-UK studies 
used mainly unclear definitions when identifying the rate of errors. This reflects the 
need for using clear definitions by researchers from any country.       
Comparing the quality assessment of the UK studies with other studies (UK and non-
UK); 15%, 31% and 46% of the UK studies with quality assessment (13 studies) 
respectively met 8, 9 and 10 criteria. From the total 143 studies with their quality 
assessed; 27%, 28% and 33% respectively met 8, 9 and 10 criteria. The 
methodological quality of UK studies therefore seems to be slightly higher compared 
to the studies overall.  
3.6. /LPLWDWLRQ 
1. Few numbers of comparable studies with wide variation in error rate were 
identified from my literature review due to the number of different denominators 
and methods used. 
2. There is no standard definition for the term ³ZLGHYDULDWLRQ´DQGWKHUHIRUHLWZDV 
considered to occur when the difference between the highest and lowest error rate 
was more than 50%. 
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3. Some studies used ³RI DOO HUURUV´ as the denominator which does not reflect the 
actual rate of each type of medication error but rather provides the proportion of 
each type of error amongst others.  
4. No guidance on writing a good definition of an error exists therefore my 
supervisors and I agreed our own rating scale. 
5. Because of the low number of studies that can be compared due to different 
denominators being used; the rate of specific types of errors in particular settings 
FDQQRWEHJHQHUDOLVHGWRWKH8.FKLOGUHQ¶VSRSXODWLRQ 
3.7. &RQFOXVLRQ 
The reasons for the wide variation in error rates found in studies using the same 
methods and denominators were identified in many cases. Different settings are a 
significant reason for wide variations in error rates in some studies. Other important 
causes of variation are the use of interventions, country, identifying subtypes of 
errors, identifying errors with specific medications, different inclusion criteria, 
HQYLURQPHQWVWXG\GHVLJQVDQGGLIIHUHQFHLQSDUWLFLSDQWV¶OHYHORIHGXFDWLRQWUDLQLQJ
and experience. Neonates are involved in a number of the studies and showed a high 
rate of errors.   
Despite the challenges of the current literature base the main messages to be taken 
from this review of the methods of data collection on the identified rate of medication 
errors are:-  
x Prescribing errors are more likely to be detected using chart review though the 
addition of incident reporting, questionnaires and/or parental interview may 
improve error detection rates in some settings.   
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x Administration errors may be best studied using direct observational techniques 
though incident reporting seems to be useful here. The Hawthorne effect may 
however be important and affect results so study design and awareness of this is 
very important.  
x Chart review seems to identify more medication errors in general than other 
methods and incident reporting in combination with this may improve the results.  
x Transcribing, monitoring and dispensing errors have been less well studied than 
other error types. Incident reporting schemes may be better to detect transcribing 
and dispensing errors whereas chart review may be better for monitoring errors. 
Definitions of such errors are very important as the current literature is unclear.  
There is no globally agreed definition for medication errors. Many studies used 
definitions which were unlikely to adequately meet their study aims. It is 
unfortunately not possible to decide what influence the definition has on the results of 
these studies as they cannot be compared adequately. Future researchers are however 
advised to give careful consideration to the definitions they use, to ensure that they 
will meet the aims of their study and where possible to use previously used definitions 
in order to be able to compare their results with those of others.  
It is important not only to identify the rate of errors in paediatric patients but rather to 
find out solutions for these errors. Using electronic prescribing has been found to be a 
good intervention to reduce prescribing errors. Moreover, use of dosing supporting 
tools, such as computerised automatic dosage calculation, were found to be useful to 
reduce administration errors. It seems that measuring the effect of some interventions 
may need time before making a judgment as to their effect as healthcare professionals 
sometimes need time to adapt to such interventions.     
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The rates of medication errors from the UK studies identified in this systematic 
review cannot be generalised due to the low number of studies that were conducted in 
the same setting, using the same methodology and the same denominators to identify 
the rate of the same type of errors. However, the data suggests that the rate of 
prescribing and administration errors is higher in paediatric units in general hospitals 
FRPSDUHG WR VSHFLDOLVW FKLOGUHQ¶V KRVSLWDOV This trend should be explored in future 
work. The authors of the UK studies however focused mainly on identifying and 
reducing the rate of prescribing errors more than any other types of errors. Further 
investigations regarding the incidence and causes of medication errors in children in 
the UK are required to develop interventions to reduce risk. I recommend that UK 
researchers should consider the following when starting new studies: 
x More studies investigating the reasons for medication errors happening in 
children need to be done.  
x Choose appropriate denominators to identify each type of error so that results 
can be compared to previous studies and lessons learned if possible. 
x Studies should include different types of medication errors (e.g. prescribing 
and administration errors).  
x Use clear definitions which are designed to meet the study aims.  
x Examine the effect of other types of interventions such as clinical pharmacy 
services. 
x )RFXVVHSDUDWHO\RQQHRQDWHVDQGRWKHUFKLOGUHQ¶Vage classifications.  
There are few studies that identified errors in different time frames. These were often 
different as some studies divided the day time to two shifts whereas others to three 
shifts. Even though some studies identified the error rate in the same number of shifts; 
the start and the end times of these shifts often differed. These differences make it 
difficult to draw conclusions.  
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&KDSWHU6\VWHPDWLFOLWHUDWXUHUHYLHZRIWKHUROHRI
WKHSDHGLDWULFFOLQLFDOSKDUPDFLVWLQUHGXFLQJWKHUDWH
RIPHGLFDWLRQHUURUV 
4.1. ,QWURGXFWLRQ 
The American College of Clinical Pharmacy (ACCP) defined clinical pharmacy as 
³WKDWDUHDRISKDUPDF\FRQFHUQHGZLWKWKHVFLHQFHDQGSUDFWLFHRIUDWLRQDOPHGLFDWLRQ
XVH´ (199) 7KH WHUP ³3KDUPDFHXWLFDO &DUH´ ZDV ILUVWO\ LQWURGXFHG E\ +HSOHU DQG
Strand in DQGZDVGHILQHGDV³7KHUHVSRQVLEOHSURYLVLRQRIGUXJWKHUDS\IRUWKH
SXUSRVHRIDFKLHYLQJGHILQLWHRXWFRPHVWKDWLPSURYHDSDWLHQW¶VTXDOLW\RIOLIH´(200). 
Compliance with standards (e.g. cooperating with other healthcare professionals) that 
should be followed to protect patients from unsafe use of medications, as detailed in 
regulation 13 of the Health and Social Care Act 2008, can only be achieved by 
providing an effective clinical pharmacy service (201).  
 
Clinical pharmacy was started in the University of Michigan in the US in the early 
1960s by students studying in the pharmacy school (202). After graduation of these 
students; three of them, David Burkholder, Paul Parker, and Charles Walton, made a 
strong effort to initiate clinical pharmacy services (202). The first university that 
started offering a clinical pharmacy degree was the University of Kentucky in the late 
1960s (202). In the US, the board of pharmacy specialties provides clinical pharmacy 
in eight specialities; ambulatory care, critical care, nuclear, nutrition support, 
oncology, paediatrics, pharmacotherapy and psychiatry (203). 
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Pharmacy practice in the UK changed from being product oriented to patient oriented 
in the mid-1960s and increased after the 1970s (204). Postgraduate courses started in 
Bradford, London and Manchester universities in the 1970s (205-207)7KH³FOLQLFDO
SKDUPDF\´WHUPZDVIRUPDOO\XVHGLQWKH8.E\WKH1XIILHOGUHSRUWLQ(204). 
Prescriptions and medication charts are reviewed by pharmacists to identify errors, 
drug interactions, and appropriateness of prescribing in terms of choice of drug and 
compliance with local policies. Patients may be asked by pharmacists to give details 
of e.g. medication history, allergy status, side effects and adverse drug reactions. 
Pharmacists provide advice to other healthcare professionals including choice of 
medication, correct dose, suitable administration routes, drug interactions and side 
effects. They monitor and provide advice on use of drugs with a narrow therapeutic 
index e.g. aminoglycosides and anticonvulsants. They also play important roles with 
anticoagulant medications to advise on keeping the international normalisation ratio 
within the therapeutic range (208).  
Pharmacists may practice in many different areas including; ambulatory care, critical 
care, drug information, geriatric and long-term care, internal medicine and 
subspecialties, cardiology, endocrinology, gastroenterology, infectious disease, 
neurology, nephrology, obstetrics and gynaecology, pulmonary disease, psychiatry, 
rheumatology, nuclear pharmacy, nutrition, neonatal intensive care, paediatrics, 
pharmacokinetics and surgery (209). There is currently limited formal specialist 
training in such areas for UK pharmacists however.   
Clinical pharmacists are involved before, during and after writing the prescription 
(210) %HIRUH SUHVFULSWLRQV DUH ZULWWHQ FOLQLFDO SKDUPDFLVWV¶ UROHV LQFOXGH WKH
decision of which products should be purchased, which medications should be 
included in hospital formularies and which management guidelines should be 
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implemented (210). During prescription writing; their role involves advising doctors 
around the best medications and dose regimen to use including cost (210). After 
writing prescriptions; they ensure the suitability and accuracy of medications 
prescribed and monitoring process are in place (210).  
Clinical pharmacists are a primary source for providing information and advice, based 
on scientific evidence, to ensure delivery of the correct, safest and most effective 
medication to patients (199). In order for them to work effectively they need to have a 
good background knowledge about diseases, therapeutics, medications and their 
mechanism of actions, drug monitoring, good therapeutic planning skills, the ability to 
do a risk assessment and interpret their findings, the effect of the body on drugs and 
the effect of drugs on the body, adverse drug events, the economic and effective 
impact of using some medications over others and good communication skills (211).  
The goals of clinical pharmacy involve (211, 212):  
1. 8VLQJ VXLWDEOH PHGLFDWLRQV DFFRUGLQJ WR WKH LQGLYLGXDO SDWLHQW¶V Vituation to 
obtain the desired effects. 
2. Minimising adverse drug events, drug interactions and other medication-
related problems as far as possible. 
3. Monitoring the medication effectiveness for each patient. 
4. Monitoring medication adherence by patients. 
5. Providing effective alternative medications to decrease cost where possible.  
6. Simplifying dosing regimens.  
7. Making sure that all medications are used according to national or local 
guidelines.  
8. Avoid waste of medications and ensure all currently prescribed medications 
are required. 
9. Counselling and education of patients, parents and other healthcare 
professionals. 
10. $VVHVVLQJSDWLHQWV¶DELOLW\to take medications. 
11. Encouraging patient adherence and providing compliance aids when required.  
 
As identified in Chapter 2, the literature on medication errors in paediatric patients 
has increased since 2006. It is important to know what different paediatric clinical 
SKDUPDFLVWV¶ DFWLYLWLHV DUH being used to improve healthcare services and their 
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effectiveness in reducing medication errors. Therefore a systematic review of the 
literature to explore WKHHIIHFWRIFOLQLFDOSKDUPDFLVWV¶DFWLYLWLHVin reducing paediatric 
medication errors was conducted.  
4.2. $LPV 
1. To identify contributions and interventions made by clinical pharmacists to 
minimise or prevent medication errors in neonatal and paediatric patients. 
2. To use this knowledge to inform development of my own study involving directly 
observing clinical pharmacists locally to identify their role in decreasing the rate 
of medication errors and improving care provided to paediatric patients.   
4.3. 0HWKRGV 
Five databases were searched to identify relevant studies: 
x EMBASE 1974-July 2013 
x International Pharmaceutical Abstracts (IPA) 1970- July 2013 
x Ovid MEDLINE(R) 1946- July 2013 
x Allied and Complementary Medicine (AMED) 1985- July 2013 
x CINAHL (Cumulative Index to Nursing and Allied Health Literature) 1982- 
July 2013 
There were no limitations for the search.  
4.3.1. Search strategy 
EMBASE, IPA, MEDLINE and AMED databases were searched separately and then 
combined together to remove duplication. CINAHL could not be combined with the 
other databases; hence, it was searched alone and manually reviewed to remove 
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duplication and to identify relevant articles. A hand search of bibliographies was done 
to include relevant articles that were not identified from the databases. 
4.3.2. Keywords 
Forty-four keywords were used from Ghaleb et al. 2006 (17) who had previously 
conducted a well-recognised systematic review of medication errors in children.  
Sixteen keywords were added to strengthen their strategy. These were: prescribing 
mishap OR prescribing mishaps OR incorrect drugs OR incorrect doses OR incorrect 
routes of administration OR error reduction OR medical error OR medical errors OR 
calculation error OR calculation errors OR calculation mistake OR calculation 
mistakes OR error rate OR dose error OR dosing error AND baby.  
The most sensitive and specific keywords for neonatal and paediatric patients 
according to a validated age specific search strategy by the Hedges Team (213) are as 
follows: children or infant or pe*diatric* or neonate or adolescence or adolescences or 
adolescent (213). Therefore three keywords were added: children OR adolescence OR 
adolescences.  
Eleven keywords used by five previous systematic review studies (214-218) exploring 
the role of pharmacists were included: pharmacist OR pharmacists OR pharmacy OR 
clinical pharmacy OR pharmaceutical care OR pharmacy services OR clinical 
pharmacist OR clinical pharmacists OR pharmaceutical services OR ward-based 
pharmacists OR pharmacists interventions    
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 The combined strategy for the search was therefore:  
medication error OR medication errors OR administration error OR administration 
errors OR prescribing error OR prescribing errors OR dispensing error OR 
dispensing errors OR drug error OR drug errors OR drug mistake OR drug mistakes 
OR prescribing mishap OR prescribing mishaps OR drug mishap OR drug mishaps 
OR medication mistake OR medication mistakes OR medication mishap OR 
medication mishaps OR administration mistake OR administration mistakes OR 
dispensing mistake OR dispensing mistakes OR prescribing mistake OR prescribing 
mistakes OR wrong drug OR wrong drugs OR wrong dose OR wrong doses OR 
incorrect drug OR incorrect drugs OR incorrect dose OR incorrect doses OR 
incorrect route of administration OR incorrect routes of administration OR error 
reduction OR medical error OR medical errors OR calculation error OR calculation 
errors OR calculation mistake OR calculation mistakes OR error rate OR drug death 
OR dose error OR dosing error 
AND 
pediatric OR pediatrics OR paediatric OR paediatrics OR child OR children OR 
infant OR infants OR neonate OR neonates OR neonatal OR adolescent OR 
adolescents OR adolescence OR adolescences OR baby 
AND 
pharmacist OR pharmacists OR pharmacy OR clinical pharmacy OR pharmaceutical 
care OR pharmacy services OR clinical pharmacist OR clinical pharmacists OR 
pharmaceutical services OR ward-based pharmacists OR pharmacists interventions 
 
A paediatric patient was defined according to the International Conference on 
Harmonisation (129) to be 18 years  or less.   
4.3.3. Inclusion criteria 
2ULJLQDOUHVHDUFKVWXGLHVLGHQWLI\LQJWKHHIIHFWRISKDUPDFLVWV¶DFWLYLWLHVRQUHGXFLQJ
or detecting medication errors either in neonatal or paediatric patients or in the 
general population, where the neonatal or paediatric data are separately identified. 
4.3.4. Exclusion criteria 
x 6WXGLHV LGHQWLI\LQJ WKH HIIHFW RI SKDUPDFLVWV¶ DFWLYLWLHV RQ UHGXFLQJ HUURUV LQ
adults only. 
x 6WXGLHV LGHQWLI\LQJ WKHHIIHFWRISKDUPDFLVWV¶DFWLYLWLHVRQUHGXFLQJHUURUV LQ WKe 
general population where paediatric data are not separately identified. 
x Studies identifying drug toxicity and not errors. 
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x Review articles. 
x Editorial article, reply, comment, letter, news, notes and case reports. 
A random 10% of all papers identified, and all those where it was not immediately 
obvious whether it should be excluded or included from the abstract, were 
independently reviewed by my supervisor (Dr Conroy) to confirm whether the study 
met the inclusion/exclusion criteria or not. 
4.3.5. Quality assessment of studies 
All included studies were assessed to determine the quality of each study. The 
assessment was made using ten FULWHULDDGDSWHG IURP*KDOHE¶VVWXG\ (17) and 
$OODQ¶VVWXG\(113): 
1. Aims/objectives of the study clearly stated. 
2. Errors to be studied specified. 
3. Errors to be studied defined. 
4. Presence of a clearly defined denominator. 
5. Data collection method described clearly. 
6. Setting in which study conducted described. 
7. Sampling described. 
8. Reliability of methods used. 
9. Limitations of study listed. 
10. Ethical approval mentioned. 
 
Only studies available as full articles (or conference abstracts) with quality ratings six 
or more were included. A research nurse and I scored the quality assessments 
independently. Any disagreement was resolved by discussion.   
4.3.6. Extraction of data and analysis  
All data was entered into three tables according to their methodology: authors, 
country, setting, aim, type of error, period of study, sample, method, type of 
contributions, error rate, sub-types of errors, medications associated with error, other 
significant results and quality rating. Data was analysed descriptively. 
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4.4. 5HVXOWV 
The total number of references identified was 1,712. After removing duplication; 
1,234 abstracts remained. All were reviewed against the inclusion and exclusion 
criteria. Of these, 39 were relevant and one study was added following hand search of 
bibliographies. Fifteen studies (two full articles and 13 abstracts) were excluded 
because they had a quality assessment score of less than six and therefore 25 studies 
remained (18 full articles and seven abstracts). Table 4.1 illustrates reasons for 
exclusion and Figure 4.1 illustrates the search strategy and results.  
Table 4.1: Reasons for excluding articles from review 
Reason for exclusion Number of papers  
Not relevant  727 
Not original research 126 
Literature review 121 
Editorial article, reply, comment, letter, news, notes 107 
Case reports 67 
Studies not separating paediatric results from adult results 32 
Quality rating less than six 15 
Adverse drug events not involving medication errors 12 
Insufficient information from abstract (full article not available) 3 
Total number of studies  1,210 
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Figure 4.1: Summary of search and review process 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CINAHL MEDLINE EMBASE IPA AMED 
Until end of July 2013 
800 282 418 
 
0 212 
1,712 
 
After removing duplications  
1,234 
After excluding 1,195 references  
40 
1 study from hand search 
of bibliographies   
 
25 
After excluding 15 studies with 
quality rating less than 6  
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4.4.1. Quality assessment  
Quality assessment was completed on all studies with full articles available (20) and 
on those only available as conference abstracts (20). Quality assessment (by myself 
and the research nurse had R-value for agreement before discussion of 0.975%. Only 
one study needed discussing. The results can be seen in Figure 4.2. Two full articles 
and 13 abstracts had a score of less than 6 and therefore were excluded.  
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Figure 4.2: Quality assessment of studies 
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4.4.2. Countries 
The 25 remaining studies were conducted in 13 different countries of which nine were 
in the US, three in the UK, two in Canada and two in Spain (Figure 4.3).  
  
4.4.3. Settings 
The studies were conducted in 12 different settings (Figure 4.4), of which the majority 
ZHUHLQVSHFLDOLVWFKLOGUHQ¶VKRVSLWDOV8), paediatric units in general hospitals (5) and 
intensive care units (3). The setting for one study (a conference abstract) was not 
provided. The remaining eight studies were each conducted in different settings.  
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Figure 4.3: Countries 
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4.4.4. Methods of data collection  
Three different methods of data collection were used:  
Nineteen used chart review, four used review of incident reports, one used direct 
observation of parents and nurses administering medications and one used a mixed 
method and identified the rate of prescribing errors (using chart review) and 
administration errors (using direct observation of parents) separately and therefore 
will be included twice in the analysis.   
The following sections illustrate the 25 included studies according to the methodology 
used for data collection.  
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4.4.4.1. Studies using chart review 
Twenty studies used chart review. Seventeen studies identified prescribing errors and 
three identified medication errors in general. Error rates varied greatly and five 
studies just provided a number with no denominator.  
Most studies looked at the introduction of clinical pharmacy services (chart review, 
medication reconciliation, annotating prescriptions with administration information, 
provision of information, answering queries, quiz and feedback for doctors, 
pDUWLFLSDWLRQ LQ GRFWRUV¶ URXQGs, developing clinical guidelines, identifying 
opportunities for cost saving and education of healthcare providers, patients and 
parents) and the effects they have.  
Antibiotics were the most common class of drug where errors were found. Six studies 
identified the medications most often associated with errors that were intercepted by 
clinical pharmacists. Five studies (117, 219-222) identified antibiotics as the group of 
medications mostly associated with errors and one study (223) identified central 
nervous system drugs. Two studies identified single medications mostly associated 
with errors of which the most common medication was omeprazole (224) in a Spanish 
ICU and paracetamol in a French paediatric surgical unit (225). Wrong doses 
(especially overdoses) were the commonest errors intercepted. 
Two studies (226, 227) showed that discharge prescriptions are best checked by 
pharmacists on the ward rather than in the dispensary as they are familiar with the 
SDWLHQWV¶PHGLFDWLRQVDQGKLVWRU\ and have access to charts and medical notes. 
Only one study was a randomised controlled trial (221) in a Chinese paediatric unit. 
This study showed error prevention, cost savings and reduced length of stay after 
SKDUPDFLVWV¶FRQWULEXWLRQDQVZHULQJKHDOWKFDUHSURIHVVLRQDOV¶TXHVtions, suggestions 
of treatment and educating patient). Doctors¶ acceptance rate of interventions was 
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high where stated except in a US emergency department (227) and a Dutch specialist 
FKLOGUHQ¶VKRVSLWDO (222).  
Three studies found that clinical pharmacists were effective in reducing the cost. Chan 
et al. 1990 (226) saved $263 per month following a decrease in discharge medications 
wasting. This was because patients were given the medications issued during 
hospitalisation to be taken home at discharge. Two studies found clinical pharmacists 
effective in saving the cost of medications; $1,977 was saved in a US ICU by 
reducing drug acquisition costs (228) and $5485.80 was saved in a Canadian child and 
adolescent mental health unit by reducing total drug costs (229). 
 
Table 4.2 illustrates the 20 studies using chart review as a method of data collection. 
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Table 4.2: Studies using chart review 
Reference 
number 
Aim Method Rate of errors  Sub-types of errors  Medications 
associated with 
errors  
Other results  
Qu
al
ity
 
ra
tin
g 
Authors Type of error  
Country Period  Types of contributions  
Setting Sample 
(219) To assess prospectively the 
impact of clinical 
pharmacists at two hospital 
pharmacies on detecting and 
preventing prescribing errors 
before dispensing 
medications  
Prescriptions with errors were 
detected prospectively by clinical 
pharmacists before dispensing and 
passed to a doctor and two clinical 
pharmacists for confirmation 
1.35 per 100 
patient days (4.9 
per 1000 orders) 
in the 1st hospital 
& 
1.77 per 100 
patient days (4.5 
per 1000 orders) 
in the 2nd hospital  
Over-dose (55.1%), 
under-dose (26.9%), 
wrong medication 
(5.6%), IV 
incompatibility (2.7%), 
wrong route of 
administration (1.9%), 
drug interaction (1.9%), 
drug allergy (0.4%) and 
others (5.4%) 
Most errors were 
associated with 
antibiotics (28.1% 
of all errors at the 
1st hospital and 
47% at the 2nd 
hospital) followed 
by theophylline at 
the first hospital 
(16.4% of all 
errors) and 
analgesics (14.6% 
of all errors)  
100% agreement was 
identified between the 
doctor and the two 
clinical pharmacists.  
49.7% of all errors 
occurred on NICU 
compared with 23.2% 
on PICU and 27.1% at 
other paediatric units. 
8 
Folli et al. 
1987 
MPEs 
US 6 months (February- July 
1985)  
Not mentioned  
Two specialist 
FKLOGUHQ¶V
hospitals 
57,394 orders at the first 
hospital and 43,628 orders at 
the second hospital 
(226) 
 
To assess the effect of 
reviewing discharge 
prescriptions by pharmacists 
(on paediatric ward) rather 
than by pharmacists in 
outpatient pharmacies  
Pharmacists on paediatric ward 
reviewed discharge medications 
instead of pharmacists at outpatient 
pharmacies and compared the 
discharge medications with the 
SDWLHQWV¶LQSDWLHQWPHGLFDWLRQV 
18% of all orders  Omissions errors (17%), 
incomplete prescriptions 
(13 %), wrong dose 
(10%), wrong dosage 
form (15%), wrong 
direction (3%), wrong 
drugs (3%) and others 
(39%). 
Not mentioned  Pharmacists decreased 
the cost (decreased 
waste of medication). 
'RFWRUVDQGQXUVHV¶
time saved because 
pharmacists are 
familiar with the 
SDWLHQWV¶PHGLFDWLRQV
and history.   
$263 per month saved 
7 
Chan et al. 
1990 
MPEs 
US August 1988 to May 1989 Not mentioned 
Paediatric unit 
in a general 
hospital  
 
An average of 154 
prescriptions per month 
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Reference 
number 
Aim Method Rate of errors  Sub-types of errors  Medications 
associated with 
errors  
Other results  
Qu
al
ity
 
ra
tin
g 
Authors Type of error  
Country Period  Types of contributions  
Setting Sample 
(230) 
 
To assess the effect of 
paediatric clinical 
pharmacists on reducing the 
rate of prescribing errors  
Two methods 
1. Prospective chart review by 
clinical pharmacists 
2. Retrospective prescriptions 
review (from the hospital 
pharmacy) by a quality assurance 
pharmacist  
516 interventions 
identified 
retrospectively. 
Prospectively 390 
interventions were 
identified  
Wrong dose, omission of 
dose, omission of 
frequency, wrong length 
of therapy, prescribing 
medication to allergic 
patients, ADRs, not 
adherence to guideline, 
wrong formulation  
 
Not mentioned  Major cause for dosage 
error was 
miscalculation 
resulting from 
misplacing of decimal 
point  
7 
Koren et al. 
1991 
MPEs 
Canada One month retrospectively 
(March 1989) and another 
month (June 1989) 
prospectively 
Suggestions and recommendations 
of treatment  
Specialist 
FKLOGUHQ¶V
hospital 
Not mentioned  
(220) 
 
To identify the effect of 
pharmacists on preventing 
prescribing dosing errors  
Four months study. Pharmacist 
reviewed prospectively all 
prescribed doses for 
appropriateness according to mg/kg 
basis.    
80 dosing errors 60% were overdose and 
40% were under dose 
Antibiotics were 
associated with 
49% of all dosing 
errors. 
 
Doctors accepted 
97.5% of all 
SKDUPDFLVWV¶
recommendations. 
6 
Grinder et al. 
1991 
MPEs (dosing errors) 
US 4 months (period not 
mentioned)  
Not mentioned  
 
 
 
 
 
 
 
 
 
 
Not mentioned  69,282 prescriptions 
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Reference 
number 
Aim Method Rate of errors  Sub-types of errors  Medications 
associated with 
errors  
Other results  
Qu
al
ity
 
ra
tin
g 
Authors Type of error  
Country Period  Types of contributions  
Setting Sample 
(231) 
 
To assess the effect of using 
quiz program followed by 
feedback (once monthly for 
11 months) on reducing the 
rate of prescribing errors  
Prescribing errors were identified 
and reviewed by two pharmacists 
and one doctor before and after the 
intervention. The rate of prescribing 
errors was compared before and 
after the intervention using chart 
review 
Prescribing errors 
decreased from 
6.2% to 4.1% of 
all orders 
Not mentioned  Not mentioned  Not mentioned  6 
Zangwill et al. 
2000 
MPEs 
US Two weeks (period not 
mentioned) after the 
intervention 
Quiz +feedback for doctors  
Paediatric unit 
in a general 
hospital 
Not mentioned  
(228) 
 
To identify the types and 
numbers of clinical 
pharmacists interventions.   
Pharmacist reviewed medication 
charts prospectively  
 
 
 
35 
recommendations 
per 100 patient 
days (28% dosage 
changes, 26% 
drug information) 
 
Wrong medication, 
wrong route of 
administration, wrong 
dose, omission of 
medications, unnecessary 
medication, TDM and 
ADRs 
 
 
Not mentioned  $1,977 was saved 
(from drug acquisition 
costs) 
8 
Krupicka et al. 
2002 
MEs in general  
US 19th November 1996 to 6th 
May 1997 
PDUWLFLSDWLRQLQGRFWRUV¶URXQG
answering healthcare SURYLGHUV¶
queries and educating healthcare 
professionals. 
 
 
 
 
 
 
 
 
Intensive care 
unit  
215 patient admissions (493 
patient days) 
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Reference 
number 
Aim Method Rate of errors  Sub-types of errors  Medications 
associated with 
errors  
Other results  
Qu
al
ity
 
ra
tin
g 
Authors Type of error  
Country Period  Types of contributions  
Setting Sample 
(229) 
 
To identify the effect of 
clinical pharmacists on 
reducing the medication 
error rate and on reducing 
the financial cost  
Pharmacists collected all 
SKDUPDFLVWV¶LQWHUYHQWLRQV
prospectively by chart review.  
A retrospective cost analysis was 
done (not mentioned by whom). 
 
48 interventions 
in 4 weeks 
 
32 errors were identified. 
These involved adverse 
drug reactions (38%), 
under-dose (19%), drug 
not indicated (19%), 
wrong medication (6%), 
over-dose (3%), drug 
indicated but not 
prescribed (3%) and 
others (12%).  
 
Not mentioned  98% were accepted by 
doctors 
$5485.80 was saved 
(21% decrease in total 
drug cost).    
7 
Virani et al. 
2003 
MPEs  
Child and 
adolescent 
mental health 
unit 
4 week interval (June 4 to 
June 29, 2001) for 
prospective review  
12 months (September 1998-
August 1999) before and 12 
months after the intervention 
(September 1999-August 
2000) for retrospective 
review  
3KDUPDFLVWVSDUWLFLSDWHGLQGRFWRUV¶
rounds, provided consultation to 
healthcare professionals and 
answering their queries, preventing 
medication errors, cost saving and 
provide interdisciplinary staff 
support.   
 
 
 Canada  Not mentioned  
(232) 
 
To measure the accuracy of 
doses measurement by 
parents and the accuracy of 
prescribing by doctors. 
Doctors received feedback from the 
Group 1 prescribing errors results 
and given a paediatric dosing chart 
for paracetamol to calculate doses 
DFFRUGLQJWRSDWLHQWV¶ZHLJKW 
% recommended 
doses prescribed 
by doctors in 
group 1 was 
38.2% and 98.7% 
in group 2. 
 
 
 
 
 
Dosing errors Not mentioned  Not mentioned  9 
Angalakuditi 
et al. 2003 
MPEs 
India One-week study. Feedback to doctors+dosing chart 
 
 
 
 
 
Specialist 
FKLOGUHQ¶V¶
hospital 
175 patients in Group 1 and 
162 patients in Group 2  
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Reference 
number 
Aim Method Rate of errors  Sub-types of errors  Medications 
associated with 
errors  
Other results  
Qu
al
ity
 
ra
tin
g 
Authors Type of error  
Country Period  Types of contributions  
Setting Sample 
(86) 
 
To assess the effect of 
clinical pharmacists services 
on the rate of serious 
medication errors  
Data from medication orders, 
incident reports, MARs and 
SDWLHQWV¶FKDUWVZHUHUHYLHZHG
prospectively by trained nurses. All 
suspected medication errors were 
passed to two doctors for 
confirmation 
Serious MEs rate 
decreased in ICUs    
from 29 to 6 per 
1000 patient days 
after the 
intervention but 
did not decrease       
in the general 
medical unit 
(from 8 to 9 per 
1000 patient days 
after the 
intervention) or in 
the general 
surgical unit 
(from 7 to 9 per 
1000 patient days 
after intervention)  
Not mentioned  Not mentioned  RIDOOSKDUPDFLVWV¶
interventions occurred 
during prescribing 
stage.  
10 
Kaushal et al. 
2008 
Serious MEs in general 
US 6-8 weeks in three paediatric 
unit (PICU, medical unit and 
surgical unit) for 6 months 
between March- August 
2000 and for 3 months in 
each unit between June- 
November 2000 
Introduction of clinical pharmacy   
Specialist 
FKLOGUHQ¶V
hospital 
1249 admissions in the 
PICU, 1690 admissions in 
the paediatric medical unit 
and 1924 admissions in the 
paediatric surgical unit. 
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Reference 
number 
Aim Method Rate of errors  Sub-types of errors  Medications 
associated with 
errors  
Other results  
Qu
al
ity
 
ra
tin
g 
Authors Type of error  
Country Period  Types of contributions  
Setting Sample 
(117) 
 
To assess the effect of 
clinical pharmacist services 
on the quality assurance of 
drug management  
Chart review was done by 
pharmacists six months after 
starting the clinical pharmacy 
services  
103 orders 
(26.8%) involved 
137 MPEs 
48 (35%) related to 
dosage, 35 (26%) drug 
choice, 32 (23%) related 
to monitoring, 18 (13%) 
illegible writing, 3 (2%) 
interaction and 1 (0.7%) 
ADR. 
Most prescribing 
errors were 
associated with 
antibiotics, 
followed by 
diuretics 
Not mentioned  9 
Kjeldby et al. 
2009 
MPEs 
Norway February 2006- March 2007 3DUWLFLSDWLRQLQGRFWRUV¶URXQG
discussing errors with doctors and 
nurses, answering queries from 
healthcare professionals, education, 
cost saving and developing clinical 
guidelines 
Paediatric unit 
in a general 
hospital  
384 orders  
(233) 
 
To identify the effect of 
medication reconciliation by 
pharmacists on reducing 
MPEs 
Prospective observational study of 
medication reconciliation by one 
clinical pharmacist to compare 
medications prescribed on 
admission with medications from 
before admission  
 
 
39% of initial 
medication orders 
differed from pre-
admission 
medication 
orders. 
Not mentioned  Not mentioned  Not mentioned  9 
Terry et al. 
2010 
MPEs 
UK September 200- March 2007  Medication reconciliation 
Neurosurgical 
ward 
 
 
100 patients  
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Reference 
number 
Aim Method Rate of errors  Sub-types of errors  Medications 
associated with 
errors  
Other results  
Qu
al
ity
 
ra
tin
g 
Authors Type of error  
Country Period  Types of contributions  
Setting Sample 
(223) 
 
To identify the effect of 
different interventions by 
pharmacists on the rate of 
prescribing errors 
Charts were reviewed by one 
pharmacist before and after an 
intervention  
78.1% of all 
orders before the 
intervention 
involved 
prescribing errors 
and 35.2% of all 
orders after the 
intervention. 
Unclear orders, 
incomplete orders, wrong 
instructions for nurses 
(most types of errors 
after intervention), 
wrong selection, wrong 
frequency, wrong 
concentration, wrong rate 
of administration (most 
type of error before 
intervention) and wrong 
dose  
Most groups 
associated with 
prescribing errors 
before 
intervention: 
cardiovascular 
drugs and central 
nervous system 
drugs. Most 
groups associated 
with prescribing 
errors after 
intervention: 
central nervous 
system drugs and 
respiratory drugs.  
Most route of 
administration 
associated with errors 
before the intervention 
was IV and after the 
intervention was 
inhalation 
9 
Alagha et al. 
2011 
MPEs 
Egypt October 2008- March 2009 
(pre-intervention) and 
October 2009- March 2010 
(post-intervention) 
Starting new charts, educating 
doctors, assisting with dosing and 
provide feedback for doctors 
regarding their performance. 
Intensive care 
unit  
1,417 orders for 139 patients 
(pre-intervention) and 1,097 
orders for 101 patients (post-
intervention)  
 
 
 
(225) 
 
 
To identify the effect of 
clinical pharmacists 
activities on reducing the 
rate of prescribing errors  
Pharmacists identified prescribing 
errors by chart review. 
558 
recommendations 
in 2007, 223 in 
2008 and 387 in 
2009 
 
13% of medication 
orders: 50.9% about 
overdose, 20% wrong 
route or wrong 
administration, 11.6% 
under-dose 
 
Acetaminophen 
(23.2% of all 
recommendation), 
ondansetron 
(19.7%), 
nalbuphin 
(15.6%) codeine 
(12.8%) 
 
61.9% accepted in 
2007, 75.9% accepted 
in 2008 and 69.1% 
accepted in 2009 by 
doctors 
6 
Maire et al. 
2011 
MPEs 
France 2007- 2009 Provide recommendations  
Paediatric 
surgical unit 
 
 
Not mentioned  
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Reference 
number 
Aim Method Rate of errors  Sub-types of errors  Medications 
associated with 
errors  
Other results  
Qu
al
ity
 
ra
tin
g 
Authors Type of error  
Country Period  Types of contributions  
Setting Sample 
(224) 
 
To identify the effect of 
clinical pharmacists 
activities on reducing the 
rate of prescribing errors  
Prospective review of charts by 
pharmacists. Any intervention or 
contribution was recorded 
prospectively and stored on 
database  
40 interventions 
and contributions 
(4 per 100 patient 
days).   
1. Documentation of 
allergy status                       
2. Clarification of 
prescriptions            
3.Preventing medication 
errors: duplication, 
wrong dose, illegible 
writing, non-adherence 
to guideline, incomplete 
information, interaction, 
wrong dosage interval, 
unnecessary medication, 
omission of medication, 
ADR and wrong route of 
administration. 
Most drugs 
associated with 
recommendations 
were omeprazole 
followed by 
acetylcysteine.   
95% of pharmacists 
recommendations were 
accepted by doctors  
9 
Echarri-
Martínez et al. 
2011 
MPEs 
Spain October- December 2009 Financial saving and annotate 
prescription with administration 
information.  Intensive care 
unit  
Not mentioned  
(234) 
 
To assess the effect of 
clinical pharmacist 
intervention on reducing 
prescribing errors.   
Prospective review of charts by 
pharmacists. All interventions 
activities were recorded 
prospectively and stored on 
database  
1,475 
contributions and 
interventions 
(0.019 per bed 
day or 2.4% of all 
orders) 
As above (same research 
group)  
 
Not mentioned  Not mentioned  10 
Fernandez-
Llamazares et 
al. 2012 
MPEs 
Spain 2007-2009 Financial saving and annotate 
prescription with administration 
information.  
 
 
 
 
 
Specialist 
FKLOGUHQ¶V
hospital  
61,458 prescriptions 
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Reference 
number 
Aim Method Rate of errors  Sub-types of errors  Medications 
associated with 
errors  
Other results  
Qu
al
ity
 
ra
tin
g 
Authors Type of error  
Country Period  Types of contributions  
Setting Sample 
(235) 
 
To assess the effect of 
clinical pharmacy services 
on reducing MPEs 
Prescribing error rate compared one 
year before intervention and one 
year after the intervention (not 
mentioned by whom it was 
reviewed)  
Prescribing errors 
decreased from 20 
to 9. 
3KDUPDFLVWV¶
intervention 
decreased from 
4.05 to 2.09 per 
100 medications 
prescribed. 
 
 
Not mentioned  Not mentioned  Not mentioned  8 
Patel et al. 
2012 
MPEs 
UK November 2010- November 
2011 
The intervention involved 
pharmacist daily review of 
prescriptions, taking medication 
history within 24 hours of 
admissions and discuss any errors 
with the prescribers.    
 
Haematology/ 
oncology ward 
Not mentioned  
(221) 
 
To investigate the effect of 
clinical pharmacists on 
reducing medication errors 
and to identify the different 
types of intervention made 
by pharmacists  
Randomised controlled trial. The 
interventional group involved 
clinical pharmacists care and the 
other group was a control group. 
$OOFOLQLFDOSKDUPDFLVWV¶
interventions were reviewed (not 
mentioned by whom)  
109 interventions 
(31 prevention of 
medication errors) 
 
Prescribing errors, 
dosage errors, 
preparation errors, 
technology errors and 
compliance errors  
 
42.2% of all 
interventions were 
associated with 
antibiotics 
 
Length of stay at the 
hospital was less in 
intervention group 
compared to the control 
group (6.45 days vs. 
10.83 days) 
 
8 
Zhang et al. 
2012 
MEs in general  
China  December 2010 to March 
2011 
Answering healthcare 
SURIHVVLRQDOV¶TXHVWLRQV
suggestions of treatment, patient 
education and prevention of 
medication errors (by review of 
medication charts). 
 
 
 
 
Paediatric unit 
in a general 
hospital  
80 patients in the 
interventional group and 80 
patients in the control group 
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Reference 
number 
Aim Method Rate of errors  Sub-types of errors  Medications 
associated with 
errors  
Other results  
Qu
al
ity
 
ra
tin
g 
Authors Type of error  
Country Period  Types of contributions  
Setting Sample 
(236) 
 
To identify the effect of 
clinical pharmacy services 
on prescribing process 
Interventions and activities of 
clinical pharmacists were collected 
and reviewed by one pharmacist by 
review of medication charts.  
73 interventions 
made (5.4 per 100 
patients care days 
and 9.1 % of all 
prescriptions).  
 
 
 
47.9% was dosing errors 
 
Not mentioned  Doctors accepted 
91.8% of all 
interventions 
8 
Conway et al. 
2012 
MPEs 
Ireland Three months (period not 
mentioned)  
Not mentioned 
Neonatal unit  110 patients 
 
(222) 
 
To identify the types and 
numbers of interventions 
prevented by clinical 
pharmacist intervention on 
prescribing errors.   
Prospective cohort study. All 
electronic medication prescriptions 
for paediatric inpatients were 
verified prospectively (not 
mentioned by whom).  
 
2282 
interventions for 
1577 orders (1.1% 
of all orders). 
 
 
18.9% related to 
completion and 81.1% 
related to corrections of 
prescriptions. 
Most completions were 
absence of body weight 
(55.7%) followed by 
absence of dosage form 
(17.9%) and absence of 
strength/concentration 
(16.2%).  
Most corrections were 
wrong dose (45%) 
followed by wrong drug 
formulation (9.4%). 
15.6% of all 
interventions were 
about antibacterial 
agents. 
Risk of intervention 
was higher in children 
younger than two years 
old. 
Doctors accepted 
57.5% of all 
interventions. 
31.1% of all 
interventions were in 
immunology/haematol
ogy unit, 20.3% in 
neurology unit and 
17.5% in internal 
medicine unit.  
More interventions 
were identified on oral 
dosage form and oral 
administration route.  
 
 
 
10 
Maat et al. 
2013 
MPEs 
Netherlands 1st March 2004- 1st January 
2008 
Not mentioned 
Specialist 
FKLOGUHQ¶V
hospital 
(excluding 
ICU) 
138,449 orders 
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Reference 
number 
Aim Method Rate of errors  Sub-types of errors  Medications 
associated with 
errors  
Other results  
Qu
al
ity
 
ra
tin
g 
Authors Type of error  
Country Period  Types of contributions  
Setting Sample 
(227) 
 
To identify the rate of 
SKDUPDFLVWV¶LQWHUYHQWLRQIRU
discharge prescriptions 
Pharmacists reviewed discharge 
prescriptions prospectively. One 
pharmacist reviewed and analysed 
all interventions.     
 
17 interventions 
(23.6% of all 
orders).  
Wrong patient, drug, 
drug omission, drug or 
class duplication, drug 
interaction, allergy, 
contraindication, dosage 
form, strength, route of 
administration, dose, 
frequency, duration, 
monitoring, quantity, 
refills and non-formulary 
medications.                        
 
 
Not mentioned  24% of all 
recommendation were 
accepted by doctors 
9 
Cesarz et al. 
2013 
MPEs 
US Three weeks in 2010. Chart review   
Emergency 
department  
72 
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4.4.4.2. Studies using review of incident reports 
Four studies used review of incident reports. Two studies identified prescribing errors 
and two studies identified medication errors in general. None of the four studies 
identified the error rate (i.e. they all identified the error number without using a 
denominator). Only one study by Bauters et al. 2010 (237) identified the group of 
medications mostly associated with errors which was antibiotics. Two studies (237, 
238) LGHQWLILHG WKH DFFHSWDQFH UDWH RI SKDUPDFLVWV¶ UHFRPPHQGDWLRQV E\ GRFWRUV
which was between 91-92%. 3KDUPDFLVWV¶ DFWLYLWLHV were provided by three studies 
and involved provision of information, educating and answering of healthcare 
SURIHVVLRQDOV¶ TXHULHV PHGLFDWLRQ UHFRQFLOLDWLRQ DQQRWDWLQJ SUHVFULSWLRQV ZLWK
administration information and introduction of a new reporting form. Wrong doses 
were the commonest errors intercepted.  
  
 
Table 4.3 illustrates the four studies using review of incident reports as a method of 
data collection. 
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Table 4.3: Studies using review of incident reports 
Reference 
number 
Aim Method Rate of errors  Sub-types of errors  Medications 
associated with 
errors  
Other results  
Qu
al
ity
 
ra
tin
g 
Authors Type of error  
Country Period  Types of contributions  
Setting Sample 
(238) 
 
To investigate the different 
types of contributions made 
by paediatric pharmacists to 
prevent medication errors  
Interventions were recorded by 
paediatric pharmacists on an 
LQFLGHQWV¶GDWDEDVHDQGZHUHWKHQ
reviewed by another pharmacist.  
4605 
interventions  
 
Drug therapy change 
(mostly dosing errors) 
and pharmacokinetic 
monitoring 
Not mentioned  91% of all 
interventions were 
accepted by doctors 
 
9 
Condren et al. 
2004 
MEs in general  
US 2002 Answer KHDOWKFDUHSURIHVVLRQDOV¶ 
queries, medication reconciliation 
and annotating prescription with 
administration information 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Paediatric unit 
in a general 
hospital  
3978 patients 
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Reference 
number 
Aim Method Rate of errors  Sub-types of errors  Medications 
associated with 
errors  
Other results  
Qu
al
ity
 
ra
tin
g 
Authors Type of error  
Country Period  Types of contributions  
Setting Sample 
(191) 
 
To identify the effect of 
pharmacists on the rate of 
medication errors reporting 
Phase 1: retrospective collection of 
medication error reports 
Phase 2: prospective collection of 
medication error reports.  
Phase 3: after pharmacist led 
paediatric medication safety team 
(including paediatric critical care 
nurse, paediatric intensivist). 
At the end of each month, one 
pharmacist and one nurse review 
medication error incident reports 
and then the pharmacists entered 
WKHLQFLGHQWVWRWKHLQFLGHQWV¶
database. 
109 MEs were 
identified. MEs 
reporting 
increased between 
phase1 and 2 to 
two fold, between 
phase 2 and 3 to 
three fold and 
between phase 1 
and 3 to six fold.  
Reporting of 
nurses errors 
increased from 
9% in phase 1 to 
38% in phase 2 
and 51% in phase 
3 
 
 
 
 
Omission error, wrong 
medicine, wrong dosage, 
wrong patient, 
incomplete prescription, 
transcribing error, wrong 
rate and unauthorized 
medicine. 
Not mentioned  Not mentioned  7 
Costello et al. 
2007 
MEs in general  
Specialist 
FKLOGUHQ¶V
hospital 
Phase 1: (September- 
December 2004)  
Phase 2: (February- May 
2005) 
Phase 3: (June- September 
2005) 
Implementing new reporting form 
and educational forum  
US Not mentioned  
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Reference 
number 
Aim Method Rate of errors  Sub-types of errors  Medications 
associated with 
errors  
Other results  
Qu
al
ity
 
ra
tin
g 
Authors Type of error  
Country Period  Types of contributions  
Setting Sample 
(237) 
 
To identify different 
interventions made by 
clinical pharmacists 
Interventions made by clinical 
pharmacists were collected (not 
mentioned by whom) 
 
142 interventions 
 
26.8% of all 
interventions were 
related to change of 
therapy, 55.4% increased 
drug monitoring, 16.1% 
start drug therapy, 1.7% 
clarification of order 
 
 
Antibiotics were 
associated with 
28.9% of all 
interventions, 
antineoplastic and 
immunomodulatin
g agents (28.9%) 
92% of all 
interventions were 
accepted by doctors 
 
7 
Bauters et al. 
2010 
MPEs  
Belgium  10 weeks (non-consecutive 
days). 
AQVZHUKHDOWKFDUHSURIHVVLRQDOV¶ 
queries  
Paediatric 
stem cell 
transplantation 
unit 
Not mentioned  
(239) 
 
 
To identify the effect of 
pharmacists on reducing 
prescribing errors 
3DHGLDWULFSKDUPDFLVWV¶
interventions were retrieved from 
the hospital database to identify 
prescribing errors (not mentioned 
who collected and analyse them).  
489 interventions. Wrong dose, wrong 
frequency, interventions 
regarding wrong 
calculations, decimal 
point or unit of mass 
errors, wrong or cheaper 
formulation, altered drug 
handling e.g. renal 
impairment, illegible 
prescribing, incorrect or 
incomplete history on 
admission.  
 
  
Not mentioned  Not mentioned  7 
Isaac et al. 
2012 
MPEs 
UK Not mentioned  Not mentioned  
Specialist 
FKLOGUHQ¶V
hospital 
500 prescriptions  
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4.4.4.3. Studies using direct observation 
Two studies used direct observation of parents and/or nurses to identify 
administration dosing errors. High error rates were identified with both parents and 
nurses before education $IWHU SKDUPDFLVWV¶ HGXFDWLRQ D VLJQLILFDQW UHGXFWLRQ LQ
dosing errors were identified in both studies. 
 
Angalakuditi et al. 2003 (232) identified paracetamol suspension administration errors 
by parents. They divided parents into two groups (the 1st group were educated by 
hospital staff other than pharmacists and used a cup, whereas the 2nd group were 
educated by a pharmacist and used a marked syringe). The percentage of 
recommended doses measured by parents in group 1 was 48.6% and in group 2 was 
98.7%. Bertsche et al. 2010 (240) identified administration errors by nurses and 
parents before and after education. Medication administration errors decreased by 
nurses from 40.4% to 7.9% of all administrations and by parents from 96.6% to 5.6% 
of all administrations. This study identified anticonvulsants as the most common 
group of medications associated with errors. It also identified an annual cost saving of 
¼SHUSDWLHQW 
 
 
 
 
Table 4.4 illustrates the two studies using direct observation as a method of data 
collection. 
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Table 4.4: Studies using direct observation of parents and/or nurses 
Reference 
number 
Aim Method Rate of errors  Sub-types of errors  Medications 
associated with 
errors  
Other results  
Qu
al
ity
 
ra
tin
g 
Authors Type of error  
Country Period  Types of contributions  
Setting Sample 
(232) 
 
To measure the accuracy of 
doses measurement by 
parents  
Direct observation of parents: 
Group 1 parents asked to measure 
the dose of paracetamol suspension 
using a cup after verbal instructions 
by the hospital staff other than 
pharmacists. Group 2 parents asked 
to measure the dose of antipyretic 
suspension using a marked syringe 
and were educated by a pharmacist. 
The percentage of 
recommended 
doses measured 
by parents in 
group 1 was 
48.6% and in 
group 2 was 
98.7%. 
 
 
 
 
 
Dosing errors Not mentioned  Not mentioned  9 
Angalakuditi 
et al. 2003 
MAEs 
India One-week study. Education for parents  
Specialist 
FKLOGUHQ¶V¶
hospital 
175 patients in Group 1 and 
162 patients in Group 2  
(240) 
 
To identify MAEs by 
parents and nurses  
Prospective two-period 
observational study. Clinical 
pharmacists observe 
administrations made by parents 
and nurses and identified 
administration errors.  
Medication 
administration 
errors decreased 
by nurses from 
40.4% to 7.9% of 
all administrations 
and by parents 
from 96.6% to 
5.6% of all 
administrations.  
 
Dosing errors Most errors were 
associated with 
anticonvulsants  
Annual saving of 
¼532.90 per patient  
 
7 
 Bertsche et al. 
2010 
MAEs 
Germany Not mentioned  The intervention included teaching 
of nurses and parents and providing 
information pamphlets. 
Paediatric 
neurology 
ward 
Not mentioned  
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4.4.5. Rate of medication errors    
All of the 25 included studies found that clinical pharmacists were effective, 
according to their authors, in either reducing or preventing medication errors. Nine 
studies (191, 220, 221, 225, 229, 230, 237-239) did not provide the rate but only the 
number of medication errors that received an intervention by pharmacists. The 
remaining 16 studies identified the error rate using seven different denominators.  
 
Of the 16 studies that identified the error rate; ten identified the rate of errors only 
after intervention by pharmacists (117, 219, 222, 224, 226-228, 233, 234, 236). The 
remaining six studies (86, 223, 231, 232, 235, 240) identified the rate before and after 
starting clinical pharmacy services. All of these six studies resulted in a decrease in 
medication error rate after starting this service. This ranged from 6.2-78.1% of all 
orders before to 1.1-35.2% of all orders after intervention.  
 
Table 4.5 illustrates the rate of different types of medication errors identified by 
pharmacists categorised according to the denominators and the methods used. Three 
studies (219, 234, 236) each provided the prescribing error rate using two different 
denominators. One study identified prescribing errors and administration errors (232). 
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Table 4.5: Rate of medication errors identified before and/or after FOLQLFDOSKDUPDFLVWV¶VHUYLFHV 
Denominator  Methodology  Type of error Country  Setting  Error rate Reference Range  Median  
Before  After  
Of all orders  Chart review  Prescribing errors  US Paediatric unit in a general hospital Not provided 18% (226) 6.2-78.1% 
before and 
1.1-35.2% 
after 
intervention 
61.8% 
before and 
14% of all 
orders after 
intervention  
US Paediatric unit in a general hospital 6.2% 4.1% (231) 
Norway Paediatric unit in a general hospital Not provided 26.8%  (117) 
UK Neurosurgical ward Not provided 39% (233) 
Egypt Intensive care unit 78.1% 35.2% (223) 
Spain  6SHFLDOLVWFKLOGUHQ¶VKRVSLWDO Not provided 2.4% (234) 
Ireland Neonatal unit Not provided 9.1% (236) 
Netherlands 6SHFLDOLVWFKLOGUHQ¶VKRVSLWDO
(excluding ICU) 
Not provided 1.1% (222) 
US Emergency department Not provided 23.6% (227) 
India 6SHFLDOLVWFKLOGUHQ¶VKRVSLWDO 61.8% 1.3% (232) 
Per 100 patient 
days  
Chart review Prescribing errors US 7ZRVSHFLDOLVWFKLOGUHQ¶VKRVSLWDOV Not provided 1.35-1.77 (in two 
different hospitals) 
(219)  1.3-5.4 after 
intervention 
2.8 per 100 
patient days 
Spain Intensive care unit Not provided 4 (224) 
Ireland Neonatal unit Not provided 5.4 (236) 
Medication errors 
in general 
US Intensive care unit Not provided 35 (228)   
Per 1000 orders Chart review Prescribing errors  US 7ZRVSHFLDOLVWFKLOGUHQ¶VKRVSLWDOV Not provided 4.9-4.5 (in two 
different hospitals) 
(219) 4.5-4.9 after 
intervention 
4.7 per 1000 
orders 
Per 1000 patient 
days  
Chart review Medication errors 
in general 
(serious) 
US 6SHFLDOLVWFKLOGUHQ¶VKRVSLWDO 29 6 (86)   
Per bed day Chart review Prescribing errors  Spain 6SHFLDOLVWFKLOGUHQ¶VKRVSLWDO Not provided 0.019 (234)   
Per 100 
medications 
Chart review Prescribing errors  UK Haematology/ oncology ward 4.05 2.09 (235)   
Of all 
administrations  
  
Direct 
observation  
 
Administration 
errors by nurses 
Germany Paediatric neurology ward 40.4% 7.9% (240)   
Administration 
errors by parents  
96.6%  5.6%   
Administration 
errors by parents 
India 6SHFLDOLVWFKLOGUHQ¶VKRVSLWDO 51.4% 1.3% (232)   
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4.4.6. Types of interventions identified  
Twenty-one studies identified 29 different subtypes of medication errors. Table 4.6 
illustrates the different types of medication errors that needed intervention by 
pharmacists. Wrong dose followed by wrong drug were identified by most studies.  
Table 4.6: Subtypes of medication errors intercepted by pharmacists.  
 Type of error Explanation/example  Number of 
studies 
identified in 
References 
1 Wrong dose  Either over- or under-dose 21 (117, 191, 219-230, 232, 234, 
236-240) 
2 Wrong drug  Prescribing drug not according to guidelines 11 (117, 191, 219, 222, 223, 226-
229, 237, 238) 
3 Wrong route of 
administration  
IV instead of oral 8 (219, 222, 224, 225, 227, 228, 
234, 238) 
4 Incomplete prescription  Not writing the dose 8 (117, 191, 222, 224, 226, 234, 
238, 239)  
5 Omission of medication  Not prescribing salbutamol inhaler on 
admission for patients with asthma 
8 (191, 224, 226-229, 234, 237)  
6 Drug interaction  Prescribing morphine and codeine together 7 (117, 219, 222, 224, 227, 234, 
238)  
7 Non formulary medicine  Using an adult only drug for treating a child 7 (191, 222, 224, 227, 230, 234, 
238) 
8 Identification of actual or 
potential adverse drug 
reactions 
Harmful reactions resulting from 
administration of a medication  
7 (117, 224, 228-230, 234, 238)  
9 Unclear prescription  Not writing the dose clearly 7 (117, 223, 224, 234, 237-239)  
10 Wrong dosage form  Capsule instead of liquid 6 (222, 226, 227, 230, 234, 238)  
11 Wrong 
frequency/interval  
8 hourly instead of 6 hourly 5 (222, 223, 227, 238, 239)  
12 Therapeutic drug 
monitoring  
Adjusting interval 5 (117, 227, 228, 237, 238)  
13 Duplication  Prescribing pseudoephedrine twice 5 (222, 224, 227, 234, 238)  
14 Drug prescribed to which 
patient is allergic  
Prescribing amoxicillin to patients with 
known allergy toward penicillin 
4 (219, 227, 230, 238)  
15 Changing the length of 
therapy  
For five days instead of seven days  4 (222, 227, 230, 238)  
16 Wrong 
concentration/strength  
0.45% NaCL instead of 0.9% 4 (222, 223, 227, 238) 
17 Wrong patient  Prescribing a drug to the wrong patient 4 (191, 222, 227, 238)  
18 Medicine not indicated  Prescribing ineffective drug for indication 3 (224, 229, 234)  
19 Wrong 
direction/instruction  
Wrong administration instruction for nurses 3 (223, 226, 238)  
20 Omission of dose  Not writing amoxicillin dose 3 (191, 230, 238)  
21 Omission of 
frequency/interval  
Not writing how many times the drug should 
be taken 
3 (224, 230, 234)  
22 Wrong rate of IV 
administration  
Wrong rate of IV gentamicin administration 3 (191, 223, 238)  
23 IV drug incompatibility   2 (219, 238)  
24 Wrong administration 
technique by nurses  
Crushing tablets which should not be 
crushed  
2 (225, 238)  
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 Type of error Explanation/example  Number of 
studies 
identified in 
References 
25 :URQJSDWLHQW¶V
weight/BSA on drug 
chart  
 2 (222, 238)  
26 Compliance of patients 
(by phone interview of 
patients after discharge)  
Taking drug twice daily instead of three 
times daily 
1 (221)  
27 Wrong preparation   1 (221)  
28 Contraindication  
 
 1 (227) 
29 Wrong quantity   1 (227) 
4.4.7. Types of contributions   
Eight studies (86, 219, 220, 222, 226, 227, 236, 239) did not mention the types of 
SKDUPDFLVWV¶FRQWULEXWLRQV7KHUHPDLQLQJVWXGLHVKLJKOLJKWHGGifferent types of 
contributions (Table 4.7). Answering queries about drug use, education of other 
healthcare professionals and making cost savings were most commonly documented.  
Table 4.7: PKDUPDFLVWV¶FRQWULEXWLRQV 
 
 Type of contribution Explanation/example  Number of 
studies seen in 
References 
1 Reactive information giving in response to other 
healthcare SURIHVVLRQDOV¶TXHULHV 
Information about drug usage 7 (117, 221, 228, 
229, 235, 237, 
238) 
2 Education of healthcare professionals About different formulation  6 (117, 191, 223, 
228, 229, 240) 
3 Cost saving Change drug to a cheaper one 5 (117, 224, 228, 
229, 234) 
4 Medication reconciliation  Take history of all medications 
patient taking regularly before 
admission  
3 (233, 235, 238) 
 
5 Education of patients or parents About side effects 3 (221, 232, 240) 
6 3DUWLFLSDWLQJLQGRFWRUV¶URXQG To provide information and 
recommendations to doctors 
3 (117, 228, 229) 
 
7 Recommendations and suggestions Using combination of drugs 3 (221, 225, 230) 
8 Annotating prescriptions with administration 
information 
With food/milk 3 (224, 234, 238) 
 
9 Providing feedback+ dosing chart to doctors To help prescribing the correct 
dose 
2 (223, 232) 
 
10 Introduction of new prescribing chart form Using a clearer drug chart  1 (223) 
11 Developing internal clinical guidelines  1 (117) 
 
12 Assessment+ feedback of doctors   1 (231) 
13 Staff support  1 (229) 
14 Providing dosing supporting tools To help nurses and parents 
measuring the correct dose  
1 (240) 
 
15 Implementing new reporting form  1 (191) 
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4.4.8. Acceptance of recommendations by doctors  
Nine studies (220, 222, 224, 225, 227, 229, 236-238) identified the percentage of 
GRFWRUV¶DFFHSWDQFHRIDOOSKDUPDFLVWV¶UHFRPPHQGDWLRQV7KHDFFHSWDQFHUDWHUDQJHG
between 24-98%. None of the 25 studies identified the acceptance rate by healthcare 
professionals other than doctors. All studies identified a more than 50% acceptance of 
SKDUPDFLVWV¶ UHFRPPHQGDWLRQV apart from a US study by Cesarz et al. 2013 (227). 
They identified only 24% of all recommendations were accepted by doctors in an 
emergency department and did not explain the reason for the low rate. Maat et al. 
2013 (222) also identified a slightly low rate of acceptance (57.5%) in a specialist 
FKLOGUHQ¶V KRVSLWDO LQ 1HWKHUODQGV The authors stated that the reason for this was 
because many patients were either discharged or transferred to other units, received 
once only medications or because doctors had no time.  
4.5. 'LVFXVVLRQ 
Healthcare professionals should take particular care when treating paediatric patients 
because they are more vulnerable to medication errors than adults. Different strategies 
have been applied; including clinical pharmacy services to try to prevent this. Clinical 
pharmacists work in various healthcare specialities, including paediatric wards, to not 
only prevent medication errors but also to provide other contributions that lead 
directly to improving healthcare services for patients.  
Many studies note the effects of clinical pharmacists on reducing the rate of 
medication errors, but this review only identified 25 studies that directly researched 
the effects of clinical pharmacists in paediatric patients. Sixteen of these studies 
(64%) identified an error rate. The first step in measuring the effects of clinical 
pharmacists on reducing error rates would logically be to identify the rate of errors 
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using a specific denominator. The second step is to identify the rate of errors before 
and after starting clinical pharmacy services or a specific intervention from them. 
However, only six studies (24%) identified the error rate before and after the 
LPSOHPHQWDWLRQRIFOLQLFDOSKDUPDFLVWV¶VHUYLFHVThis ranged from 6.2-78.1% of all 
orders before to 1.1-35.2% of all orders after intervention. All of these studies showed 
that clinical pharmacists were able to reduce error rates.  
The most common contributions identified in this review were related to interactions 
of the clinical pharmacist with other healthcare professionals, i.e., educating them and 
answering their queries. A previous systematic review of the different types of 
contributions by clinical pharmacists was conducted in general emergency 
departments by Cohen et al. (2009) (214). Similar to my research, 17 studies were 
included and the most common types of contributions were related to educating, 
FRQVXOWLQJ DQG DQVZHULQJ KHDOWKFDUH SURIHVVLRQDOV¶ TXHVWLRQV 7KLV VXSSRUWV WKH
information provided by the American College of Clinical Pharmacy (199), which 
states that clinical pharmacists are considered important sources of knowledge by 
healthcare professionals. 
Another systematic review by Kaboli et al. (2006) (218), of all peer-reviewed 
English-language articles published January 1985 to April 2005, identified different 
activities by clinical pharmacists in relation to adult patients only. They found 36 
relevant articles and identified three types of activities: medication reconciliation, 
SDUWLFLSDWLQJ LQ GRFWRUV¶ URXQGV DQG GUXJ-class-specific pharmacist services, e.g., 
providing inpatLHQW DQWLFRDJXODWLRQ VHUYLFHV7KH ODVW W\SHRISKDUPDFLVWV¶ DFWLYLWLHV
was not identified in my review in children. Similar to my review, medication 
UHFRQFLOLDWLRQDQGSDUWLFLSDWLQJLQGRFWRUV¶URXQGVZHUHLGHQWLILHGE\.DEROLHWDO The 
current thesis also LGHQWLILHG D IXUWKHU  W\SHV RI DFWLYLWLHV 7KHVH SKDUPDFLVWV¶
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contributions such as education of healthcare professionals and patients, are not 
specific for children, but were not considered by Kaboli et al.   
Even though two thirds (64%) of all studies only identified the rate of medication 
errors after starting clinical pharmacy services, they all stated that clinical pharmacists 
were effective either in reducing the rate of errors or in detecting errors. However, 
some studies also included the effects of clinical pharmacists on other important 
measures. For example, Chan et al. (1990) (226) found that the rate of waste of 
medications was decreased after implementing clinical pharmacist services, as they 
stopped supplying medications for discharged patients who already had enough of the 
medicine from their admission. Moreover, for doctors and nurses, a saving of time 
was seen, as they were less frequently consulted regarding medications at discharge, 
since the pharmacists DOUHDG\ NQHZ SDWLHQWV¶ GLDJQRVHV DQG PHGLFDWLRQV IURP WKHLU
visits to the paediatric ward.   
Some studies identified the causes of errors. For example, Koren et al. (1991) (230) 
found that most dosage errors occurred as a result of miscalculation when a decimal 
point was misplaced. This might lead to interventions to improve the performance of 
healthcare professionals through discussing and providing feedback about errors to 
them. Providing feedback is an effective method of reducing the rate of errors, as 
demonstrated by Angalakuditi et al. (2003) (232) who found that prescribing the 
correct dose by doctors increased from 38.2% to 98.7% after feedback by pharmacists. 
The types of errors needing intervention by pharmacists were identified in 21 out of 
25 studies. The most common type was wrong dose. This was followed respectively 
by wrong drug, wrong route of administration, incomplete prescriptions, and omission 
of medications. Similar to this review, a previous systematic review found that wrong 
dose was the most common type of error in children (17).  
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7KH UDWH RI DFFHSWDQFH RI SKDUPDFLVWV¶ UHFRPPHQGDWLRQV E\ GRFWRUV ZDV RQO\
measured in a third of studies (nine studies) and the acceptance rate varied from 24 to 
98%. It is important to measure the rate of acceptance by all healthcare professionals 
who are involved in medication errors and monitor why feedback is not accepted.   
Similarly to my systematic review of all studies of errors in paediatric patients 
(Chapter 2), the majority of clinical SKDUPDFLVWV¶VWXGLHVZHUHFRQGXFWHGLQWKH86
followed by the UK, and in specialised paediatric hospitals. This illustrates the 
interest of these two countries in identifying and preventing medication errors and 
their implementation of clinical pharmacy sHUYLFHVHVSHFLDOO\LQFKLOGUHQ¶VKRVSLWDOV
Most studies (nine) were conducted in the US where the medicines management 
system is completely different from the UK. Three studies were conducted in the UK 
but in three different settings (neurosurgical ward, haematology/oncology ward and 
VSHFLDOLVW FKLOGUHQ¶VKRVSLWDO7KHVH WKUHH VWXGLHVGRQRWSURYLGHPXFK LQIRUPDWLRQ
DERXW SKDUPDFLVWV¶ FRQWULEXWLRQV DQG PHQWLRQHG only medication reconciliation and 
reviewing of prescriptions. Clinical pharmacy is an expensive resource in the UK and 
only three studies were identified which assessed their efficacy on reducing errors in 
paediatric patients but no other measures, such as cost saving. 
Only two studies were conducted in Asia (8%) and one study was conducted in Africa 
(4%). The North American and European studies were conducted in high-income 
countries whereas the Asian and Africa countries were middle-income countries. This 
shows the high interest of high-LQFRPH FRXQWULHV LQ LGHQWLI\LQJ WKH SKDUPDFLVWV¶
efficacy on reducing the error rate in paediatric patients unlike other countries which 
may have no clinical pharmacy services. This also shows the narrow spread of 
countries. Only one Middle East country (Egypt) was identified with no studies 
identified from my country (Saudi Arabia) to show the effect of pharmacists on 
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reducing paediatric medication errors, even though there are clinical pharmacy 
services in some hospitals there. Therefore more work is needed to assess the effect of 
clinical pharmacy services on reducing error rates particularly in paediatric settings in 
Saudi Arabia.   
This review provided the rate/number of errors prevented or decreased after the 
implementation of paediatric clinical pharmacy services in the literature. It also 
provided me with knowledge RI SKDUPDFLVWV¶ DFWLYLWLHV DQG WKH GLIIHUHQW W\SHV RI
errors in which they intervene. This information was used in the methodology for my 
own study (Chapter 5) to create GDWD FROOHFWLRQ OLVWV RI SKDUPDFLVWV¶ FRQWULEXWLRQV
and interventions, adapted from this systematic review and other important sources.  
Three different methods of data collection were identified in this review. Chart review 
and review of incident reports were mainly used by pharmacists to identify 
prescribing errors and medication errors in general. Direct observation of nurses 
and/or parents was the primary method used to identify administration errors. 
However, none of the included studies were found to have used direct observation of 
paediatric pharmacists. Pharmacists make many interventions on a regular basis, but 
these are often not documented or reported due to time and workload constraints 
(241). The method of direct observation of clinical pharmacists allows the 
pharmacists to focus on their daily jobs while the researcher records their activities. 
With direct observation many problems related to self-reporting or incident reporting, 
such as, under reporting can be avoided (242, 243).  
This review has a number of limitations. Few studies were identified. Moreover, 
many included studies do not contain enough information, especially regarding the 
types of contributions. Different methodologies and denominators make comparison 
between studies difficult. Even though some studies used the same methods of data 
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collection to identify the same type of error rate, they used different denominators 
which makes comparison impossible. Fifteen out of 40 studies (37.5%) were excluded 
as they had a quality rating of less than 6. This indicates that many studies that 
LGHQWLILHG WKH HIIHFW RI SKDUPDFLVWV¶ DFWLYLWLHV RQ UHGXFLQJ HUURUV KDG ORZ
methodological quality or they did not report all the information required for the 
assessment of quality. Twenty studies were available as full papers and 20 others were 
only available as conference abstracts. Unsurprisingly less full articles, compared to 
abstracts, were excluded because of low quality rating (2 vs. 13) as the chance to 
identify the 10 criteria used for quality assessment was more likely. It is a shame that 
the conference abstracts were not written up as full papers, to fully demonstrate their 
methods and results. 
 
4.6. &RQFOXVLRQ 
Only 25 studies were identified describing the ability of clinical pharmacists to reduce 
medication errors in paediatric patients. It is important to have more literature on this 
topic to compare the percentages of different types of medication errors prevented by 
clinical SKDUPDFLVWV ,W LV DOVR LPSRUWDQW WR OLQN WKH GLIIHUHQW FOLQLFDO SKDUPDFLVWV¶
contributions with different types of medication errors prevented by each type of 
contribution.     
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&KDSWHU$QREVHUYDWLRQDOVWXG\RIWKHUROHRIWKH
SDHGLDWULFFOLQLFDOSKDUPDFLVW 
5.1. ,QWURGXFWLRQ 
My systematic literature review to identify what is known already about the effect of 
paediatric clinical pharmacy services on reducing the rate of medication errors 
(Chapter 4) showed that there had been no study that used direct observation of 
paediatric pharmacists to assess their contributions and interventions in the healthcare 
services provided to patients. Twenty-five relevant studies were identified of which 
19 used chart review, four review of error incident reports, one used direct 
observation of nurses and parents and the last one used both chart review and direct 
observation of parents.    
Direct observation allows the pharmacists to focus on their job while the researcher 
records their contributions and interventions. It also allows the researcher to be 
involved in the event in its natural setting e.g. conversations between the pharmacist 
and other healthcare professionals and patients/families. This allows them to have a 
better understanding of the situation and to collect and document more accurate data 
e.g. document potential as well as actual medication errors. With direct observation 
many problems related to self-reporting or incident reporting (such as under reporting) 
can be avoided. It also helps the observer to document the outcome and the response 
of healthcare professionals, i.e. either to accept proposed interventions or not  (242, 
243).   
Pharmacists are known to make many interventions on a regular basis, but these are 
often not documented due to time and workload constraints (241). Direct observation 
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was therefore hypothesised to be the most robust method of data collection in order to 
get a more accurate picture of the role of the paediatric clinical pharmacist.  
5.2. $LP 
The aim was to observe paediatric pharmacists doing their day to day work in order to 
describe their role, to document their contributions to patient care and safety and to 
identify errors that are being prevented by their presence. I was not able to do a before 
and after study as clinical pharmacy services are already established.   
5.3. 0HWKRGV 
5.3.1. Setting   
Because contributions and interventions made by pharmacists can vary in different 
circumstances; I decided to collect data from several paediatric specialties in three 
different hospitals to gain a broad overview. 
5.3.1.1. 'HUE\VKLUH&KLOGUHQ¶V+RVSLWDO'&+DWWKH5R\DO'HUE\+RVSLWDO 
7KH'HUE\VKLUH&KLOGUHQ¶V+RVSLWDO'&+DWWKH5R\DO'HUE\+RVSLWDOLQFOXGHVILYH
paediatric wards classified according to patient ages and conditions (244, 245): 
1. Neonatal Intensive Care Unit (NICU): babies born with any health condition 
(or prematurity) admitted directly from the labour wards.  
2. Dolphin ward (Paediatric High Dependency Unit (PHDU)): children with a 
critical illness or requiring one to one care. 
3. Ladybird ward (LBW): children under 2 years of age with acute medical or 
surgical conditions. 
4. Puffin ward (PW): children older than 2 years with acute medical or surgical 
conditions. 
5. Sunflower ward (SFW): children undergoing elective surgery. 
     
Four specialist clinical pharmacists and one shift working pharmacist were shadowed. 
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The aim was to shadow pharmacists to document interventions and contributions 
made for at least 1000 patients in DCH. This number of patients was chosen because 
during a pilot study it was anticipated that around 25 patients would be a realistic 
number to be seen per visit. Therefore I decided to aim for at least 40 visits which was 
possible in the time available.  
5.3.1.2. 1RWWLQJKDP &KLOGUHQ¶V +RVSLWDO 1&+ DW 4XHHQ¶V 0HGLFDO &HQWUH LQ
Nottingham 
7KLV KRVSLWDO LV D WHUWLDU\ UHIHUUDO FKLOGUHQ¶V KRVSLWDO ZLWK  EHGV ZKLFK DGPLWV
40,000 patients each year. Data was collected from ten wards with different 
specialities (246): 
1. NICU (Neonatal Intensive Care Unit (medical and surgical))  
2. PICU (Paediatric Intensive Care Unit) 
3. Paediatric High Dependency Unit (PHDU) 
4. Ward D33 (cystic fibrosis and gastroenterology related diseases)  
5. Ward D34 (surgical unit including: orthopaedics; spinal; ear, nose and throat; 
cleft lip and plate; ophthalmic and maxillofacial).   
6. Ward D35 (general surgery)  
7. Ward E17 (renal and urological conditions)  
8. Ward E39 (oncology ward) 
9. Ward E40 (neuroscience including neurosurgery, neuro-oncology and 
neurology)   
10. Ward E37 (medical short stay unit) 
Eight pharmacists were shadowed: (five specialist pharmacists (in PICU, nephrology, 
neonatology, oncology, parenteral nutrition and cystic fibrosis), two senior clinical 
pharmacists and one junior clinical pharmacist).  
5.3.1.3. NICU at Nottingham City Hospital  
Visits to a neonatal unit at the City Hospital on five consecutive days were arranged 
with one specialist clinical pharmacist. Data collected from this unit were combined 
with the data collected from NCH because they are part of the same NHS Trust.  
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The aim was to shadow clinical pharmacists during a 6-week period in Nottingham. 
This was the time the Chief Pharmacist at NCH agreed and would give the 
opportunity to accompany pharmacists to wards with different specialities.   
5.3.2. Ethics 
According to the UK National Research Ethics Service the project was classified as 
service evaluation and therefore it was not necessary to obtain formal ethical or 
Research and Development department approval (247). I was required to follow the 
clinical governance procedures of the NHS trusts where the study took place. This 
included Criminal Records Bureau clearance, obtaining honorary contracts and 
undergoing induction procedures. Permission was obtained from the Chief 
Pharmacists, Chief Nurses and clinical governance leads in each hospital.  
In accordance with the requirements of the UK National Information Governance 
Board for Health and Social Care (248)FRQVHQWZDVUHTXLUHGWR ORRNDWDQ\FKLOG¶V
prescriptions and/or medical notes from his/her carer. Consent was taken from 
patients themselves only if they were 16 years old or more and understood an 
explanation of the project. A consent form was designed in accordance with those 
used by the National Research Ethics Service (Figure 1 in Appendix 3). I was 
supervised taking consent on the wards of the DCH during a pilot study with my 
supervisor until I was judged competent.  
Reasons for not obtaining permission from patients/carers included their refusing for 
any reason, carers not being available or special precautions being in place (such as 
QRWEHLQJDEOHWRHQWHUWKHSDWLHQW¶VURRPGXHWRLQIHFWLRQFRQWUROPHDVXUHV,I,FRXOG
not obtain consent, data was not seen or recorded.  
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5.3.3. Data collection form 
 After reviewing each relevant study from the clinical pharmacists systematic 
literature review (Chapter 4) in detail, and discussion with my two supervisors (a 
paediatric clinical pharmacist and a consultant paediatrician), none of the studies were 
felt to provide a comprehensive list of contributions and interventions. A preliminary 
data collection list was therefore written as described below. It was spilt into two 
sections: 
1. Interventions: where a medication error was identified by the pharmacist who 
intervened to prevent further doses of the medication reaching the patient. These 
interventions (Table 5.1) were adapted from the American Society of Hospital 
Pharmacists (82), the Pharmaceutical Care Network Europe Foundation (249) and a 
list of interventions adapted from 21 studies in Chapter 4 (117, 191, 219-230, 232, 
234, 236-240).  
Table 5.1: Medication errors identified and addressed by pharmacists.  
I Type of medication error  
1 Omission error 
2 Wrong dose (including dose amendment for accuracy of administration) 
3 Illegible prescribing 
4 Wrong frequency/duration/interval 
5 Wrong ward documented on drug chart 
6 Monitoring errors (including drug level not monitored appropriately & 
providing recommendations to adjust dose or interval) 
7 Wrong medication prescribed 
8 Wrong route of administration prescribed 
9 Unnecessary medication prescribed 
10 Duplication of medication 
11 Wrong formulation prescribed 
12 Wrong time of administration selected/ written on drug chart 
13 Wrong concentration/strength prescribed 
14 Wrong weight documented on drug chart  
15 Wrong rate of administration prescribed 
16 Drug interaction 
17 Contraindication 
18 Allergy error (prescribing to a patient allergic to that medication) 
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19 Adherence error by patient or carer 
20 Wrong date on drug chart 
2. Contributions to care: made by the pharmacist to enhance the care provided to 
patients (Table 5.2). These were adapted from the Royal Derby Hospital medicines 
code (250), the NHS careers website (working as a hospital pharmacist) (251) and 
from a list of contributions from 17 studies in Chapter 4 (117, 191, 221, 223-225, 
228-235, 237, 238, 240).  
Table 5.2: Different types of contributions made by pharmacists.  
Code Type of contribution   
A Drug history checked   
B Allergy status checked   
C Answering queries/educating nurses and doctors 
D Supplying medications  
E Annotating prescriptions with information e.g. administration instructions 
F Education and providing of information to patient/carer 
G Therapeutic drug monitoring (record blood level/ document on prescription 
when levels are due to be taken/ advice to doctors or nurses)   
H Miscellaneous  
 
Using this preliminary data collection list I conducted a pilot study for five days (one 
day every week for five consecutive weeks) with my supervisor (Dr Conroy) in the 
paediatric wards in DCH. The aim of this pilot study was to assess the preliminary list 
and to create a comprehensive list and data collection system before starting my study. 
Another aim was to practice taking consent from parents or children aged 16 years or 
older under supervision. Three interventions were added to the list (wrong ward, date 
and weight documented on drug chart) after the pilot study.  
5.3.4. Data entry 
All data was entered into a password protected Excel spread sheet according to the 
IROORZLQJ SKDUPDFLVWV¶ FRGH GDWH ZDUG SDWLHQW QXPEHU DJH VH[ QXPEHU RI
prescriptions, type of contributions, type of intervention, explanation and response of 
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healthcare professionals to identified medication errors (accepted and corrected, not 
measured or not accepted). Each prescribed drug was considered to be one 
prescription. All data from Derby and Nottingham hospitals were separately analysed. 
Data entries from 10-day visits (220 patients (16%)) were reviewed by an independent 
person to ensure that the data was entered and categorised correctly.   
5.4. 5HVXOWV 
Only one mistake out of 671 data entries (0.15%) was identified independently by my 
colleague. This mistake was duplication of an entry.       
5.4.1. Results from DCH 
Five pharmacists were shadowed on 61 separate days (total 150 ward visits) on the 
five paediatric wards for the period between the 7-6-2012 and 18-4-2013. During 
these visits 4,204 prescriptions for 1,039 patients were checked by pharmacists (472 
patients (45%) were new admissions). There was at least one intervention or 
contribution for 785 patients (75.6%). In total 2,637 contributions (62.7% of all 
prescriptions) and 366 interventions on medication errors (8.7% of all prescriptions) 
were observed.  
5.4.2. Results from NCH 
Nine pharmacists were shadowed on 30 separate days (total 47 ward visits) over the 
period between the 8-5-2013 to 4-7-2013 on ten paediatric wards. During these visits 
1,830 prescriptions for 332 patients were checked by pharmacists (86 patients (26%) 
were new admissions). There was at least one intervention or contribution for 210 
patients (63.3%). In total 674 contributions (36.8% of all prescriptions) and 139 
interventions on medication errors (7.6% of all prescriptions) were observed.  
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5.4.3. 6XPPDU\RIDOOSKDUPDFLVWV¶YLVLWV 
All patients were aged 17 years or less. More new patients were identified in DCH 
compared with NCH (45% vs. 26% of all patients). Similar range of prescriptions per 
patient was identified in both hospitals (range: 0-18 vs. 0-17; median: 5 vs. 3). Similar 
rates of interventions were identified in DCH and NCH (8.7% vs. 7.6% of all 
SUHVFULSWLRQV ZKLOH PRUH SKDUPDFLVWV¶ FRQWULEXWLRQV ZHUH LGHQWLILHG LQ '&+
compared with NCH (62.7% vs. 36.8% of all prescriptions).  
Table 5.3: Summary of visits to paediatric and neonatal wards  
 DCH NCH Total 
Age range 1 day- 17 years 
Number of patients 
(boys vs. girls) 
1,039 patients 
(561 boys & 478 girls) 
332 patients 
(191 boys & 141 girls) 
1,371 
Number of new admissions              
      (% of all patients) 
472                      
(45%) 
86                      
(26%) 
558          
(40.7%) 
Number of prescriptions 
(Range/Mean/Median) per patient 
4,204 prescriptions 
(0-18/5.5/5) 
1,830 prescriptions 
(0-17/4/3) 
6,034 
1XPEHURISKDUPDFLVWV¶VKDGRZHG 5 9 14 
Number of paediatric wards 5 10 15 
Number of separate day visits  61 30 91 
Number of ward visits 150 47 197 
Number of patients with intervention   
or contribution (% of all patients) 
785                      
(75.6%) 
210                     
(63.3%) 
995          
(72.6%) 
Number of contributions                
   (% of all prescriptions) 
2,637                     
(62.7%)                   
674                     
(36.8%)                 
3,311        
(54.8%)      
Number of interventions                   
 (% of all prescriptions) 
366                      
(8.7%)      
139                     
(7.6%) 
505          
(8.4%)       
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5.4.4. Interventions  
During the study period; 505 medication errors were identified and interventions 
made (366 interventions in DCH and 139 interventions in NCH). These errors were 
grouped into 20 different categories (I1-20) (Table 5.4).  
Table 5.4: Interventions made in DCH and NCH 
Code Type of medication errors  DCH 
4,204 
prescriptions for 
1,039 patients 
NCH 
1,830 
prescriptions for 
332 patients 
All (% of all 
errors) 
I Number of interventions (% of all 
prescriptions) 
1 Omission error 96 (2.3%) 45 (2.5%) 141 (27.9%) 
2 Wrong dose 94 (2.2%) 27 (1.5%) 121 (24%) 
3 Illegible prescribing 85 (2%) 12 (0.7%) 97 (19.2%) 
4 Wrong frequency 23 (0.5%) 6 (0.3%) 29 (5.7%) 
5 Wrong ward 19 (0.4%) 7 (0.4%) 26 (5%) 
6 Monitoring error 9 (0.2%) 9 (0.5%) 18 (3.6%) 
7 Wrong medication prescribed 10 (0.2%) 3 (0.2%) 13 (2.6%) 
8 Wrong route of administration 7 (0.2%) 6 (0.3%) 13 (2.6%) 
9 Unnecessary medication 2 (0.04%) 10 (0.5%) 12 (2.4%) 
10 Duplication 6 (0.1%) 3 (0.2%) 9 (1.8%) 
11 Wrong formulation 1 (0.02%) 6 (0.3%) 7 (1.4%) 
12 Wrong time of administration 6 (0.1%) 0 6 (1.2%) 
13 Wrong concentration/strength 1 (0.02%) 3 (0.2%) 4 (0.8%) 
14 Wrong weight documented on drug chart  1 (0.02%) 1 (0.1%) 2 (0.4%) 
15 Wrong rate of administration 1 (0.02%) 1 (0.1%) 2 (0.4%) 
16 Drug interaction 1 (0.02%) 0 1 (0.2%) 
17 Contraindication 1 (0.02%) 0 1 (0.2%) 
18 Allergy error (prescribing a medication to a 
patient who is allergic to that medication) 
1 (0.02%) 0 1 (0.2%) 
19 Compliance error by patient/carer 1 (0.02%) 0 1 (0.2%) 
20 Wrong date documented on drug chart 1 (0.02%) 0 1 (0.2%) 
Total (% of all prescriptions) 366 (8.7%) 139 (7.6%) 505 (8.4%) 
 
7KH PRVW FRPPRQ W\SH RI SKDUPDFLVWV¶ LQWHUYHQWLRQ ZDV for an omission error 
followed by wrong dose, illegible prescribing and wrong frequency. These are 
discussed in more detail in the following sections.   
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5.4.4.1. Omission error (2.3% of all prescriptions)  
This was the most common type of error (involving 15 different sub-categories) 
identified in 141 cases (27.9% of all errors). Similar error rates were identified in 
DCH and NCH (2.3 vs. 2.5% of all prescriptions). The most common sub-types of 
omission error were omission of medications on admission (60.3% of all omission 
errors or 15.2% of all new patients) followed by omission of dose (12.8% of all 
omission errors). No omission errors were considered serious. Figure 5.1 illustrates 
the top ten types of omission errors. 
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Figure 5.1: Top ten types of omission errors 
DCH NCH All
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5.4.4.2. Dosing error (2% of all prescriptions) 
The second most common errors were dosing errors identified in 121 cases (24% of 
all errors). Dosing errors included:  
1. Dose amended for accuracy of administration (63, 52%). Pharmacists changed the 
dose to be measurable by nurses. 
2. Overdose (28, 23.1%). These included: three double doses, two doses calculated 
according to actual weight for overweight patients, one tenfold dose error 
(diazepam), one misplacing of numbers (gentamicin 210 mg instead of 120 mg), 
one adding a zero (1400 mg cefuroxime instead of 140 mg) causing a tenfold error 
and one was wrong unit (co-amoxiclav 600g instead of 600mg).    
3. Under-dose (28, 23.1%). The cause for under-dose was identified in one case and 
was because the patient previously had impaired renal function which improved 
and therefore the dose of cotrimoxazole was required to be increased. In three 
cases doctors were asked to increase the dose because the patients had gained 
weight. In two cases pharmacists advised doctors to double the dose of antibiotics 
because of severe infection.  
4. Side effect of a medicine (1, 0.9%) (advised doctor to decrease the dose of 
Modigraf® because of side effect (diarrhoea)). 
5. Dose of morphine was written for heparin and vice versa (1, 0.9%) for a one day 
old boy in the intensive care unit. 
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5.4.4.3. Illegible prescribing (1.6% of all prescriptions) 
Illegible prescribing was the third most common type of error identified in 97 cases 
(19.2% of all errors). The illegible prescribing rate was higher in DCH compared to 
NCH (2% vs. 0.7% of all prescriptions). The most common examples of illegible 
prescribing were unclear drug name (43.3%) followed by unclear dose (29.9%) and 
unclear time of administration (12.4%). Figure 5.2 illustrates all types of illegible 
prescribing.   
 
5.4.4.4. Wrong frequency, duration or interval (0.5% of all prescriptions) 
This type of error was identified in 29 cases (5.7% of all errors). An example was 
prescribing paracetamol five times a day instead of four times a day.   
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Figure 5.2: Types of illegible prescribing 
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5.4.4.5. Wrong ward documented on drug chart (0.4% of all prescriptions) 
Twenty-six charts were identified with the wrong ward documented on the drug chart 
(5% of all errors). All of these cases were because of patients transferring from one 
ward (mostly from ICU or PHDU) to other units without changing the ward name.  
5.4.4.6. Monitoring error (0.3% of all prescriptions) 
Monitoring errors were identified in 18 cases (3.6% of all errors) and included: 
1. Pharmacist documenting blood level if it was not recorded by other healthcare 
professionals (nine cases). 
2.  Pharmacists advising dose or interval adjustment to doctors when blood levels 
were outside the therapeutic range (nine cases).  
5.4.4.7. Wrong medication prescribed (0.2% of all prescriptions) 
Thirteen medications (2.6% of all errors) were found inappropriate by pharmacists 
because: 
1. Not according to hospital guideline (six cases) mostly when treating babies 
with sepsis using combination of antibiotics which changes after the age of 
three months. 
2. More potent drug/strength needed (two cases): nicotine patch and diuretic 
(furosemide)  
3. Similarity in concentration in one case (0.45% dextrose was prescribed instead 
of 0.45% sodium chloride) 
4. Not suitable for indication in one case: cefotaxime was recommended to be 
used instead of cefuroxime for management of meningitis 
5. Not recommended in children in one case: prochlorperazine 
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6. Not recommended for children less than 12 months old in one case: 
chlorphenamine 
7. Not recommended for children less than 12 years old in one case: codeine  
5.4.4.8. Wrong route of administration (0.2% of all prescriptions) 
Thirteen medications were prescribed with wrong route of administration (2.6% of all 
errors): 
1. Nine medications were prescribed IV or IM even though patients could take 
orally   
2. One medicine was prescribed orally for a patient who was not able to eat or 
drink.  
3. Salbutamol was prescribed IV/Nebuliser for a patient and changed to nebuliser. 
4.  Buccastem was prescribed sublingually (should be buccal). 
5. IV/oral to NG (one case) 
5.4.4.9. Unnecessary medication (0.2% of all prescriptions) 
Twelve cases (2.4% of all errors) involved prescribing unnecessary medications: 
x Ten because courses of antibiotics were complete and should be discontinued 
x One to stop prophylaxis (IV ceftriaxone and IV aciclovir) for a 14 year old 
child with stroke  
x To stop domperidone because the patient started to eat and drink  
5.4.4.10. Duplication (0.1% of all prescriptions) 
Medications (e.g. ondansetron, paracetamol and ibuprofen) were written both as 
required and regularly in nine cases (1.8% of all errors). 
5.4.4.11. Wrong formulation (0.1% of all prescriptions) 
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Seven cases (1.4% of all errors) were associated with prescribing the wrong 
formulation e.g. capsule instead of liquid.  
5.4.4.12. Wrong time of administration (0.1% of all prescriptions) 
Six cases (1.2% of all errors) of medications in DCH were prescribed at the wrong 
time, e.g. 16.00 instead of 18.00.  
5.4.4.13. Wrong concentration/ strength (0.07% of all prescriptions) 
Four cases (0.8% of all errors) of wrong concentration/ strength, e.g. 0.45% sodium 
chloride to 0.9%, were identified.  
5.4.4.14. Wrong patient weight documented (0.03% of all prescriptions) 
Two cases (0.4% of all errors) ZHUH LGHQWLILHG LQZKLFK WKHSDWLHQWV¶ZHLJKWRQ WKH
drug chart was not the same as in the medical notes. This also required doctors to 
change all doses calculated according to the wrong weight. 
5.4.4.15. Wrong rate of administration (0.03% of all prescriptions) 
Two cases (0.4% of all errors) were identified in which wrong rate of IV fluid was 
identified in one case and of morphine IV in another case.  
5.4.4.16. Drug interaction (0.02% of all prescriptions) 
One case (0.2% of all errors) was identified in DCH. Both codeine and morphine were 
prescribed regularly for a patient.  
5.4.4.17. Contraindication (0.02% of all prescriptions) 
One case (0.2% of all errors) was identified in DCH. Non-recommended medication 
in children (sodium chloride 0.18% and glucose 4% solution) was prescribed. 
5.4.4.18. Allergy error (0.02% of all prescriptions) 
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One case (0.2% of all errors) was identified in DCH. Patient with penicillin allergy 
was prescribed amoxicillin.  
5.4.4.19. Compliance error by patient/carer (0.02% of all prescriptions) 
One case (0.2% of all errors) was identified in DCH. The mum was applying Fucidin® 
cream on the chiOG¶VVNLQRQO\RQFHGDLO\EXW WKH ODEHODQG WKH%1)ERWKVD\ WZLFH
daily therefore advice given to mum. 
5.4.4.20. Wrong date documented on drug chart (0.02% of all prescriptions) 
One case (0.2% of all errors) was identified in DCH of which the date on the drug 
chart was not correct.  
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5.4.5. Contributions  
SKDUPDFLVWV¶FRQWULEXWLRQVWRKHDOWKFDUHZHUHUHFRUGHGFRQWULEXWLRQVLQ
DCH and 674 contributions in NCH). These contributions were grouped into eight 
categories (A-H) (Table 5.5).  
Table 5.5: Contributions made in DCH and in NCH  
Co
de
 Type of contribution  DCH 
(4,204 prescriptions     
for 1,039 patients for 
150 ward visits) 
NCH 
(1,830 prescriptions     
for 332 patients    for 
47 ward visits) 
Total                  
(6,034 prescriptions      
for 1,371 patients    for 
197 ward visits)  
Number of contributions  
A Drug history checked (% of all new patients)    620 (97.7%) 80 (93%) 700 (97%) 
B Allergy status checked (of all new patients)     550 (100%)  86 (100%)  636 (100%) 
C Answering queries/educating nurses and 
doctors (of all ward visits)  
91 (60.7%)  19 (40.4%)  110 (55.8%) 
D Supplying medications (of all prescriptions)  435 (10.3%)  177 (9.7%)  612 (10.1%) 
E Annotating prescriptions with information e.g. 
administration instructions (of all prescriptions) 
907 (21.6%)  253 (13.8%)  1160 (19.2%) 
F Education and providing of information to 
patient/carer (of all patients)     
20 (1.9%)  6 (1.8%)  26 (1.9%) 
G Therapeutic drug monitoring (record blood 
level + document on prescription when levels 
are due to be taken) (of all ward visits) 
8 (5.3%)  47 (100%)  55 (27.9%) 
H Miscellaneous (of all ward visits) 6 (4%) 6 (12.8%) 12 (6%) 
Total number of contributions (of all prescriptions)  2,637 (62.7%)        674 (36.8%)  3311 (54.8%)        
 
$V FDQ EH VHHQ WKH PRVW FRPPRQ SKDUPDFLVWV¶ FRQWULEXWLRQ ZDV DQQRWDWLQJ
prescriptions with information followed respectively by checking drug history, 
checking allergy status and supplying medications. The overall contribution rate was 
54.8% of all prescriptions. More contributions (mainly annotating prescriptions and 
answering queries) were identified in DCH compared to NCH (62.7 vs. 36.8% of all 
prescriptions). Unlike DCH, NCH provides bedside guidelines which doctors and 
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nurses can use to find out information required on some medications, which was 
thought to be the reason for the lower level seen.  
Contributions are explained in more detail in the following sections.  
5.4.5.1. Drug history  
Drug history (i.e. history of all medications used regularly prior to admission) was 
checked for 461 new patients (97.7% of all new patients) in DCH and for 80 new 
patients (93% of all new patients) in NCH. This was mostly checked from information 
from the medical notes and parents (Figure 5.3).  
 
5.4.5.2. Allergy checked  
Allergy status was checked for all new patients in DCH and in NCH. Again this was 
mostly obtained from medical notes and parents (Figure 5.4).  
46.3 
42.1 
7.4 
3.2 1 
51.3 
20 
28.7 
0 0 
0
10
20
30
40
50
60
Medical notes Parents Patient own
medications
Patients  GP letter/
telephone call
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5.4.5.3. Answering queries/educating nurses and doctors 
Pharmacists answered 21 types of queries from doctors and nurses (Figure 5.5). 
Ninety one queries were answered by pharmacists in DCH and 19 queries in NCH. 
The most common queries asked by doctors involved choice of doses and 
medications. The most common queries by nurses were regarding drug supply and 
administration instructions.   
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5.4.5.4. Supplying medications 
Pharmacists are required to supply medications prescribed to patients which are not 
available as ward stock. These come from pharmacy for inpatients and discharges or 
from the central intravenous additive service (CIVAS) for pre-prepared IV doses for 
inpatients where stability data allows.   
Pharmacists requested new labels for medications on six occasions (three in DCH and 
three in NCH) due to the lack of clarity of the ODEHORQDSDWLHQW¶VRZQPHGLFLQHD
change in dose or to add additional instructions. Pharmacists were also involved in 
disposing of expired or no longer needed medications. No medication was disposed of 
from DCH whereas seven medications were disposed of by pharmacists from NCH. 
Figure 5.6 illustrates the percentage of medications supplied from the aseptic units 
and from pharmacy (for either inpatient or discharge patient). Most medications 
requested by pharmacists in DCH were from the aseptic unit and in NCH were from 
the pharmacy. This is because DCH provide a comprehensive CIVAS services and 
NCH has a more limited service.   
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5.4.5.5. Annotating prescriptions  
Pharmacists annotate prescriptions when important information is missing or when 
clarification/completion of the prescription is required. Prescriptions were annotated 
with 15 types of different information. The most common five were:  
1. Rate of administration of IV medications e.g. vancomycin ³LQIXVHRYHU
PLQXWHV´ 
2. Administration information, e.g. Tacrolimus 2 hours after food or one hour 
before food 
3. Strength of formulations e.g. 2 puffs of ipratropium inhaler = 40mcg  
4. Generic name (or brand name for drugs where it is important that the same 
brand is always used) e.g. amoxicillin/clavulanate instead of augmentin®  
5. )UHTXHQF\RIPHGLFDWLRQDGPLQLVWUDWLRQRQ³DVUHTXLUHG´ e.g. paracetamol 
QID   
Pharmacists made 907 prescription annotations in DCH and 253 annotations in NCH 
(Figure 5.7).  
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MRUHSKDUPDFLVWV¶DQQRWDWLRQVZHUHPDGHLQ'&+ than NCH, particularly about the 
rate of administration (6.8% vs. 0.2% of all prescriptions) and drug administration 
information (4.4% vs. 0.9% of all prescriptions). This may be because bedside 
guidelines are available in NCH but not in DCH. However, there were more 
prescriptions annotations with strength in NCH compared to DCH (6.7% vs. 1% of all 
prescriptions). This might be because more unlicensed medications were used in NCH 
compared to DCH, due to the more specialist patients treated there. 
5.4.5.6. Education and provision of information to patient/carer 
Information and education was provided to patients and parents 20 times in DCH and 
six times in NCH. This aimed to increase SDWLHQWV¶DGKHUHQFHZKHQXVLQJinhalers and 
to provide instructions about using discharge medications. Other education by 
pharmacists was related to educating parents on how to reconstitute antibiotic 
powders after the first bottle has finished and about the clinical effect of medications.  
5.4.5.7. Therapeutic drug monitoring (TDM) 
TDM is usually done for medications with a low therapeutic index or for patients with 
VSHFLILF FLUFXPVWDQFHV HJ UHQDO LPSDLUPHQW 3KDUPDFLVWV¶ FRQWULEXWLRQV LQYROYHG
recording the blood level of drugs and advising when the next blood level monitoring 
VKRXOG EH GRQH 3KDUPDFLVWV¶ DFWLYLWLHV UHgarding TDM were identified in 55 cases 
(eight in DCH and 47 in NCH). They also provide advice on dose adjustment when 
levels are not in the therapeutic range (e.g. gentamicin blood level). Most cases where 
patients were on low therapeutic index medications occurred on intensive care units, 
high dependency unit and specialised units. As NCH has more such speciality units 
WKLVLVOLNHO\WREHWKHFDXVHIRUPRUHSKDUPDFLVWV¶ TDM activities in NCH compared 
to DCH.     
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5.4.5.8. Miscellaneous 
Pharmacists also made ten other types of contributions on six occasions in DCH and 
six occasions in NCH. Examples of these include advising doctors to prescribe 
medications regularly instead of when required, doing a second check for medication 
administration with a nurse and changing one drug to a cheaper one.    
5.4.6. Comparing the rate of contributions and interventions made by 
pharmacists in the same wards in different hospitals  
Fifteen different paediatric wards were visited in Derby and Nottingham. Because 
data was collected from three different hospitals; I wished to compare activities in the 
same type of ward. Two wards can be compared: the NICUs and PHDUs (Table 5.6).  
 
Table 5.6: Contributions and interventions identified in NICU and PHDU 
Hospital % of contributions 
(of all 
prescriptions) 
% of interventions 
(of all prescriptions) 
Number 
of visits 
Number of 
pharmacists 
NICU 
DCH 29.6 4.2 18 3 
NCH 20.6 9.1 10 5 
PHDU 
DCH 51.4 12.8 32 5 
NCH 47.5 6.3 3 1 
 
As can be seen; the highest rate of contributions in NICU and PHDU was identified in 
DCH. Higher interventions rates were identified in NICU at NCH compared with 
DCH. However, more interventions were identified in PHDU at DCH compared with 
NCH. The results cannot be generalised as only three visits by one pharmacist to 
PHDU were in NCH compared to 32 visits by five pharmacists in DCH.   
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5.4.7. Recommendations accepted by doctors 
Some errors were corrected by pharmacists without asking doctors. These were 
related to illegible prescribing (clarity issues), omissions (ward name, time of 
administration, weight, date, age and hospital number), wrong paediatric wards, 
adherence errors by patients/ parents and accuracy of measurement. In total 138 errors 
were corrected by pharmacists (27.3% of all errors). Of 367 errors highlighted to 
doctors 365 (99.5%) errors were acknowledged and corrected. One doctor refused to 
correct an error and therefore an incident report was written. This doctor increased the 
dose of vancomycin regardless of a high blood level measured after the last dose. The 
other error was a recommendation from the pharmacist to change one diuretic to a 
more potent one. However, the doctor did not change the medication and preferred to 
discuss other options with other doctors. Therefore the response could not be 
measured.  
5.4.8. Other activities 
Paediatric pharmacists are involved in many activities other than those on ward visits. 
These include writing and keeping drug monographs up to date, participating in the 
HosSLWDO¶V*XLGHOLQHV&RPPLWWHH WKH7UXVWMedicines Management Committee and 
the Paediatric, Obstetric and Neonatal Governance Groups. 
Paediatric pharmacists in Nottingham have a monthly meeting with doctors and 
nurses to discuss current issues and to answer their queries. In both cities they are 
involved in teaching pharmacy, nursing and medical staff and medical students and 
supervising pre-registration and junior pharmacists. They are also involved in the 
development of prescription charts, and in Derby the development of the electronic 
prescribing system which is to be introduced soon. 
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5.5. 'LVFXVVLRQ 
Medication errors occur on all paediatric wards (Chapter 2). Different interventions 
have been implemented in order to reduce the rate of errors (Chapter 3). One of the 
most effective interventions was a paediatric clinical pharmacist (Chapter 4). To our 
knowledge this study is the first to use direct observation of pharmacists on paediatric 
wards and suggests that pharmacists improve healthcare services provided to 
paediatric patients and are an effective tool in identifying and preventing medication 
errors. 
An Australian observational study by Stuchberg et al. 2007 (252) of six clinical 
pharmacists in adult medical and surgical wards (in two general hospitals) was carried 
out for six separate days during March and April 2004. They used a preliminary list of 
SKDUPDFLVWV¶ DFWLYLWLHV DGDSWHG IURP OLWHUDWXUH UHYLHZ DQG WKH H[SHULHQFH RI
UHVHDUFKHUV7KH\GLYLGHGWKHSKDUPDFLVWV¶DFWLYLWLHVinto four main groups involving 
28 sub-groups and did not separate contributions from interventions. They identified 
807 different activities for 195 patients. Most activities were related to review of 
medication charts, annotating prescriptions with information and checking drug 
history. In our study the pharmDFLVWV¶ activities were separately divided into 
contributions (eight types) and interventions (20 types) with a total of 3,816 different 
activities for 1,371 patients identified during 91 day visits. Similar to Stuchberg et al., 
annotating prescriptions with information was the most common contribution 
followed by drug history check. I did not define reviewing of medication charts as a 
contribution.  
%DVJHU HW DO¶V  V\VWHPDWLF OLWHUDWXUH UHYLHZ (253) identified English-language 
studies (in both adults and children) published from January 2000 to July 2013 that 
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used a classification system and identified drug-related problems, including 
medication errors. From the 268 studies reviewed, these authors identified 20 
classification systems; most studies modified existing systems or devised their own. 
They concluded that no ideal classification system exists. For my current study I 
adapted two lists, one for contributions, the other for interventions, from studies in the 
systematic review of paediatric clinical pharmacy (Chapter 4), as well as other 
sources. This aimed to provide a comprehensive list for paediatric pharmacists.   
5.5.1. Results from DCH and NCH 
DCH and NCH involve different specialities and therefore results identified from both 
hospitals cannot be directly compared. Similar overall intervention rates were 
identified in DCH and NCH (8.7 vs. 7.6% of all prescriptions). However, where there 
was a clear difference in the rate of contributions or interventions possible causes 
were explored.  
The contribution rate was higher in DCH compared to NCH (62.7% vs. 36.8% of all 
prescriptions). This is likely to be due to the higher percentage of new admissions at 
DCH compared to NCH (45% vs. 26% of all patients). Pharmacists made more 
contributions for newly admitted patients by taking drug and allergy status history. 
:KHQ WKH SKDUPDFLVWV¶ FRQWULEXWLRQV ZHUH UH-calculated without considering drug 
history and allergy status check for new patients; the contribution rate was found to be 
similar between DCH and NCH (34.9% vs. 27.8%). NCH also provides bedside 
guidelines which may be another explanation for the lower contribution rate 
(especially answering queries from healthcare professionals) compared with DCH. 
This suggests that even though the study was conducted in different settings; 
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SKDUPDFLVWV¶ DFWLYLWLHV Fontributions and interventions) are similar overall between 
the two sites.  
The higher new admission rate in DCH compared to NCH may be because of the time 
of the year. Many visits to DCH were in winter which is often associated with more 
admissions, especially for paediatric patients due to causes such as bronchiolitis. 
Reasons for the lower admission rate in NCH might be because DCH is a general 
medical hospital with only one PHDU and one NICU unlike NCH which involves two 
NICUs, one PICU, one PHDU and different specialist units. Patients usually have a 
longer stay in specialist wards and intensive care units compared to patients on the 
general wards.  
5.5.2. Medication reconciliation 
Pharmacists spend a great deal of time checking and recording the drug history and 
allergy status of newly admitted patients. Doing so is clearly important, since it can 
reduce the chance of anaphylaxis and improve the quality of care. The 1+6¶V
mandatory requirement for medication reconciliation concerns adults, but not 
paediatric patients (254). In our study, the most common error was omission error (2.3% 
of all prescriptions and 27.9% of all errors). The most common omission was missing 
medication upon admission (60.3% of all omission errors and 15.2% of all new 
patients). Previous studies have identified higher rates. Terry et al. 2010 (233) found 
that in 39% of paediatric patients receiving medication on a UK neurosurgical ward 
this differed from that prescribed prior to admission. This finding emphasises the 
importance of medication reconciliation for paediatric patients. 
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5.5.3. Methods of data collection  
Franklin et al. 2009 (255) identified prescription errors in adult surgical wards in the 
UK using four different methods of data collection: prospective collection by 
pharmacists, retrospective trigger tools, retrospective chart review, and spontaneous 
reporting. They found that prospective data collection by pharmacists was better in 
detecting prescribing errors than using retrospective trigger tools and spontaneous 
reporting but less effective than retrospective chart review. Using these four methods 
the error rate was 10.7% of all prescriptions before using CPOE and 7.9% after.   
Our study found in three UK hospitals from June 2006±July 2007, the rate of 
prescription errors was 8.4% of all prescriptions. The effect of directly observing 
paediatric pharmacists to investigate medication errors had not previously been 
assessed to the best of my knowledge. To compare the effectiveness of this method of 
data collection requires comparing our study with previous studies that identified 
SUHVFULSWLRQHUURUVE\SKDUPDFLVWVLQSDHGLDWULFSDWLHQWVXVLQJ³RIDOOSUHVFULSWLRQV´DV
a denominator. Of 25 identified studies in my systematic literature review (Chapter 
4), only ten (all using chart review) identified prescription errors using the 
GHQRPLQDWRU³RIDOOSUHVFULSWLRQV´ and therefore are comparable. 
Two studies identified similar rates of prescription errors associated with discharge 
prescriptions. Chan et al. 1990 (226) identified that 18% of all discharge prescriptions 
from a US paediatric unit were associated with errors. In a US emergency department, 
Cesarz et al. 2013 (227) identified that 23.6% of all orders involved prescription 
errors. By comparing prescribed medications with medications regularly taken before 
admission in a UK neurosurgical department, Terry et al. 2010 (233) identified that  
39% of all prescriptions were associated with errors. These three studies identified 
higher prescription error rates than found in my observational study, perhaps because 
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these studies focused only on medication reconciliation or occurred in different 
paediatric settings, not because of any difference in methods used for data collection. 
Kjeldby et al. 2009 (117) conducted a study in a Norwegian paediatric unit and 
identified that 26.8% of all prescriptions were associated with prescription errors. 
Zangwill et DO¶VVWXG\FRQGXFWHGin a similar setting in the US (231) identified a 
lower error rate of 6.2% of all prescriptions, while in an Egyptian paediatric ICU, 
Alagha et al. 2011 (223) identified a much higher error rate (35.2%). In a specialist 
FKLOGUHQ¶V KRVSLWDO H[FOXGLQJ WKH ,&8 LQ WKH 1HWKHUODQGV 0DDW HW DO  (222) 
identified that only 1.1% of all prescriptions were associated with prescription errors. 
The above four studies suggested that more errors may be identified in paediatric 
ICUs. In NICUs, as in Conway et al. 2012 (236), 9.1% of all prescriptions involved 
errors, which though lower than the error rate identified by studies conducted in 
paediatric ICUs, is nevertheless similar to the rate identified in my observational 
study of 9.1% of all prescriptions in NICU in NCH. 
Similar to my study, two studies have been done in paediatric wards only. In a 
Spanish ward, Fernández±Llamazares et al. 2012 (234) identified a prescription error 
rate of 2.4% of all prescriptions, while in India, Angalakuditi et al. 2003 (232) 
identified a prescription error of 61.8% of all prescriptions. The latter study identified 
only prescription dosage errors, which might have inflated the error rate beyond that 
found by Fernández±Llamazares et al.  
From all of the above studies, it is clear that different error rates were identified in 
different settings and therefore comparing the effect of direct observation of 
paediatric clinical pharmacists with other methods of data collection cannot be done. 
Only one study (Fernández±Llamazares et al. 2012 (234)) was identified to be 
comparable with my study as this study identified prescribing errors in general, 
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conducted in the same setting as in my study and used the same denominator. From 
this comparison it seems that using direct observation of paediatric clinical 
pharmacists may be more effective in detecting prescribing errors than using chart 
review as the error rate found was higher. However, due to the low number of 
comparable studies, this conclusion cannot be generalised.   
5.5.4. Significance of some of interventions 
In my observational study many potentially serious errors were identified. These 
included omission of medications, omission of doses, omission of the route of 
administration; wrong doses, illegible prescribing, wrong frequency, wrong 
medications, duplication of medications, wrong weight, wrong rate of administration, 
drug interaction, contraindication and prescribing medications to patients with allergy. 
I was unfortunately not able to identify the outcome of the medication errors 
identified however, this is an important area for future studies. 
Pharmacists are required to not only detect prescription errors, but also encourage 
doctors to adhere to national and hospital-specific guidelines. Doing both is crucial in 
treating paediatric patients, since the rate of potentially harmful medication errors 
may be three times higher in paediatric than adult patients (9). Among 20 types of 
errors, I identified wrong dosage as the second most common type of medication error. 
Similar to my findings, two systematic literature reviews by Ghaleb et al. 2006 (17) 
and Wong et al. 2004 (71) found dosage errors to be the most common type of 
medication error.  
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5.5.5. 'RFWRUV¶DFFHSWDQFHUDWHRIUHFRPPHQGDWLRQV 
My systematic review of studies addressing paediatric clinical pharmacists¶DFWLYLWLHV 
(Chapter 4) LGHQWLILHGQLQHVWXGLHVUHSRUWLQJGRFWRUV¶DFFHSWDQFHUDWHV(220, 222, 224, 
225, 227, 229, 236-238). Acceptance rates ranged from 24±98%. In my observational 
study, the acceptance rate of doctors was very high (99.5% of all recommendations), 
which indicates that paediatric pharmacists are trusted and respected members of the 
paediatric team in these hospitals. It also suggests WKDWWKHUHLVQREDUULHU WRGRFWRUV¶
DFFHSWDQFHRISKDUPDFLVWV¶UHFRPPHQGDWLRQV in these hospitals.     
 
5.5.6. Study implications 
This study identified the presence of clinical pharmacists as an effective method for 
averting prescription errors. Since clinical pharmacy services were not provided at 
night or weekends, these periods may face greater risks of medication errors. Future 
research is needed to investigate this. In addition most of the studies identified in this 
thesis were conducted in the US followed by the UK. The use of clinical pharmacists 
in other countries is therefore unclear. Their benefits may be being missed in many 
hospitals treating children across the world. A future study would be needed to clarify 
this and its effects. 
5.5.7. Limitations 
The severity and consequences of the errors identified and the medications associated 
with errors were not always recorded, due to time constraints, since I was required to 
shadow pharmacists to observe their activities at all times. As such, future studies 
could investigate this further.  
I visited DCH and NCH at different times of the year, which may have affected the 
number of pharmDFLVWV¶ FRQWULEXWLRQV VLQFH SKDUPDFLVWV SHUIRUP PRUH DFWLYLWLHV
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related to checking drug history and allergy status with influxes of new patients. It 
might have also affected admission rates, which might in turn have affected the total 
error rate (i.e., tKHFKDQFH WKDWSKDUPDFLVWV¶FRQWULEXWLRQVDQG LQWHUYHQWLRQV LQFUHDVH
when more new patients are admitted). Different paediatric ward specialties at DCH 
and NCH made comparing the two hospitals less reliable, apart from the two common 
wards (i.e., NICU and PHDU). 
Observing pharmacists doing their daily jobs may have been associated with the 
Hawthorne effect, i.e. the effect of being observed improving the shadowed paediatric 
pharmacists practice. It is very difficult to know how this may have affected the 
results.   
5.5.8. Strengths 
To the best of my knowledge, this study is the first to involve the direct observation of 
pKDUPDFLVWVLQFKLOGUHQ¶VZDUGV,W was multi-centred and involved various specialities. 
The data collection form used in my observational study was adapted from studies 
included in my previous systematic literature review (Chapter 4) and so was 
evidence-based. The study identified two types of information: contributions and 
interventions by pharmacists regarding improving paediatric healthcare and 
intercepting medication errors. It provided detailed subtypes of errors that had not 
previously been reported. 
5.6. &RQFOXVLRQ 
The key finding of this study is that clinical pharmacists play a very important role in 
preventing medication errors and contributing to the safe and effective use of drugs. 
Pharmacists intercepted medication errors in 8.4% of all prescriptions. The most 
FRPPRQ W\SH RI SKDUPDFLVWV¶ FRQWULEXWLRQ ZDV DQQRWDWLQJ SUHVFULSWLRQV ZLWK
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important information. At the same time, the most common type of medication error 
intercepted by pharmacists was omission errors, especially the omission of 
medications and doses at admission; the second most common was wrong dosage. 
'RFWRUV¶ DFFHSWDQFH UDWH RI SKDUPDFLVWV¶ UHFRPPHQGDWLRQV ZDV KLJK DQG WKRXJK
similar error and intervention rates occurred in DCH and NCH, DCH reported a 
higher contribution rate than NCH. 
 
 
&KDSWHU&RQFOXVLRQ 
6.1. ,QWURGXFWLRQ 
Literature on paediatric medication errors has increased dramatically in the last few 
years. Through detailed analysis of the current literature base it was hoped to learn 
some important lessons to inform and improve the use of medicines in children by 
identifying means of reducing errors. Some of these lessons were used to inform my 
own study of the role of the paediatric clinical pharmacist in their everyday practise.  
By directly observing pharmacists, I aimed to provide evidence regarding their ability 
to reduce or prevent medication errors and contributions to paediatric health care 
services.  
6.2. .H\ILQGLQJV 
The systematic review of literature (Chapter 2) from the 5-year period from April 
2006 to March 2011 identified 153 studies, mainly conducted in the US. Most studies 
used chart review, while the second greatest number reviewed incident reports. 
Studies identified prescription and administration errors as the first and second most 
common type of medication errors, respectively. Twenty-six different denominators 
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were used, the most common being ³RIDOOHUURUV´IROORZHGE\³RIDOORUGHUV´Error 
rates could not be compared for most studies and nine factors were identified which 
influenced the error rates. These factors are the use of 26 different denominators, 
study of six types of medication errors, use of five different methods of data 
collection, use of 236 definitions, inclusion of patients from five different age 
categories, inclusion of 30 different countries, investigation of 48 different groups of 
medications, in 22 different settings, and the use of 65 interventional tools. Of these, 
the most important factor was felt to be a difference in denominator, which generally 
precluded meaningful comparison of studies as their results were presented in such 
diverse ways. 
The wide ranges of error rates seen in these studies (Chapter 3) stemmed from 
studies using interventional tools and reporting pre and post intervention error rates, 
identifying subtypes of errors (e.g., prescription dosage errors), studying different 
specific or groups of medications, implementing different inclusion criteria, and using 
different study designs. Neonatal unit setting, work environment, and differences in 
SDUWLFLSDQWV¶ OHYHO RI HGXFDWLRQ WUDLQLQJ DQG H[SHULHQFH were associated with high 
error rates. 
I tried to study the relationship between methods of data collection and results 
(Chapter 3) in order to establish which methods are best used to study which types of 
error. Results suggest that prescription errors are best studied using chart review, 
administration errors by using direct observational techniques, and transcription and 
dispensing errors by reviewing incident reports. Monitoring and documentation errors 
are rarely studied and their importance should probably be better recognised.  
I also studied the relationship between clarity of definitions used in studies and results 
(Chapter 3). Many studies used definitions that were unlikely to adequately meet the 
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VWXG\¶VDLPV,WZDVunfortunately not possible to determine how clarity of definition 
influenced results of studies as few could be adequately compared. 
In all, 59 studies used interventional tools and assessed their benefits (Chapter 3). 
Forty-nine studies (83%) identified the error rate before and after the intervention. 
Forty-six of these concluded that their interventions were effective. The two most 
common types of intervention were dosing support tools, mostly used to reduce 
administration errors, and electronic prescription systems, mostly used to reduce 
prescription errors.  
 
Of the 16 UK studies, 13 used 11 different denominators, while the other three did not 
use any denominator but provided only numbers of errors (Chapter 3). Most studies 
identified prescription errors. The rates of errors cannot be generalised to characterise 
the rate of medication errors in children across the UK, because too few studies 
occurred in the same setting and used the same methodology and denominators to 
identify the rate of the same type of medication errors. The findings however suggest 
that prescribing and administration errors may be more prevalent in paediatric units in 
general hospitals than in speciaOLVWFKLOGUHQ¶VKRVSLWDOV 
Eight studies identified the time and/or day of errors (Chapter 3). Four studies 
identified the time most associated with errors, three the time of day and days of the 
week most associated with errors, and one the days of the week most associated with 
errors. However, these studies used various definitions of times of day, shifts, and 
weekdays. It was impossible to draw conclusions about the time or day of errors 
because of the low number of studies and because different studies used different 
definitions of times of day, shifts and weekdays.  
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The second systematic review (Chapter 4) examined the role of paediatric clinical 
pharmacists in reducing the rate of medication errors. The review included 25 studies, 
all of which reported that pharmacists were effective in either reducing or preventing 
medication errors and highlighted their many activities. From this I developed two 
lists, one of SKDUPDFLVWV¶LQWHUYHQWLRQVwhich involved 29 different subtypes of errors 
identified and addressed by pharmacists. The second list involved 15 different types 
of contributions where pharmacists made additional contributions to patient care. 
Though clinical pharmacy services in the UK began in the mid-1960s, only three UK 
studies were found which assessed the effectiveness of clinical pharmacy services in 
reducing the error rate of medication errors in paediatric patients. Of these, two used 
chart review, while another reviewed incident reports. 
I conducted an observational study of the role of paediatric clinical pharmacists in two 
NHS Trusts in the UK (Chapter 5). This study showed that paediatric clinical 
pharmacists identified medication errors in 8.4% of all prescriptions and made 
contributions to 54.8% of all prescriptions. Most types of medication errors identified 
by pharmacists were omission errors, followed by incorrect dosage and illegible 
prescriptions UHVSHFWLYHO\ 3KDUPDFLVWV¶ FRQWULEXWLRQV mainly included annotating 
prescriptions with administration advice, checking drug history and allergy status, 
UHVSHFWLYHO\ 'RFWRUV¶ DFFHSWDQFH UDWH RI SKDUPDFLVWV¶ UHFRPPHQGDWLRQV ZDV high 
(99.5%).   
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6.3. /LPLWDWLRQV 
The systematic review of paediatric medication error studies had some limitations: 
1. There is no standard definition IRU ³ZLGH YDULDWLRQ´ in terms of rates of errors 
reported. I therefore considered such variation to occur when the difference 
between the highest and lowest error rate exceeded 50%. This would be unlikely 
to occur as a result of chance or seasonal variation.  
2. No guidance on writing a good definition of an error exists therefore my 
supervisors and I agreed our own rating scale.  
The systematic review of the effect of clinical pharmacists on reducing medication 
errors in paediatric patients also had limitations. Few studies examined the effect of 
SDHGLDWULFFOLQLFDOSKDUPDFLVWV¶DFWLYLWLHVRQUHGXFLQJHUURUUDWHVZKLOHPDQ\VWXGLHV
lacked sufficient information regarding the types of contributions. I excluded studies 
WKDW LGHQWLILHG SKDUPDFLVWV¶ FRQWributions without providing a rate or number of 
medication errors. 
The observational study of paediatric clinical pharmacists had some limitations. I did 
not record the severity and consequences of medication errors identified by the 
pharmacists or which medications were associated with the errors. Being required to 
shadow pharmacists at all times in order to observe their activities; I was unable to 
leave their sides to search for other information in medical notes or medication charts. 
Also the studies at DCH and NCH were conducted at different times of the year, 
ZKLFKPLJKWKDYHDIIHFWHGWKHQXPEHURISKDUPDFLVWV¶FRQWULEXWLRQV and interventions, 
since pharmacists conduct more activities involved with checking drug history and 
allergy status when new patients are admitted.  
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6.4. &KDOOHQJHV 
A large number of relevant papers (153) was identified in the first systematic review 
and generated a large amount of data which I was required to manage and analyse. 
The aim of this review was not only to identify the error rate but to look in more depth 
at each of the 153 studies to find out similarities and differences between studies in 
order to draw conclusions about factors influencing the error rates.  
Firstly I identified studies that used each single denominator. Secondly I combined 
studies that used the same denominator to identify the same type of errors. Thirdly I 
separated these studies according to their methods of data collection. Doing this I was 
able to explore the reasons for the wide variations in error rate, the relationship 
between methods and results and the relationship between definitions and results. 
I also searched the 153 included studies to identify different interventional tools used 
to minimise errors and to identify their effectiveness; the UK studies to identify 
similarity and differences between these studies and to identify the time and/or day of 
errors. Doing all this analysis meant that I was required to search the relevant papers 
many times and to make sense of a huge amount of information.  
When I started my observational study I faced the challenges of taking consent from 
each individual patient (or carer). This was time consuming and I had to explain to 
each patient/carer the aim of my study and ask for their permission. Moreover, since 
pharmacists need to work very quickly and since I was required to shadow them 
without interrupting, I could not always capture all required information (e.g., 
medications associated with errors). In addition given the lack of a recognised 
classification system, I had to develop a list of interventions and contributions from 
different studies and sources. 
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6.5. 5HFRPPHQGDWLRQVIRUIXWXUHVWXGLHV 
It is important that future studies consider all factors in their study design when 
exploring the rate of medication errors in paediatric patients, especially clear 
denominators, definitions, and appropriate methods of data collection. Doing so 
should make future studies comparable with each other so that lessons can be learned 
from their finding to improve patient safety. 
In my opinion it is better to detect prescribing errors using direct observation of 
clinical pharmacists and administration errors using direct observation of nurses and 
parents. Dispensing, monitoring and transcribing errors are probably better studied 
using a mixed method (e.g. chart review and review of incident reports). I think 
identifying medication errors from only incident reports does not reflect the actual 
error rate. This is because incident reports are associated with many drawbacks such 
as under-reporting.  
Future researchers should give particularly careful consideration to the definitions 
they use to ensure that they will meet the aims of their study, and use established 
definitions when possible in order to facilitate the comparison of different studies 
results. In my opinion the best approach seems to be using a brief definition of each 
type of medication error, along with detailed explanations of subtypes of errors, 
including examples. 
In my opinion it is better to identify interventions used to reduce the error rate and to 
assess their effectiveness rather than just identifying the error rate. Studies should 
measure the rate of errors before and after interventions in order to estimate the 
LQWHUYHQWLRQ¶V HIILFDF\ LQ WHUPV RI HUURU UHGXFWLRQ using an appropriate and robust 
method of data collection. 
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Future research should examine the influence of time of day and days of the week, 
subtypes of medication errors and drugs most associated with medication errors, as 
little is known in these areas. Future studies should also further investigate the 
consequences of medication errors, including harm, prolonged hospitalisation, and 
increased cost of care.  
6.6. /HVVRQVOHDUQHGDQGIXWXUHSODQV 
The systematic reviews of studies of paediatric medication errors and the role of 
paediatric clinical pharmacists provided me with a good picture of the incidence and 
nature of medication errors in paediatric patients and factors influencing the error rate. 
Shadowing pharmacists in Derby and Nottingham provided me with knowledge and 
experience of different clinLFDOSKDUPDFLVWV¶DFWLYLWLHV in the UK. In Saudi Arabia, by 
contrast, clinical pharmacy services are relatively new, especially in paediatric wards. 
In fact, no study has yet identified the effect of paediatric clinical pharmacists on 
reducing the rate of medication errors in Saudi Arabia. 
The experience gained from the work for this thesis will help me to initiate paediatric 
clinical pharmacy services in Saudi Arabia that can hopefully also improve health 
care services and minimise the risk of medication errors in paediatric patients in my 
country. I plan to investigate the error rate in different paediatric wards in Saudi 
Arabia and assess the effectiveness of paediatric clinical pharmacy services there in 
both reducing the error rate and improving the health care services provided. 
6.7. &RQFOXVLRQ 
The heterogeneity of studies reviewed precludes useful comparison of the rate of 
medication errors in different settings or countries. Instead of conducting additional 
studies, purely measuring error rates researchers should perhaps concentrate on 
identifying interventions that will decrease errors. Careful measurement of error rates 
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before and after interventions is essential to assess their efficacy and should be done 
using reproducible and appropriate methods that include clear definitions, a well-
defined patient population, and appropriate denominators. 
This research confirms my hypothesis, since I found that paediatric clinical 
pharmacists do effectively reduce errors, as well as improve paediatric health care 
services. Moreover, this research is the first to directly observe paediatric clinical 
pharmacists, and clarify the different types of their activities performed in paediatric 
wards. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
216 
 
$SSHQGL[ 
 
Section 1: Types of medications studied  
Medication studied  Chart/medical 
record review 
Direct 
observation 
Review of 
medication error 
incident reports 
Mixed 
methods  
Simulation  Total  
All medications 32 3 24 14  73 
Chemotherapy  2 1 2 2  7 
Specific medications on a list 3 1   3 7 
Intravenous medications 2 1   2 5 
Antimicrobials 2 1 1   4 
Resuscitation medications  2    2 4 
Controlled analgesic 2  1   3 
Acetaminophen      3 3 
Parenteral nutrition 1  1   2 
Surgical medications  1  1   2 
All except parenteral nutrition  1   1  2 
Opioids    2   2 
Medications with serious errors    2  2 
Harmful medications    1  1 2 
Epinephrine 1    1 2 
Topical corticosteroids 1     1 
Asthma medications 1     1 
Nephrotic medications 1     1 
Acetaminophen & ibuprofen 1     1 
Sedation 1     1 
Ambulatory medications 1     1 
Iron preparations 1     1 
Antimicrobials & analgesics 1     1 
Aciclovir 1     1 
Insulin 1     1 
Aminoglycosides 1     1 
Intravenous methotrexate   1    1 
All except oral fluids and nutrition   1    1 
Medication with pharmacist intervention     1   1 
22 look-alike sound-alike medications    1   1 
Analgesics    1   1 
Escitalopram    1   1 
Fat emulsion    1   1 
Cough and cold medications    1   1 
Anaesthetics    1   1 
Medications with 10-fold exposure    1   1 
Oseltamivir    1   1 
Post-anaesthesia medications    1   1 
Intravenous acetylcysteine    1   1 
Intralipid medications    1   1 
Medications for patients with attention 
deficit hyperactivity disorder  
  1   1 
Cardiovascular medications    1   1 
Antidepressants    1   1 
Aseptic products    1   1 
Medications for patients with severe injury 
or death 
  1   1 
Medications for patients with fever, 
asthma, head trauma, otalgia and dysuria  
   1  1 
Dipyrone & acetaminophen     1  1 
Naloxone & insulin     1  1 
Total  60 9 50 22 12 153 
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Section 2: Tables of studies identifying the rate of medication errors according to the methodology 
used 
 
1. Studies using chart/medical record review (60 studies) 
Studies identifying prescribing errors (34 studies) 
(112) 
[Kozer et al. 
2006] 
(185) 
[Kim et al. 
2006] 
(154)          
[Al khaja et 
al. 2006] 
(153) 
[Al Khaja et 
al. 2007] 
(155) 
[Al Khaja et 
al. 2007] 
(179)          
[Brown et al. 
2007] 
(188)          
[Vardi et al. 
2007] 
(157) 
[Oshikoya et. 
2007] 
(256)          
[Rinke et al. 
2008] 
(182)           
[Zimmer et al. 
2008] 
(10) 
[Burmester et 
al. 2008] 
(107) 
[Sard et al. 
2008] 
(104) 
[Davey et al. 
2008] 
(193)           
[Cunningham 
et al. 2008] 
(177)          
[Pallas et al. 
2008] 
(101) 
[Jani et al. 
2008] 
(117) 
[Kjeldby et 
al. 2009] 
(114) 
[Diez et al. 2009] 
(68) 
[Lee et al. 
2009] 
(178) 
[Ginzburg et 
al. 2009] 
(165) 
[Di Pentima et 
al. 2009] 
(189) 
[Campino et 
al. 2009] 
(96) 
[Broussard et 
al. 2009] 
(257) 
[Neuner et al. 
2009] 
(156) 
[Al Khaja et 
al. 2010] 
(258)          
[Miller et al. 
2010] 
(181) 
[Hennings et 
al. 2010] 
(57) 
[Condren et al. 
2010] 
(259)          
[Pandey et al. 
2010] 
(260)           
[Kneen et al. 
2010] 
(152)           
[Jani et al. 
2010] 
(187) 
[Neal et al. 
2010] 
(120) 
[Camara et al. 
2011] 
(166)           
[Eisenhut et 
al. 2011] 
      
Studies identifying administration errors (2 studies) 
(170) 
[Kaji et al. 2006] 
(168) 
 [Sullivan et al. 2010] 
      
Studies identifying dispensing errors (one study) 
(42)  
[Costa et al. 2008] 
        
Studies identifying medication errors in general (6 studies) 
(128) 
[Sharek et al. 
2006] 
(261) 
[Dharmar et 
al. 2007] 
(75)            
[Lerner et al. 
2008] 
(14) 
[Shah et al. 
2009] 
(262) 
[Agarwal et 
al, 2010] 
(194) 
[Booth et al. 
2010] 
    
Studies identifying medication monitoring errors (one study)  
(133) [Abboud et al. 2006]      
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Studies identifying different types of errors (16 studies) 
(115) 
[Campino et al. 
2006] 
(164) 
 [Marcin et al. 
2007] 
(109) 
[Holdsworth 
et al. 2007] 
(167)          
[Larose et al. 
2008] 
(131) 
[Campino et 
al. 2008] 
(29) 
[Otero et al. 
2008] 
(132)          
[Takata et al. 
2008] 
(263) 
[Sirithongthavorn 
et al. 2009] 
(27) 
[Walsh et al. 
2009] 
(192)          
[Kalina et al. 
2009] 
(105) 
[Kadmon et al. 
2009] 
(70) 
[Jain et al. 
2009] 
(116) 
[Rivas et al. 
2010] 
(102) 
[Kazemi et al. 
2010] 
(264) 
[Simons et 
al. 2010] 
(130)          
[Kazemi et 
al. 2011] 
    
 
 
 
 
 
2. Studies using direct observation (8 studies) 
Studies identifying prescribing errors (one study) 
(134) 
[Osterholt et al. 2006]   
        
Studies identifying administration errors (7 studies) 
(265) 
[Parshuram et 
al. 2006] 
(174)           
[Taylor et al. 
2008] 
(88)          
[Raja Lope 
et al. 2009] 
(158)    
[Feleke et al. 
2010] 
(67) 
[Chua et al. 
2010] 
(169)          
[Bertsche et 
al. 2010] 
(266)          
[Russell et al. 
2010] 
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3. Studies using review of medication error incident reports (50 studies) 
Studies identifying prescribing errors (6 studies) 
(135) 
[Takata et al. 
2008] 
(4) 
[Engum et 
al. 2008] 
(186) 
[Van De 
Velde et al. 
2009] 
(72) 
[Basco et al. 
2010] 
(180) 
[Senner et al. 
2010] 
(136) 
[Smith et al. 
2011] 
    
Studies identifying administration errors (12 studies) 
(267)           
[Jirapaet et al. 
2006] 
(268) 
[Forrester. 
2007] 
(195) 
[Hicks et al. 
2007] 
(269) 
[Schaefer et 
al. 2008] 
(8)  
[Ferranti et 
al. 2008] 
(270) 
[Llewellyn et 
al. 2009] 
(271) 
[Taylor et al. 
2009] 
(272)           
[Schillie et al. 
2009] 
(7)    
[Crouch et 
al. 2009] 
(273) 
[Forrester. 
2010] 
(274)           
[Sadat-Ali et 
al. 2010] 
(275)         
[Yip et al. 
2011] 
        
Studies identifying medication errors in general (17 studies) 
(138)            
[Burny et al. 
2006] 
(276)        
[Hicks et 
al. 2006] 
(277)        
[Hain et al. 
2007] 
(58)       
[Taylor et al. 
2007] 
(191) 
[Costello et 
al. 2007] 
(40) 
[Payne et al. 
2007] 
(278)             
[Alj et al. 2007] 
(137) 
[Hayes et al. 
2008] 
(36)          
[Kuitunen 
et al. 2008] 
(6) 
[Hicks et al. 
2008] 
(119) 
[Festini et al. 
2008] 
(121) 
[Trotter et 
al. 2009] 
(279)           
[Tzimenatos et 
al. 2009] 
(280) 
[Shah et al. 
2009] 
(281) 
[Snijders et 
al. 2009] 
(282) 
[Skapik et al. 
2009] 
(283) 
[Lillis et al. 
2010] 
   
Studies identifying different types of errors (15 studies) 
(284)           
[Miller et al. 
2006] 
(196) 
[Chuo et al. 
2007] 
(140)     
[Rinke et al. 
2007] 
(63)           
[Ligi et al. 
2008] 
(285) 
[Bundy et al. 
2008] 
(286) 
[Alexander et 
al. 2009] 
(141) 
[Stavroudis et al. 
2010] 
(139) 
[Narula et al. 
2010] 
(76) 
[Miller et 
al. 2010] 
(15)          
[Ligi et al. 
2010] 
(66)  
[Rinke et al. 
2010] 
(287) 
[Bateman et 
al. 2010] 
(288)           
[Morton et al. 
2010] 
(37)  
[Conroy. 
2011] 
(289)          
[Mc Donnell 
et al. 2011] 
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4. Studies using mixed methods (23 studies) 
Studies identifying prescribing errors (2 studies) 
(162) 
[Pote et al. 
2007] 
(163)   
[Porter et al. 
2008] 
        
Studies identifying administration errors (4 studies) 
(47)             
[Van Den Bemt 
et al. 2007] 
(171) 
[Alves et al. 
2007] 
(290)          
[Lemer et al. 
2009] 
(291)          
[Muething et 
al. 2010] 
      
Studies identifying medication errors in general (6 studies) 
(160) 
[Walsh et al. 
2006] 
(159)            
[Walsh et al. 
2008] 
(292)      
[Parihar et al. 
2008] 
(86)           
[Kaushal et 
al. 2008] 
(172)          
[Benkirane 
et al. 2009] 
(90) 
[Morriss et 
al. 2009] 
    
Studies identifying different types of errors (11 studies) 
(93) 
[Lehmann et al. 
2006] 
(173) 
[Taylor et al. 
2006] 
(190)          
[Robinson et 
al. 2006] 
(142) 
[Conroy et al. 
2007] 
(143)          
[Buckley et 
al. 2007] 
(144) 
[Kaushal et 
al. 2007] 
(106) 
[Wang et al. 
2007] 
(161)   
[Landrigan 
et al. 2008] 
(118) 
[Valizadeh 
et al. 2008] 
(145)       
[Kunac et al. 
2008] 
(24) 
[Ghaleb et al. 
2010] 
         
 
5. Studies using simulation studies (12 studies) 
Studies identifying prescribing errors (one study) 
(146)[Vaidya et al. 2006]         
Studies identifying administration errors (11 studies) 
(99)   
[Morgan et al. 
2006] 
(147)            
[Wheeler et al. 
2008] 
(100)     
[Fineberg et 
al. 2008] 
(176)          
[Hohenhaus 
et al. 2008] 
(148) 
[Sobhani et 
al. 2008] 
(183)          
[Feleke et al. 
2009] 
(150)          
[Pauly-
O'Neil. 
2009] 
(184)          
[Yamamoto 
et al. 2010] 
(110)      
[Sowan et al. 
2010] 
(48)   
[Yin et al. 
2010] 
(149)          
[Yin et al. 
2011] 
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$SSHQGL[&RPSDULVRQRIVWXGLHVXVLQJWKHVDPHGHQRPLQDWRUWRLGHQWLI\WKHVDPHW\SH
RIHUURUVEXWXVLQJGLIIHUHQWPHWKRGV 
 
Table 1: Studies identifying prescribing error UDWHVXVLQJFKDUWPHGLFDOUHFRUGUHYLHZDQG³RIDOORUGHUV´DVDGHQRPLQDWRU 
Reference Study Country Setting Age classification Medications 
studied Intervention 
5DWHRISUHVFULELQJHUURUV³RIDOO
RUGHUV´ 
Before intervention After intervention 
(115) Campino et al. 2006 Spain  Neonatal unit  Neonates All  -  35.2% 
(179) Brown et al. 2007 US Neonatal unit Neonates Parenteral 
nutrition   
Computerised 
parenteral nutrition 
worksheet  
14.5% 6.8% 
(131) Campino et al. 2008 Spain  Neonatal unit Neonates All  Physicians and nurses 
were informed that 
prescriptions will be 
reviewed to identify 
prescribing errors (by 
physicians) and 
transcribing errors (by 
nurses) to measure the 
effect of observation. 
32.8% 19.2% 
(177) Pallas et al. 2008 Spain  Neonatal unit Neonates  All  Computerised 
automatic dosage 
calculation 
39.5% 11.9% 
(189) Campino et al. 2009 Spain  Neonatal unit Neonates  All medication 
except parenteral 
nutrition 
 
 
Education about 
medication errors by a 
pharmacist 
20.7% 3% 
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Reference Study Country Setting Age classification Medications 
studied Intervention 
5DWHRISUHVFULELQJHUURUV³RIDOO
RUGHUV´ 
Before intervention After intervention 
(112) Kozer et al. 2006 Canada  Emergency department  Not mentioned All  Education of doctors 
by one author (30 
minutes tutorial 
followed by test) 
12.4% by trainees who attended 
tutorial  
12.7% by trainees who did not attend 
tutorial 
 
(256) Rinke et al. 2008 US Emergency department  Not mentioned All  - 12.5% from in-house 
4.3% from ambulatory  
(167) Larose et al. 2008 Canada  Emergency department  Not mentioned Intravenous 
medications and 
fluids 
Pre-printed order form 9% 2% 
(107) Sard et al. 2008 US Emergency department  Neonates+ infants+ 
children+ 
adolescent 
All  CPOE 31% 14% 
(114) Diez et al. 2009 Spain  Emergency department  Not mentioned All  - 43% 
(96) Broussard et al. 
2009 
US Specialist children 
hospital 
Neonates+ infants+ 
children+ 
adolescent  
Sedation 
medication  
Pre-printed order from  25% 9% 
(68) Lee et al. 2009 US Specialist children 
hospital  
Neonates+ infants+ 
children+ 
adolescent 
Controlled 
substances (e.g. 
opiates) 
- 82% 
(152) Jani et al. 2010 UK Specialist children 
hospital 
 
Not mentioned All  CPOE 2.2% 1.2% 
(120) Camara et al. 2011 Senegal   Specialist children 
hospital 
- All  - 17% 
(154) Al Khaja et al. 2006 Bahrain  Primary care Infants Antimicrobials  - 22% subtherapeutic doses 
5.2% supratherapeutic doses  
(155) Al Khaja et al. 2007 Bahrain  Primary care Infants Topical 
corticosteroid 
- 21.6% omission errors related to 
dosing frequency 
43.6% omission errors related to length 
of therapy  
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Reference Study Country Setting Age classification Medications 
studied Intervention 
5DWHRISUHVFULELQJHUURUV³RIDOO
RUGHUV´ 
Before intervention After intervention 
(153) Al Khaja et al. 2007 Bahrain  Primary care Infants  All  - 90.5% (omission, commission and 
integration errors)  
(156) Al Khaja et al. 2010 Bahrain  Primary care Infants  Iron preparations - 9.4% unclear or incomplete names of 
iron preparations 
2.5% no daily dosages  
26.4% no dosage form 
8.8% no duration of therapy 
6.9% unavailable trade names 
(104) Davey et al. 2008 UK Paediatric unit in 
general hospital 
Not mentioned All  Education of doctors 
by a pharmacist (about 
good prescribing)  
30.5% before first 
intervention  
16.5% after 
first 
intervention  
Bedside prescribing 
guidelines  
18.4% before second 
intervention  
17% after 
second 
intervention  
(117) Kjeldby et al. 2009 Norway  Paediatric unit in 
general hospital 
Infant+ children+ 
adolescent  
All  Clinical pharmacist  No rate measured  26.8% 
(188) Vardi et al. 2007 Israel  Intensive care unit Not mentioned Resuscitation 
medications 
CPOE+CDSS 0.02% 0% 
(187) Neal et al. 2010 UK Intensive care unit Not mentioned All  CPOE 8.8% 8.1% after one 
week 
4.6% after 6 
months 
(157) Oshikoya et al. 
2007 
Nigeria  Outpatients  Preterm baby+ 
neonates+ infants+ 
children 
All  -  62.2% 
(57) Condren et al. 2010 US Outpatients Not mentioned 
 
 
 
 
 
All  -  9.7% 
224 
 
Reference Study Country Setting Age classification Medications 
studied Intervention 
5DWHRISUHVFULELQJHUURUV³RIDOO
RUGHUV´ 
Before intervention After intervention 
(185) Kim et al. 2006 US Paediatric oncology Not mentioned Chemotherapy  CPOE 5.8% calculation 
errors 
0.54% 
calculation 
errors 
2.3% improper 
dosing 
0.06% 
improper 
dosing 
18% missing 
cumulative dose 
5.7% missing 
cumulative 
dose 
4.8% incomplete 
nursing checklist 
2.5% 
incomplete 
nursing 
checklist  
 
 
 
(29) Otero et al. 2008 Argentina  Neonatal and paediatric 
unit 
Neonates+ infants+ 
children+ 
adolescent  
All  Education of all 
healthcare 
professionals (by the 
Patient Safety 
Committee) about the 
patient safety+ safety 
strategy 
 
 
17.3% 9.2% 
(116) Rivas et al. 2010 Chile  Paediatric unit in 
general hospital+ 
neonatal unit 
+intensive care unit+ 
paediatric surgical 
service 
Not mentioned Intravenous 
prescriptions 
- 21% 
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Table 2: Studies LGHQWLI\LQJSUHVFULELQJHUURUUDWHVXVLQJPL[HGPHWKRGVDQG³RIDOORUGHUV´DVDGHQRPLQDWRU 
 
R
ef
er
en
ce
 Study Country Setting Methods  Age 
classification 
Intervention  Medications 
studied   
Type of 
errors  
5DWHRISUHVFULELQJHUURUV³RI
DOORUGHUV´ 
Rate before 
intervention 
 
Rate after 
intervention 
(93) Lehmann 
et al. 2006     
US Specialist 
children's 
hospital 
Chart review  Not 
mentioned 
 
Calculator generated 
orders 
Continuous 
infusion 
medication 
MPEs 27% of all 
handwritten 
orders  
6% of all 
calculator 
generated 
orders       
Direct observation of all 
pharmacy preparation and 
dispensing 
-  MDEs 0% of all orders  
(161)    
 
Landrigan 
et al. 2008     
US Specialist 
children's 
hospital 
Chart review & review of 
medication error incident reports  
Not 
mentioned 
 
Accreditation 
Council for Graduate 
Medical Education 
(ACGME) (doctor is 
not working for more 
than 30 continuous 
hours or more than 88 
hours weekly).   
All MPEs 1.06% of all  
orders 
1.38% of all 
orders 
MEs 1.29% of all 
orders 
1.5% of all  
orders 
(145)  
 
 
Kunac et 
al. 2008        
New 
Zealand  
Paediatric 
unit in 
general 
hospital 
Chart review & review of 
medication error incident reports  
Neonates+ 
infants+ 
children+ 
adolescent 
 
 
 
 
 
 
 
 
 
-  All  MPEs 7.1% 
MDEs 1.1% 
MAEs 5.2%  
MMEs 1.7% 
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(24)  
 
Ghaleb et 
al. 2010       
UK Specialist 
children's 
hospital 
and 
paediatric 
units in 
general 
hospital 
Chart review Not 
mentioned 
 
-  All except 
parenteral and 
enteral 
nutrition  
MPEs 13.2% of all orders 
Direct observation of 
preparations and administrations 
made by nurses  
MAEs 19.1% of all possible errors 
Review of medication error 
incident reporting. 
MPEs & 
MAEs 
None  
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7DEOH6WXGLHVLGHQWLI\LQJSUHVFULELQJHUURUUDWHVXVLQJFKDUWPHGLFDOUHFRUGUHYLHZDQG³RIDOOHUURUV´DVDGHQRPLQDWRU 
Reference  Study Country Setting Age 
classification 
Intervention  Medications 
studied   
5DWHRISUHVFULELQJHUURUV³RIDOO
HUURUV´ 
Other errors identified  
Rate before 
intervention 
 
Rate after 
intervention 
(164) Marcin et al. 
2007 
US Emergency 
department  
Neonates+ 
infants+ 
children+ 
adolescent  
- All  28.6% Not specified  
(132) Takata et al. 
2008 
US Specialist 
FKLOGUHQ¶V
hospital 
Not 
mentioned  
-  All  50% MAEs, MDEs, MTEs 
& MMEs 
(105) Kadmon et al. 
2009 
Israel  Intensive 
care unit 
Not 
mentioned  
CPOE All  5.5% 5.3% Not specified  
CDSS 5.3% 3.8% 
Preventing 
nurses from 
signing orders 
instead of 
doctors 
3.8% 0.7% 
(70) Jain et al. 2009 India  Neonatal 
intensive 
care unit+ 
emergency 
department 
Neonates  -  All  70% of all errors in the emergency 
department were prescribing errors 
by senior doctors & 9% by junior 
doctors  
MDEs 
89% in neonatal intensive care unit 
were prescribing errors by senior 
doctors 
(27) Walsh et al. 
2009 
US Outpatient Not 
mentioned  
-  Chemotherapy  64% MAEs, MDEs & 
MMEs 
(263) Sirithongthavorn 
et al. 2009 
Thailand  Paediatric 
psychiatry 
care 
Not 
mentioned  
-  All  37.8% MDEs & MTEs 
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Table 4: 6WXGLHVLGHQWLI\LQJSUHVFULELQJHUURUUDWHVXVLQJUHYLHZRIPHGLFDWLRQHUURULQFLGHQWUHSRUWVDQG³RIDOOHUURUV´DVDGHQRPLnator 
Reference  Study Country Settings  Age classification Medications 
studied  
Intervention  Rate of prescribing errors of 
all erURUV´ 
Other errors 
identified  
Rate before 
intervention 
 
Rate after 
intervention 
(196) Chuo et al. 2007            US Neonatal unit   Neonates 
 
Intralipid  - 1.1% MAEs 
(15) Ligi et al. 2010              France   Neonatal unit Neonates 
 
All  Safety initiatives 
and iatrogenic 
events prevention 
strategies 
10.5%  24.4%  Not 
specified  
(140) Rinke et al. 2007           US Paediatric oncology 
and national incident 
reporting system  
All ages 
 
Chemotherapy  - 10.3% MAEs, 
MDEs, 
MTEs & 
MMEs 
(141) Stavroudis et al. 2010    US Neonatal unit and 
national incident 
reporting system 
Neonates 
 
All  -  13.9% MTEs, 
MDEs, 
MAEs & 
MMEs 
(139) Narula et al. 2010  UK Paediatric 
gastroenterology and 
nutrition ward 
Not mentioned 
 
Parenteral 
nutrition  
- 11% MTEs, 
MDEs, 
MAEs & 
others 
(76) Miller et al. 2010           US Specialist children's 
hospital  
Not mentioned 
 
All  - 12.8% MTEs, 
MDEs & 
MAEs 
(66) Rinke et al. 2010       US National incident 
reporting system 
All ages 
 
Antidepressants  - 7.8%  MAEs, 
MTEs, 
MMEs & 
MDEs  
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7DEOH6WXGLHVLGHQWLI\LQJSUHVFULELQJHUURUUDWHVXVLQJFKDUWPHGLFDOUHFRUGUHYLHZDQG³RIDOOSDWLHQWV´DVDGHQRPLQDWRU.   
 
Reference  Study Country Setting Age 
classification 
Intervention  Medications 
studied   
Rate of prescribing errors 
³RIDOOSDWLHQWV´ 
Rate before 
intervention 
 
Rate after 
intervention 
(164) Marcin et 
al. 2007 
US Emergency 
department 
Neonates+ 
infants+ 
children+ 
adolescent 
-  All  11.9% 
(10) Burmester 
et al. 2008 
UK Intensive 
care unit 
Not 
mentioned  
Pre-printed 
order form+ 
education 
for doctors 
Resuscitation 
medications  
16.8% 4.8% 
(260) Kneen et 
al. 2010 
UK Specialist 
FKLOGUHQ¶V
hospital l 
Neonates+ 
infants+ 
children+ 
adolescent 
-  Intravenous 
aciclovir 
74% (38 out of 51 patients, 
in 20 needed re-calculation 
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7DEOH6WXGLHVLGHQWLI\LQJDGPLQLVWUDWLRQHUURUUDWHVXVLQJGLUHFWREVHUYDWLRQDQG³RIDOODGPLQLVWUDWLRQV´DVDGHQRPLQDWRr.   
Reference  Study Country Setting Age 
classification 
Intervention Medications 
studied   
5DWHRIDGPLQLVWUDWLRQHUURUV³RIDOODGPLQLVWUDWLRQV´ Notes  
Rate before intervention 
 
Rate after intervention 
(265) Parshuram 
et al. 2006 
Canada  Paediatric 
oncology  
All  -  Methotrexate 23% Administrations by 
nurses 
(174) Taylor et 
al. 2008 
US Neonatal 
unit 
Neonates  CPOE All except 
fluids and 
nutrition 
19.8% 11.6% Administrations by 
nurses  
(88) Raja lope 
et al. 2009 
Malaysia  Neonatal 
unit 
Neonates  Education 
for nurses  
All  31% 15.4% Administrations by 
nurses  
(142) Conroy et 
al. 2007 
UK Paediatric 
unit in a 
general 
hospital 
Not 
mentioned  
- All  1.2% Administrations by 
nurses 
(158) Feleke et 
al. 2010 
Ethiopia  Paediatric 
unit in 
general 
hospital  
Neonates+ 
infants+ 
children+ 
adolescent 
- All  89.9% Administrations by 
nurses and parents 
(67) Chua et al. 
2010 
Malaysia  Paediatric 
unit in 
general 
hospital  
All  -  All  11.7% Administrations by 
doctors and nurses 
(169) Bertsche et 
al. 2010  
Germany  Paediatric 
neurology 
unit  
Not 
mentioned  
Education 
for nurses 
and parents   
All  40.4% 
 
7.9% 
 
By nurses  
 
96.6% 5.6% By parents 
(266) Russell et 
al. 2010 
US Intensive 
care unit 
Neonates+ 
infants+ 
children+ 
adolescent 
- Infusion 
medications 
and fluids  
24% of all medication infusions Administrations by 
nurses  
42% of all fluid infusions 
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7DEOH6WXGLHVLGHQWLI\LQJDGPLQLVWUDWLRQHUURUUDWHVXVLQJUHYLHZRIPHGLFDWLRQHUURULQFLGHQWUHSRUWVDQG³RIDOOHUURUV´ as a denominator.  
Reference  Study Country Setting Age 
classification 
Medications studied   Rate of administration errors 
³RIDOOHUURUV´ 
Other errors identified  
(140) Rinke et 
al. 2007 
US Paediatric 
oncology and 
national incident 
reporting system 
All  Chemotherapy  48.1% MPEs, MDEs, MTEs & 
MMEs 
(196) Chuo et 
al. 2007 
US Neonatal unit Neonates  Intralipid  93.2% MPEs 
(63) Ligi et al. 
2008 
France  Neonatal unit Neonates  All  63% Not specified  
(141) Stavroudis 
et al. 2010 
US Neonatal unit 
and national 
incident 
reporting system 
Neonates  All  48.2% MPEs, MDEs, MTEs & 
MMEs 
(76) Miller et 
al. 2010 
US Specialist 
FKLOGUHQ¶V
hospital  
Not 
mentioned  
All  56.4% MPEs, MDEs & MTEs  
(66) Rinke et 
al. 2010 
US National 
incident 
reporting system 
All  Antidepressants  33% MPEs, MDEs, MTEs & 
MMEs 
(139) Narula et 
al. 2010 
UK Paediatric 
gastroenterology 
and nutrition 
ward 
Not 
mentioned  
Parenteral nutrition 
 
30% MPEs, MDEs & MTEs  
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Table 8: Studies identifying administration error rates using chart/medical record 
review and ³RIDOOHUURUV´ as a denominator.   
R
ef
er
en
ce
 
 Study 
Co
u
n
tr
y Setting Age 
classification 
Medications 
studied   
Rate of administration errors 
³RIDOOHUURUV´ 
Other 
errors  
Rate before 
intervention 
 
Rate after 
intervention 
(132) Takata et 
al. 2008 
US Specialist 
FKLOGUHQ¶V
hospital 
Not mentioned  All  0% MPEs, 
MMEs, 
MDEs & 
MTEs 
(27) Walsh et 
al. 2009 
US Outpatients Not mentioned Chemotherapy  5% MPEs, 
MMEs & 
MDEs 
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Table 9: Studies identifying medication error rates in general using chart/medical record review and ³RIDOORUGHUV´ as a denominator.   
Reference  Study Country Setting Age 
classification 
Intervention Medications 
studied   
Rate of medication errors in general 
³RIDOORUGHUV´ 
Rate before 
intervention 
 
Rate after 
intervention 
(263) Sirithongthavorn 
et al. 2009 
Thailand Paediatric 
psychiatry 
care 
Not 
mentioned 
- All  2.42% 
(105) Kadmon et al. 
2009 
Israel Intensive 
care unit 
Not 
mentioned 
CPOE All  8.2% 7.8% 
CDSS 7.8% 4.4% 
Preventing 
nurses from 
signing orders 
instead of 
doctors 
4.4% 1.4% 
(70) Jain et al. 2009 India  Neonatal 
intensive 
care unit+ 
emergency 
department 
Neonates  -  All  9.6% 
(102) Kazemi et al. 
2010 
Iran  Neonatal 
unit 
Neonates  CPOE All  22.7% in physician order entry 
14.5% in nurse order entry 
(264) Simons et al. 
2010 
UK Specialist 
FKLOGUHQ¶V
hospital & 
paediatric 
unit in a 
general 
hospital 
Infants+ 
children+ 
adolescents 
- All  LQVSHFLDOLVWFKLOGUHQ¶VKRVSLWDO 
23% in paediatric unit in general 
hospital 
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Table 10: Studies identifying medication error rates in general using chart/medical 
record review and ³RIDOOSDWLHQWV´ as a denominator.   
R
ef
er
en
ce
 
 Study Country Setting Age 
classification 
Medications 
studied   
Rate of medication errors in 
JHQHUDO³RIDOOSDWLHQWV´ 
Rate before 
intervention 
 
Rate after 
intervention 
(261) Dharmer 
et al. 2007 
US Emergency 
department 
Neonates+ 
infants+ 
children+ 
adolescent 
All  26.4% 
(164) Marcin et 
al. 2007 
US Emergency 
department  
Neonates+ 
infants_ 
children+ 
adolescent 
All  39% 
(75) Lerner et 
al. 2008 
Brazil Neonatal 
unit 
Neonates All  55% 
 
 
Table 11: Studies identifying medication error rates in general using review of 
medication error incident reports and ³RIDOOSDWLHQWV´ as a denominator.   
R
ef
er
en
ce
 
 Study Country Setting Age 
classification 
Intervention Medications 
studied   
Rate of medication errors in 
JHQHUDO³RIDOOSDWLHQWV´ 
Rate before 
intervention 
 
Rate after 
intervention 
(137) Hayes 
et al. 
2008 
US Poison 
control 
centre 
All ages - IV 
acetylcysteine 
34.3% 
(15) Ligi et 
al. 
2010 
France  Neonatal 
unit 
Neonates Safety 
initiatives 
and 
iatrogenic 
events 
prevention 
strategies. 
All  4.9% 7% 
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Table 12: Studies identifying medication error rates in general using mixed methods and ³SHUSDWLHQWGD\V´ as a denominator.   
Reference  Study Country Methods  Setting Intervention  Age 
classification 
Medications 
studied   
5DWHRIPHGLFDWLRQHUURUVLQJHQHUDO³SHU
SDWLHQWGD\V´ 
Rate before intervention 
 
Rate after 
intervention 
(160) Walsh et al. 
2006  
US Chart review and 
review of incident 
reports                      
Paediatric unit in 
general hospital 
-  Not 
mentioned 
All  53.9  
(145) Kunac et al. 
2008 
New 
Zealand 
Chart review and 
review of incident 
reports 
Paediatric unit in a 
general hospital  
-  Neonates+ 
infants+ 
children+ 
adolescent 
All  121 
(106) Wang et al. 
2007  
US Chart review and 
review of incident 
reports 
Neonatal and 
paediatric unit in a 
general hospital 
-  Not 
mentioned 
All  167  
(159) Walsh et al. 
2008  
US Chart review and 
review of incident 
reports                      
Neonatal and 
paediatric units in 
general hospital 
CPOE Not 
mentioned 
All 7.9 (serious errors) 6.5 (serious errors)   
(86)             Kaushal et al. 
2008  
US Chart review and 
review of incident 
reports                      
Specialist children's 
hospital 
Clinical 
SKDUPDFLVWV¶
services 
 All 29 (serious errors) in 
ICUs                             
6 (serious errors) in 
ICUs             
8 (serious errors) in 
general medical unit     
9 (serious errors) in 
general medical unit      
7 (serious errors) in 
general surgical unit 
9 (serious errors) in 
general surgical unit 
(172)           
 
Benkirane et al. 
2009 
Morocco Direct observation 
of ordering and 
transcribing and 
review of incident 
reports 
Intensive care unit 
and neonatal unit  
-  Not 
mentioned 
All  9.1 in an intensive care unit 
 
4 in a neonatal unit 
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Table 13: Studies identifying transcribing errors rates using review of incident reports and ³RIDOOHUURUV´ as a denominator 
Reference  Study Country Setting Age 
classification 
Medications 
studied   
5DWHRIWUDQVFULELQJHUURUV³RIDOO
HUURUV´ 
Other errors identified  
Rate before 
intervention 
 
Rate after 
intervention 
(140) Rinke et al. 
2007 
US Paediatric 
oncology and 
national incident 
reporting system 
All ages Chemotherapy  7.1% MAEs, MDEs, MPEs 
& MMEs 
(141) Stavroudis et al. 
2010 
US Neonatal unit 
and national 
incident 
reporting system  
Neonates  All  18.4% MPEs, MDEs, MAEs 
& MMEs 
(139) Narula et al. 
2010 
UK Paediatric 
gastroenterology 
and nutrition 
ward 
Not 
mentioned  
Parenteral 
nutrition  
20% MPEs, MDEs, MAEs 
& other 
(76) Miller et al. 
2010 
US Specialist 
FKLOGUHQ¶V
hospital 
Not 
mentioned 
All  24.2% MPEs, MDEs & 
MAEs  
(66) Rinke et al. 
2010 
US National 
incident 
reporting system 
All ages Antidepressants  28% MAEs, MDEs, MPEs 
& MMEs 
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Table 14: Studies identifying monitoring errors rates using review of incident reports 
and ³RIDOOHUURUV´ as a denominator 
Reference  Study Country Setting Age 
classification 
Medications 
studied   
Rate of monitoring errors 
³RIDOO HUURUV´ 
Other 
errors 
identified  Rate before 
intervention 
 
Rate after 
intervention 
(140) Rinke et 
al. 2007 
US Paediatric 
oncology 
and 
national 
incident 
reporting 
system 
All ages Chemotherapy  0.6% MAEs, 
MDEs, 
MPEs & 
MTEs 
(141) Stavroudis 
et al. 2010 
US Neonatal 
unit and 
national 
incident 
reporting 
system  
Neonates  All  1.4% MPEs, 
MDEs, 
MAEs & 
MTEs 
(66) 
 
Rinke et 
al. 2010 
US National 
incident 
reporting 
system 
All ages Antidepressants  0.7% MAEs, 
MDEs, 
MPEs & 
MTEs 
 
 
Table 15: Studies identifying monitoring errors rates using chart/medical record 
review and ³RIDOOHUURUV´ as a denominator 
Reference  Study Country Setting Age 
classification 
Medications 
studied   
Rate of monitoring errors 
³RIDOOHUURUV´ 
Other 
errors 
identified  Rate before 
intervention 
 
Rate after 
intervention 
(132) Takata 
et al. 
2008 
US Specialist 
FKLOGUHQ¶V
hospital 
Not 
mentioned  
All  62.5% MAEs, 
MDEs, 
MPEs & 
MTEs 
(27) Walsh 
et al. 
2009 
US Outpatients Not 
mentioned 
Chemotherapy  5% MAEs, 
MDEs & 
MPEs  
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7DEOH6WXGLHVLGHQWLI\LQJGLVSHQVLQJHUURUUDWHVXVLQJUHYLHZRILQFLGHQWUHSRUWVDQG³RIDOOHUURUV´DVDGHQRPLQDWRU 
Reference  Study Country Setting Age 
classification 
Medications 
studied   
Rate of GLVSHQVLQJHUURUV³RIDOO
HUURUV´ 
Other errors 
identified  
Rate before 
intervention 
 
Rate after 
intervention 
(140) Rinke et al. 
2007 
US Paediatric 
oncology and 
national incident 
reporting system 
All ages Chemotherapy  30.3% MAEs, MTEs, 
MPEs & MMEs 
(139) Narula et al. 
2010 
UK Paediatric 
gastroenterology 
and nutrition 
ward 
Not 
mentioned  
Parenteral 
nutrition  
20% MPEs, MTEs, 
MAEs & other 
(76) Miller et al. 
2010 
US Specialist 
FKLOGUHQ¶V
hospital 
Not 
mentioned 
All  35.7% MPEs, MTEs & 
MAEs  
(141) Stavroudis et al. 
2010 
US Neonatal unit 
and national 
incident 
reporting system  
Neonates  All  11.8% MPEs, MTEs, 
MAEs & MMEs 
(66) Rinke et al. 
2010 
US National 
incident 
reporting system 
All ages Antidepressants  30% MAEs, MTEs, 
MPEs & MMEs 
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Table 17: Studies identifying dispensing error rates using chart/medical record review 
DQG³RIDOOHUURUV´DVDdenominator 
R
ef
er
en
ce
 
 
Study Country Setting Age 
classification 
Medications 
studied   
5DWHRIGLVSHQVLQJHUURUV³RI
DOOHUURUV´ 
Other 
errors 
identified  Rate before 
intervention 
 
Rate after 
intervention 
(132) Takata et al. 
2008 
US Specialist 
FKLOGUHQ¶V
hospital 
Not 
mentioned  
All  9% MAEs, 
MMEs, 
MPEs & 
MTEs 
(70) Jain et al. 
2009 
India  Neonatal 
unit and 
emergency 
department 
Neonates  All  21% in emergency 
department 
MPEs 
11% in neonatal unit 
(263) Sirithongtha
vorn et al. 
2009 
Thailand  Paediatric 
psychiatry 
care 
Not 
mentioned  
All  9.4% MPEs & 
MTEs 
(27) Walsh et al. 
2009 
US Outpatients Not 
mentioned 
Chemotherapy  0% MAEs, 
MTEs & 
MPEs  
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$SSHQGL[ 
 Figure 1: Consent form 
 
 
 
 
I give permission for Ahmed Alsenani, PhD student to record the hospital 
SKDUPDFLVW¶V ZRUN LQ UHODWLRQ WR P\ FKLOG , XQGHUVWDQG WKDW WKLV PD\ LQYROYH KLP
having VLJKW RI P\ FKLOG¶V WUHDWPHQW FKDUW DQG QRWHV , XQGHUVWDQG WKDW QR SHUVRQDO
information regarding my child will be documented and that this will not affect my 
FKLOG¶VFDUHLQDQ\ZD\ 
 
                              +RVSLWDOQDPH««««««« 
:DUGQDPH«««««««                     'DWH«««««« 
Bed number Patient initials Parent signature 
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